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  Electron transfer initiated cyclization reactions were successfully applied to the construction 
of carbon-carbon bonds after tuning the chemoselectivity and reactivity of the substrates. Olefins 
and allenes with several different electron-donating groups served as good nucleophiles in 
cyclization reactions to generate various carbocycles. Cascade cyclizations involving C-C bond 
formation also proved to be successful. In most cases, cyclizations gave good to excellent yields 
with short reaction times.  
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  A general protocol has been developed for synthesizing lactones from allylic and homoallylic 
alcohols using ruthenium-catalyzed hydroesterifications. The lactone synthesis only requires 1-2 
steps and can be conducted in one pot. The experimental procedure is simple and the efficiency 
is considerably improved compared to that of multi-step sequences. Mechanistic studies with 
deuterium labeling showed that the competition between hydrometalation, β-hydride elimination, 
and reductive elimination determines the efficiency and regioselectivity of the 
hydroesterification reactions.  
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 Two major fragments of integramycin have been synthesized. The synthesis of the C16-C35 
spiroketal unit of integramycin was accomplished in a convergent and stereoselective manner. 
The sequence includes the usage of a highly efficient ruthenium-mediated hydroesterification 
reaction. This sequence also demonstrates the efficiency of C,O-dianioic additions into lactones 
as a method for producing spiroketals in a single operation without recourse to extensive 
protecting group manipulations. The synthesis of the cis-decalin unit of integramycin was 
achieved using a cycloaddition and an allylic rearrangement as key steps. The dienyne substrate 
of the cycloaddition was synthesized enantioselectively in 36% yield over 9 steps. The 
conditions of the cycloaddition using [(naph)Rh(cod)]SbF6 were optimized and the 
diastereoselectivity of the cycloaddition was found to be temperature and solvent dependant. 
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Chapter 1. Carbon-carbon bond construction using electron transfer initiated 
cyclization reactions 
 
 
1.1 Introduction 
       Single electron transfer (SET) has attracted increasing attention in the past two decades in 
search for new synthetic methods as many important reactions have been found to proceed 
through SET mechanisms.1 The extensive investigation has led to numerous publications and 
applications. Examples include Burch reduction,2 Ullmann coupling,3 preparation of alkyllithium 
from alkyliodides4,5 or phenyl thioethers,6 photosensitized isomerizations and rearrangements.7 
    Radical ions, generated from single electron reduction or oxidation of neutral molecules, are 
capable of undergoing a variety of reactions.8,9 The reaction conditions are usually mild, non-
acidic, and tolerant of many functional groups. For example, properly designed radical cations 
can undergo mesolytic cleavage of generally inert bonds, forming radical fragments and cationic 
fragments. The cationic fragments can serve as good electrophiles that otherwise require acidic 
conditions for their generation.  
    Not confined to chemistry, the electron transfer process also plays a key role in many other 
science and technology fields, such as in semiconductor photocatalysis, xerography, photography 
and others.7 In biological systems, many transformations proceed in SET mechanisms, such as 
oxidative phosphorylation, DNA-photolyase reaction,7 and the important photosynthesis that 
provides the major energy source to creatures on the earth.   
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1.1.1 Radical ions 
    In an SET process, one-electron reduction or oxidation of a neutral substrate generates a 
radical anion or radical cation.  A simple illustration of the molecular orbital change is shown in 
Figure 1.1.10  
 
LUMO
HOMO
LUMO
SOMO
-e-
SOMO
HOMO
RHRH
+e-
RH
 
Figure 1.1. The formation of radical ions by SET processes. 
 
    In the following a few paragraphs, the generation and some typical reactions of radical ions 
will be discussed. 
 
1.1.2 Formation of radical ions 
1.1.2.1 Photoinduced electron transfer 
    Photoinduced electron transfer can be considered as a process where light energy is absorbed 
and transformed into chemical energy.7 In most cases, target molecules do not have the ability to 
absorb or transform photoenergy; therefore the presence of a photosensitizer is necessary to relay 
the energy from light. Upon photoexcitation, a photosensitizer induces a chemical change to its 
neighboring molecule by single electron transfer mechanism. In case 1a) of Scheme 1.1, a 
photosensitizer serves as an electronically excited acceptor (A) to oxidize the donor (D) into a 
 2
radical cation. In the case of 1b) a photosensitizer serves as an electron donor (D) to reduce A 
into a radical anion.7,10 
      D  +  A     hv    D  +  A*           D   +   A                  eq 1a
   D  +  A     hv    D*  +  A           D   +   A                  eq 1b 
Scheme 1.1. Photoinduced electron transfer.  
 
    Because of the large amount of energy provided by photons (~360 KJ/mol for UV light), 
photoinduced electron transfer is a great way to generate radical ions that may be difficult to 
achieve by other routes. However, the selectivity of the reactions under photochemical 
conditions might be poor and photosensitive functional groups could be destroyed. 
 
1.1.2.2 Chemical oxidation 
    Generating radical cations by ground state oxidation of neutral molecules is also commonly 
employed. It is operationally simpler than photooxidation and does not need special apparatus. 
However, this method might not oxidize substrates with high oxidation potentials. The scenario 
is described in equation 2 of Scheme 1.2:   
 
 D  +  A            D   +   A
D D A++   A
D+ A-
eq 2
eq 3
 
Scheme 1.2. ET under ground state oxidation conditions.  
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    Although equation 2 is a simple representation of ET, the process could be more complicated. 
The encounter between donors and acceptors can lead to outer-sphere electron transfer to form 
A•¯ and D•+, or lead to a polar association with bond formation to generate D+―A¯, which can 
then undergo inner-sphere dissociation to form A•¯ and D•+. The recombination between A•¯ and 
D•+ is also possible (equation 3 of Scheme 1.2).9 
    A list of commonly used chemical oxidants is discussed below.  
 
Ce(IV) 
    Ceric ammonium nitrate (CAN) is one of the most commonly used chemical oxidants. It is 
stable and commercially available at a low price. It is soluble in water and polar organic solvents 
such as alcohols, acetone, and acetonitrile. In less polar solvents such as 1,2-dichloroethane 
(DCE) or dichloromethane it is insoluble, but when using [Bu4N][HSO4] as a phase-transfer 
catalyst reactions can be carried out in CHCl3.11 Alternatively, ceric bis(tetra-n-butylammonium) 
nitrate (CTAN), another source of Ce(IV) which is soluble in less polar solvents such as CH2Cl2, 
can be easily made and applied in reactions.12 
    The oxidation potential of Ce(IV) varies depending on the counterions and solvents. For 
example, Ce(IV) has an oxidation potential Eo′ of 0.88 V (vs. Fc) in water, while in HClO4, the 
value is 1.30 V (vs. Fc).13 Ce(IV) can react through either inner sphere (coordination followed by 
electron transfer) or outer sphere (electron transfer without prior coordination) mechanisms.  
 
 Ag(I) 
    Silver(I) salts are also excellent one-electron oxidants and are widely used, although they are 
more expensive than cerium salts. Silver(I) salts are soluble in different types of organic solvents 
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such as CH2Cl2, acetone, THF, MeCN, alcohols and toluene. An advantage of silver(I) salts is 
that their oxidation strength is adjustable according to the solvents and counterions. For example, 
AgPF6 in acetone has an Eo′ of 0.18 V (vs. Fc), while in CH2Cl2, the Eo′ value is ca. 0.65 V (vs. 
Fc).13 
    In addition to oxidation, the silver(I) ion may abstract halide or bind to the oxygen or sulfur in 
the presence of these atoms in a reaction.13 Also, silver(I) salts are usually hygroscopic and 
photosensitive, therefore their handling might need extra caution. As a consequence, silver salts 
may not be applicable in reactions involving complex molecules.  
 
Fe(III) 
    Mainly, two iron(III) complexes are widely used: ferrocenium ion, [FeCp2]+ and 
phenanthrolineiron(III), [Fe(phen)3]3+.  
Fe
+
                
N
N
Fe
3
3+
 
[FeCp2]+                     [Fe(phen)3]3+ 
 
    Adjusting the ring substitution pattern can alter the oxidation potential of the ferrocenium ion. 
The Eo′ values of ferrocenium ions vary from –0.63 V (for [Fe(η-C5H4NMe2)2, vs. Fc]14 to 0.64 V 
(for [Fe(η-C5H4CF3)2], vs. Fc).15 The oxidation potential of the parent ferrocene/ferrocenium ion 
(Fc) is found to be almost constant in various solvents, making it desirable as a standard 
electrode to replace standard calomel electrode (SCE).16  
 5
    Phenanthrolineiron(III) is also a mild one-electron oxidant with oxidation potentials that are 
adjustable by tuning the ligand substituents. For example, depending on the substituent X, the 
trications [Fe(phenX2-4,7)3]3+ give oxidation potentials from 0.6 V (vs. Fc, X = H) to –0.26 V 
[vs. Fc, X = NH(CH2)3NH2].13 Fe(III) oxidants are cheap and readily accessible, but they usually 
have high molecular weights because of the number of ligands they bear. Thus, the mass amount 
of Fe(III) salts to be used in reactions can be large. 
There are many other one-electron oxidants such as 2,3-dichloro-5,6-dicyanoquinone (DDQ, 
Eo′  = 0.13 V vs. Fc in MeOH)13, which is also commonly used. 
 
1.1.2.3 Anodic oxidation 
    Generating radical cations through single electron transfer between an electrode and a 
substrate in solution is also well precedented.17-19 The electrode potential can be controlled to the 
desired value according to the desired transformation, hence, this is a good method that provides 
chemo- and regioselectivities.8 Also, the neutral reaction conditions allow a wide range of 
functional groups.19 Moreover, anodic oxidation has been called an environmentally benign 
method since no chemical oxidants are used, as noted by Connelly who states: “Electrodes are 
among the most benign reagents in synthetic applications”.13 Polar solvents such as methanol, 
THF, CH2Cl2, and acetonitrile are often used under anodic conditions. The presence of 
electrolytes such as lithium perchlorate, tetraethylammonium tosylate, and tetrabutylammonium 
tetrafluoroborate is also necessary to increase the conductivity of the solution and to provide 
counterions of the intermediates around the electrodes.19 
 
1.1.3 Reaction pathways of radical cations 
    Radical cations are highly reactive and can undergo several types of reactions depending on 
the property of the substrate and the reaction conditions. The main transformations are: C-C 
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bond dissociation, C-H bond dissociation (deprotonation), C-Si bond dissociation and others, as 
summarized by Schmittel.8 
 
1.1.3.1 C-H bond dissociation 
    C-H dissociation is a major pathway that many radical cations undergo, and numerous reports 
have shown the applications of this pathway. In equation 4 of Scheme 1.3, the benzylic proton on 
the tertiary carbon was deprotonated preferentially, and the resulting tertiary carbon radical was 
further oxidized to a carbocation, which was attacked by methanol to give the product.20  
 
MeO
O
MeO
O
MeO
>90%
anode
  MeOH, 
2,6-lutidine
O O
OAcAcO
anode
AcOH/AcONa
eq 4
eq 5
 
Scheme 1.3. C-H bond dissociations. 
 
     In equation 5, two allylic protons were deprotonated, followed by the same sequence in 
equation 4 to generate the diacetate product (no yield was given).21 
 
1.1.3.2 C-C bond dissociation 
    C-C bond dissociation often needs a special driving force to compete with C-H bond 
activation, which is why initial studies employed strained substrates to achieve C-C bond 
cleavage. Dinnocenzo and coworkers showed that the radical cation of optically active 
cyclopropane underwent a SN2 type replacement by methanol from the back of the ring to give 
the ring-opened product with an inverted stereocenter at C2 (Scheme 1.4).22 
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Ph
Ph
Me
D
Ph OMe
Ph DMe
hv, 1-CN
CH3CN, MeOH
1-CN = 1-cyanonaphthalene  
Scheme 1.4. C-C bond dissociation of a cyclopropane. 
 
    Arnold and coworkers23 demonstrated that by adjusting the substituent pattern, C-C bond 
activation is preferred over C-H activation (Scheme 1.5). The diphenylethyl ether substrate 
underwent C-C bond cleavage and generated an acetal and diphenylmethane that is consistent 
with the formation of the diarylmethyl radical. In this type of substrate, the two phenyl rings 
decrease the C-C bond dissociation energy of the single-electron species sufficiently to lead to of 
C-C bond cleavage in preference to C-H bond cleavage.  
 
hv, 1,4-dicyanobenzene
CH3CN, CH3OH
Ph2CHCH2OCH3 CH3OCH2OCH3 + Ph2CH Ph2CH2   
Scheme 1.5. C-C bond dissociation of a diphenylethyl ether. 
 
    An important rule regarding C-C or C-H bond cleavage is depicted in Figure 1.2.8 In this type 
of radical cation, A-B bond cleavage is preferential to the A-arene bond cleavage. This is 
attributed to the overlap between the σ* orbital of the A-B bond and the π system of the phenyl 
which weakens the A-B bond. Also, the orbital alignment stabilizes the incipient radical 
generated from A-B bond cleavage. Indeed, the cleavage of the A-arene bond is seldom 
observed.  
 
A
B
A
B
A + B
 
Figure 1.2. A-B bond cleavage is preferred over arene-A. 
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    Baciocchi and coworkers24 found that the deprotonation of p-neopentyltoluene happens 
predominately at the methyl group on the benzene ring, because in its most stable conformation 
(Figure 1.3), the C-H bonds in the neopentyl group do not align to the SOMO orbital of the 
radical cation, which is not suitable for the cleavage according to the rule stated above. These 
results indicate that both thermodynamics of bond cleavage and orbital alignment considerations 
influence the rates of bond cleavage reactions.  
 
HH
C(CH3)3
H H
HH
H
H C(CH3)3
tBu +   H+
 
Figure 1.3. Relationship between the SOMO orbital and the bond to be cleaved. 
 
1.1.3.3 C-Si bond dissociation 
    In the presence of heteroatoms (Si, S and others), C-X bond dissociation is another possible 
reaction pathway for radical cations.  
    In Scheme 1.6, the trimethylsilyl group acted as a proton surrogate (C-SiMe3 cleavage vs. C-H 
cleavage). The initially formed radical cation from the neutral molecule fragmented at C-Si bond 
to form the benzylic radical and the trimethylsilyl cation. The benzyl radical was further oxidized 
to a carbocation, which was attacked by methanol to give the product.25  
 
SiMe3
       anode
Et4NOTs, MeOH
OMe
91%     
Scheme 1.6. C-Si bond cleavage. 
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1.1.3 ETIC reactions 
    Prompted by the advances in mechanistic understanding of ET reactions, our group has 
developed a new cyclization method ― electron transfer initiated cyclizations (ETIC).26 The 
general form of ETIC reactions is shown in Scheme 1.7. The substrate is initially oxidized to a 
radical cation with a weakened benzylic C-C bond, then the benzylic radical serves as a leaving 
group that is displaced intramolecularly by oxygen or nitrogen nucleophiles to give rise to the 
heterocycles.  Many furanosides, pyranosides, and other heterocyclic ring systems have been 
prepared using this method.27,28  Two examples are shown below in Scheme 1.8.  
 
X
NuH Nu X
.
hv
- 1e-
+
( )n
( )n
X = OR or HNCOC5H11
Nu = OH or HNSO2Ar
X
Nu( )n
.+
 
Scheme 1.7. Electron transfer initiated cyclization reactions. 
OC8H17
OH hv, NMQPF6, NaOAc
DCE, tert-butylbenzene
92%
OC8H17O
OC8H17
O
OTHP O OH H
C8H17
hv, NMQPF6, NaOAc
   DCE, tert-butylbenzene
82%  
Scheme 1.8. Examples of ETIC reactions. 
 
    The unique strategy of ETIC reactions has great potential in designing novel synthetic 
pathways. This strategy allows the use of a benzyl radical as the leaving group, and it is feasible 
to incorporate the inert benzyl group into the substrate in the early stage of a synthesis. The 
relatively mild reaction conditions tolerate acid- or base-sensitive groups, and the 
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chemoselectivity of the oxidation and the reactivity of the system can be tuned by introducing 
substituents onto the arene and benzylic positions respectively. Finally, various types of 
nucleophiles are expected to be reactive with the highly electrophilic (radical) cations.  
    The mechanism of ETIC reactions is illustrated in Scheme 1.9.29 In the reaction, N-
methylquinolinium hexafluorophosphate (NMQPF6) serves as the cationic photosensitizer to 
initiate the reaction, tert-butylbenzene is the cosensitizer, relaying the energy from excited 
NMQPF6 to the cyclization substrate, 1,2-dichloroethane (DCE) is the solvent, and NaOAc is a 
base to neutralize any acid that is formed in the reaction.  
 
N N
OC8H17
OH
OC8H17
OH
OC8H17O
+ + +
+
hv *
OC8H17
OH
-H+
NMQ
 PhCH2-
 
Scheme 1.9. The mechanism of ETIC reactions. 
 
    In the sequence shown above, it is necessary to use excess amount of NMQPF6 (usually 2 
equivalents), but large amounts of NMQPF6 can make product isolation difficult. In order to 
improve the efficiency, we developed a catalytic protocol (Scheme 1.10).29 NMQPF6 is used in a 
catalytic quantity and O2 is the terminal oxidant. As little as 2.5 mol % of NMQPF6 was found to 
be sufficient to drive the cyclization reactions to completion. Solid Na2S2O3 is applied in the 
reactions to reduce reactive oxygen species such as superoxide and benzylperoxy radicals that 
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arise in the reactions. The more volatile and less expensive cosensitizer toluene was used to 
replace tert-butylbenzene, further facilitating product isolation.  
 
N
+
N
Bn
OR
Nu( )n
Bn
OR
Nu( )nO2
O2
Nu OR
( )n
 
Scheme 1.10. Aerobic quinolinium catalyst regeneration. 
 
    Many cyclizations were performed under catalytic conditions and afforded yields comparable 
or superior to those when NMQPF6 was used stoichiometrically (Scheme 1.11).29 Catalytic 
conditions also allow ETIC reactions to be conducted on multi-gram scale.  
 
OC8H17
OH
hv, NMQPF6, O2, DCE
85%
NaOAc, Na2S2O3, toluene
O
OC8H17
OH
HN C5H11
O
ON
H
C5H11
O
hv, NMQPF6, NaOAc, Na2S2O3
O2, DCE, toluene, 75%
 
Scheme 1.11. Aerobic ETIC reactions. 
 
1.1.4 Adjusting chemoselectivity and reactivity  
    Tuning the reactivity and chemoselectivity of the cyclization substrates will allow a broader 
range of nucleophiles and reaction conditions. In order to understand the relationship between 
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radical cation reactivity and the substrate structure, equation 6 can be used, which is derived 
from a thermodynamic cycle:  
 
A―B → A•  +  B•                                             BDE(S) 
B•  →  B+  +  e-        Epa(E) 
A―B•+  +  e- →  A―B                      -Epa(S) 
 A―B•+  →  A•  +  B+    BDE(RC) 
                                BDE(RC) = BDE(S) – Epa(S) + Epa(E)                             eq 6 
 
    In the equation, BDE(RC) defines the mesolytic bond dissociation energy of the radical cation, 
BDE(S) is the homolytic bond dissociation energy of the same bond in the neutral substrate, 
Epa(S) defines the oxidation potential of the substrate, and Epa(E) is the oxidation potential of the 
radical corresponding to the fragment that ultimately becomes the electrophile.  
Z
Nu Nu Z
.
- 1e- +( )n
( )n
Y
X
Y
X
X = oxidation potential modulating group
Y = reactivity modulating group
Z = electron-donating group
Nu = nucleophilic group  
Scheme 1.12. Tuning the reactivity and chemoselectivity of ETIC substrates. 
 
    With regards to our cyclization substrates (Scheme 1.12), the placement of a methoxy group in 
the para position of the phenyl ring (X = OMe) is expected to lower the oxidation potential of 
the arene part by ~0.5 V (derived from Scheme 1.13),30,31 which is anticipated to improve the 
chemoselectivity of the reaction and allow the incorporation of sensitive nucleophiles into the 
substrate. Although this change stabilizes the radical cation and increases the benzylic bond 
dissociation energy by approximately 11 kcal/mol, an additional phenyl group (Y = Ph in 
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Scheme 1.12) at the benzylic position can partially offset this stabilizing effect by activating the 
radical cation, and decreasing the bond dissociation energy by 4-8 kcal/mol while providing 
good reactivity.  
 
MeO MeO
-1 e-
-1 e-
Oxidation potential = 1.98 V     eq 730
Oxidation potential = 1.52 V     eq 831
 
Scheme 1.13. Adjusting the chemoselectivity.  
 
    The incorporation of a para-methoxy group lowers the oxidation potential of the substrate. 
Consequently, milder oxidation conditions with CAN can be used to initiate the reactions, in 
addition to photochemical conditions. The following cyclization used ceric ammonium nitrate 
(CAN) as the oxidant and gave a 47% yield (Scheme 1.14).32 Changing the reaction conditions to 
ground state oxidation conditions using CAN simplifies both the reaction procedures and the 
reaction equipment.  
 
Ph
OH
OC8H17
OC8H17
CAN, NaHCO3
CH3CN
47%MeO  
Scheme 1.14. ETIC reactions under oxidation conditions using CAN. 
 
1.1.5 Construction of C-C bonds 
    The construction of carbon-carbon bonds using electron transfer reactions has been reported. 
Yoshida and coworkers (Scheme 1.15)33 used anodic oxidation of α-stannyl ethers to generate 
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oxygen-stabilized carbocations, which underwent nucleophilic attack by C-C π-bonds to form 
heterocycles. Fluoride ions served as external nucleophiles to quench the reactions.  
Y
YSnBu3
R
R F( )n
( )n
electrolysis
Bu4NBF4, CH2Cl2
Y = O, NCO2Me
n = 1, 2
50-95%
  
Scheme 1.15. Construction of C-C bond using α-stannyl ethers.  
 
    In their more recent work (Scheme 1.16)17 they showed that under electrolysis conditions, α-
silyl ethers underwent SET oxidation twice, losing 2 electrons and the trimethylsilyl group to 
generate alkoxycarbenium ions. Allyltrimethylsilane and other nucleophiles then attacked the 
alkoxycarbenium ions to form new C-C bonds. The non-nucleophilic solvent deuterated 
dichloromethane was used in the reaction and, to improve the conductivity of the solution, the 
electrolyte tetrabutylammonium tetrafluoroborate was used.   
 
OMe
C8H17 SiMe3
OMe
C8H17
SiMe3
C8H17
OMe+
   -2e
- SiMe3
-72 oC
80%  
Scheme 1.16. Formation of C-C bond using α-silyl ethers.  
  
    Mariano and Chen34 used chemical oxidation conditions with CAN or CTAN to construct C-C 
bonds (Scheme 1.17). The oxocarbenium ions formed after oxidative cleavage of C-Sn bonds 
were attacked by the olefin on the allylsilane group to form heterocycles. However, stannyl 
reagents are usually expensive and difficult to prepare and manipulate, which limits the 
applicability of this method.  
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O O
TMS
SnBu3i-Bu
CTAN or CAN
CH3CN, 25 oC
88%
O
TMS
i-Bu
+
i-Bu  
Scheme 1.17. C-C bond construction using α-stannyl ethers.  
 
    Construction of carbon-carbon bonds is one of the most important aspects in organic synthesis. 
Although numerous methods have been established to reach this goal, novel approaches to the 
construction of C-C bonds are still valuable in the development of new synthetic strategies. 
Promoted by the extensive achievements of ET processes, and to expand the scope of our ETIC 
reactions, we decided to start a project, using olefin π-bonds as nucleophiles to construct C-C 
bonds. Reasonable design of the nucleophilicity of the olefin π-bonds and tailoring the reactivity 
and chemoselectivity of the cyclization substrates are expected to lead to the realization of this 
objective (Scheme 1.18).   
 
EDG
OR
X
MeO
OR
- 1e-
 
                             Scheme 1.18. General structure designed to construct C-C bonds.
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1.2 Results 
 
    After proving that ETIC reactions are successful in preparing heterocycles, we moved on to 
expand ETIC reactions to construct carbocycles. Our early work using substrates with 
unsubstituted arenes was unsuccessful,35 presumably because of the high oxidation potential of 
the arene relative to the olefin nucleophile. Under photooxidative conditions, the olefin 
nucleophile was oxidized preferentially because of its low oxidation potential.  
    In consideration of the introduction of a para-methoxy group to the arene lowers its oxidation 
potential, we designed substrates (Figure 1.4) based on the structure shown in Scheme 1.18. The 
electron-donating group (EDG) on the olefin is expected to increase the nucleophilicity of the 
double bond and facilitate the cyclization.36
 
Ph
OC8H17MeO
OMOM
TMS
Ph
OC8H17MeO
O
O
Ph
OR
MeO
•
Ph
OC8H17MeO
OH
1.1
1.2
1.3
1.4
TMS
 
Figure 1.4. Substrates designed to construct C-C bonds. 
 
1.2.1 C-C bond construction using an allylsilane as the nucleophile 
    The first substrate we prepared was allylsilane 1.1 through the synthetic sequence shown in 
Scheme 1.19. Commercially available para-methoxybenzophenone was treated with 
PPh3=CH(OMe) to afford enol ether 1.5 in 66% yield. Enol ether 1.5 was then hydrolyzed to its 
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aldehyde 1.6 under acidic conditions at 50 ˚C in 90% yield. A nucleophilic addition to the 
aldehyde by allylmagnesium bromide gave alcohol 1.7 in 47% yield. Alkylation of the resulting 
alcohol under solvent free conditions37 at 120 ˚C using NaH and 1-iodooctane afforded octyl 
ether 1.8 in 95% yield. These conditions proved to be superior to our typical method of using 
NaH in DMF at room temperature. A hydroboration (53%) of 1.9 followed by Dess-Martin 
oxidation (88%) generated aldehyde 1.9. Addition of Grignard 1.1038 to aldehyde 1.9 followed 
by protection of the resultant secondary alcohol with a methoxymethyl group provided the 
cyclization substrate 1.1 (2 diastereomers with 1:1 ratio) in 40% yield over 2 steps.   
 
OMOM
OC8H17
MeO
H
Ph
OC8H17
O
MeO
Ph OMe
MeO
H
Ph
O
MeO
Ph
OH
MeO
Ph
OC8H17
OMOM
SiMe3
MeO
O
Ph a b c
e, f
g, h i
MgBr
SiMe3
1.5 1.6
1.7 1.9
1.1
1.10
1.11
MeO
Ph
OC8H17
1.8
d
 
Reagents: a) PPh3=CH(OMe), THF, -78 oC to rt, 66%. b) NaI, 20% H2SO4, 1,4-dioxane, 50 oC, 90%.
c) CH2=CHCH2MgBr, THF, 0 oC, 47%. d) NaH, C8H17I, 120 oC, 95%. e) BH3, THF; NaOH, H2O2, 53%.
f) Dess-Martin Periodinane, CH2Cl2, 88%. g) 1.10, THF, -78 oC. h) CH3OCH2OCl, iPr2EtN, DMAP, CH2Cl2,
35oC, 40% over 2 steps. h) DCE, NaHCO3, 4 Å mol. sieves, 40 oC; CAN (in CH3CN), 71%.  
Scheme 1.19. The synthesis of allylsilane 1.1 and its cyclization. 
 
    Substrate 1.1 was subjected to ground state oxidation conditions using ceric ammonium nitrate 
(CAN) in acetonitrile as the oxidant, 1,2-dichloroethane (DCE) as the solvent, 4 Å molecular 
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sieves as the water scavenger, and NaHCO3 as the base to neutralize any acid that is formed in 
the reaction. At 40 ˚C, the cyclization was complete within 10 minutes generating methylene 
cyclohexane product 1.11 (2 diastereomers with 1.7:1 ratio) in 71% yield. This was our first 
success in constructing C-C bonds using the ETIC protocol, and the results clearly indicated that 
the chemoselectivity and reactivity of the substrate were indeed what we expected with olefin π-
bonds serving as good nucleophiles in the reaction. This success paved the way for more 
opportunities for further investigations of C-C bond construction using ETIC reactions.  
    Photochemical conditions (hv, DCE, toluene, NMQPF6, O2, NaOAc, Na2S2O3, 4 Å molecular 
sieves) also effected the cyclization of 1.1 to 1.11 but the reaction was much slower, taking 5 
hours and providing only a 50% yield.  
    To further compare and confirm the importance of tuning the chemoselectivity and reactivity 
of the substrate, substrate 1.12 (Scheme 1.20) was prepared. 1.12 did not give any cyclization 
product under chemical oxidation conditions using CAN, even after elongated time (3.5 h) and at 
elevated temperature (82 ˚C). Under these harsher conditions, the substrate was consumed and 
the isolated products are consistent with structures 1.13 and 1.14. 
 
OC8H17
OMOM
SiMe3
OC8H17
OMOM
OC8H17
OMOM
ONO2
1.13
1.14
CAN, NaHCO3
 4 Å molecular sieves,
     CH3CN, 82 oC
1.12
+
 
Scheme 1.20. Products derived from substrate 1.12.   
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1.2.2 C-C bond construction using an enol acetate as the nucleophile 
    In order to broaden the scope of this cyclization, we prepared several substrates that contain 
various olefinic nucleophiles. The sequence to make enol acetate 1.2 is shown in Scheme 1.21. 
Alcohol 1.15 was converted to its mesylate, which was displaced by iodide to provide 1.16 in 
92% yield over 2 steps. Iodide 1.16 was converted to diketone 1.17 using 2,4-pentanedione under 
basic conditions in refluxing acetone in 56% isolated yield at 60% conversion.39 1.17 underwent 
deacylative condensation with formaldehyde to form enone 1.18 in 58% yield.40 Treatment of 
enone 1.18 with SnCl4, 1,2-(diamino)cyclohexane, and a mild oxidant bis(trimethylsilyl) 
peroxide in the presence of 4 Å molecular sieves41 afforded Baeyer-Villiger product 1.2 in 71% 
yield.  
 
Ph
OC8H17
O
O
O
OC8H17
MeO
OH
Ph
OC8H17 MeO
I
Ph
OC8H17
MeO
Ph
OC8H17
O
MeO
Ph
OC8H17
O
MeO
O
a, b c
d e f
1.15 1.16 1.17
1.18 1.2 1.19  
Reagents: a) Et3N, MsCl, CH2Cl2, 0 oC. b) NaI, acetone, reflux, 92% over 2 steps. c) 2,4-pentanedione,
K2CO3, acetone, reflux, 56%. d) K2CO3, HCOH, H2O, 1,4-dioxane, 35 oC, 58%. e) 4 Å mol. sieves, trans-
1,2-(diamino)cyclohexane, SnCl4, CH2Cl2, 0 oC; TMSOOTMS, 71%. f) NaHCO3, 4 Å mol. sieves, DCE;
CAN (in CH3CN), 50 oC, 94%.  
Scheme 1.21. The synthesis of enol acetate substrate 1.2 and its cyclization. 
 
Under oxidation conditions using CAN at 50 ˚C, enol acetate 1.2 underwent facile cyclization 
giving the desired cyclohexanone product 1.19 in 94 % yield. The cyclization was complete 
immediately after CAN was added and the end of the reaction could be judged by the color of the 
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reaction changing from orange to yellow. Under photochemical conditions, the reaction time 
increased greatly to 2 h and only gave a 75% yield of the product. 
 
 
1.2.3 C-C bond constructions with an allene as the nucleophile 
    Substrate 1.3 with the trimethylsilylallene moiety (Scheme 1.22) was also prepared and 
subjected to ETIC conditions. 1,5-Pentanediol was mono-brominated42 with HBr in toluene at 
reflux and the resulting monobromo alcohol was oxidized to its aldehyde, which was then 
converted to its acetal 1.20.  Transformation of 1.20 to its Grignard reagent followed by 
transmetalation with CeCl3 furnished organocerium species 1.21.43 1.21 reacted with aldehyde 
1.6 and afforded alcohol 1.22 in 66% yield. Ketone 1.23 was also isolated in 11% yield and was 
reduced to 1.22 with NaBH4. Alkylation of 1.22 (57%) followed by deprotection of the acetal 
(~100%) gave aldehyde 1.24. Addition of lithium trimethylsilylacetylide to aldehyde 1.24 
generated propargylic alcohol 1.25 in 75% yield. 1.25 was treated with PPh3, DEAD, and o-
nitrobenzenesulfonylhydrazine 1.2644 in THF under Myers’s conditions45 to provide the 
cyclization substrate 1.27 in 84% yield.   
    Under ground state oxidation conditions using CAN at 40 ˚C, allene 1.3 provided 81% yield of 
the desired alkyne product 1.28 (two diastereomers, trans : cis = 1.2 : 1) in less than 3 min. 
Silylalkyne 1.29 was isolated in 10% yield and was converted to the desired product by treating 
it with TBAF. The overall yield of 1.28 was 91%. Under photochemical conditions, only 13% 
yield was obtained.  
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O
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1.20 1.21
1.6
1.22
1.24 1.25
1.26
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a-c d
1.23
+
1.22
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Reagents: a) 48% HBr, toluene, reflux. b) PCC, CH2Cl2. c) HC(OEt)3, EtOH, PTSA, 51% over 3 steps.
d) Mg, I2, THF; CeCl3, THF. e) 1.21, THF, 0 oC, 77%. f) NaH, C8H17I, 120 oC, 57%. g) TFAA, CHCl3,
H2O, 0 oC, ~100%. h) Li- -TMS, THF, 0 oC, 75%. i) PPh3, THF; DEAD; 1.25; 1.26, -10 oC, 84%. j)
DCE, NaHCO3, 4 Å mol. sieves,40 oC; CAN (in CH3CN), 91%.  
Scheme 1.22. The preparation of allene substrate 1.27 and its cyclization. 
 
1.2.4. Cleavable ethers as electron-donating groups 
Ethers that can be more readily cleaved than the octyl group broaden the scope of the method 
by allowing further manipulation of the cyclization products. To test this possibility, benzyl ether 
substrate 1.32 was prepared in a similar way to 1.27 (Scheme 1.23). Alkylation of alcohol 1.22 
with NaH and benzyl bromide (57%) followed by hydrolysis of the resulting acetal (84%) 
provided aldehyde 1.30.  Addition of lithium trimethylsilylacetylide (84%) to aldehyde 1.30 
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followed by allene formation of the resulting propargylic alcohol 1.31 (64%) under Myers’s 
conditions45 generated cyclization substrate 1.32.  
 
OBn
TMS
MeO
O
Ph
OH
O
MeO
Ph
OBn
O
H
MeO
Ph
OBn
OH
TMS MeO
Ph
OBn
•
OBn
e
a, b c
d
1.22 1.30
1.31 1.32
1.33 1.34
TMS
+
 
Reagents: a) NaH, BnBr, DMF, 57%. b) TFAA, CHCl3, H2O, 0 oC, 84%. c) Li-     -TMS, THF, 0 oC, 84%. e) 
PPh3, THF; DEAD;  1.26, -10 oC, 64%. f) NaHCO3, 4 Å mol. sieves, DCE, 40 oC; CAN (in CH3CN), 66%.  
Scheme 1.23. The synthesis of substrate 1.32 and its cyclization. 
 
    Substrate 1.32 underwent cyclization under chemical oxidation conditions using CAN, but 
afforded lower yield than 1.27. It generated 52% yield of the desired product 1.33 as two 
diastereomers (trans : cis = 1.3 : 1) and 3.5% yield of silylalkyne 1.34. 16% of the starting 
material was recovered. Silylalkyne 1.34 was converted to the desired product 1.33 by treating it 
with TBAF. The overall yield based upon unrecovered starting material was 66%. 
    Allyl ether 1.40 was also prepared as shown in Scheme 1.24. 1,5-Pentanediol was mono-
brominated42 with HBr in toluene at reflux and the resulting monobromo alcohol was protected 
as its THP ether 1.35.  1.35 was converted to its Grignard reagent, which was then transmetalated 
to the organocerium species 1.36. Addition of 1.36 to aldehyde 1.6 generated alcohol 1.37 in 
 23
66% yield. Alkylation of 1.37 with allyl bromide followed by deprotection of THP ether (84% 
over 2 steps) and Dess-Martin oxidation (77%) provided aldehyde 1.38. Similar carbonyl 
addition onto 1.38 with lithium trimethylsilylacetylide (77%) generated propargylic alcohol 1.39, 
which was subjected to Meyers’s allene formation conditions45 to provide the cyclization 
substrate 1.40 in 77% yield.  
 
Br OTHP
MeO
Ph
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H
MeO
Ph
O
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TMS MeO
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• TMS
O O
TMS
MeO
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OH
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HO OH Cl2Ce OTHP
1.36
a, b c
1.6 1.37
1.35
1.38
1.39 1.40
1.41 1.42
h i
j +
  
Reagents: a) 48% HBr, toluene, reflux. b) 3,4-dihydropyran, PPTS, CH2Cl2, 40% over 2 steps. c) Mg,
I2, THF; CeCl3, THF, 0 oC. d) 1.36, 0oC, THF, 66%. e) NaH, allyl bromide, DMF. f) MeOH, PTSA, rt, 84%
over 2 steps. g) Dess-Martin periodinane, CH2Cl2, 77%. h) Li- -TMS, THF, 0 oC, 77%. i) PPh3, THF;
DEAD; 1.26;  -10 oC, 77%. j) NaHCO3, 4 Å mol sieves, DCE; CAN (in CH3CN), rt, 72%.  
Scheme 1.24. The preparation of substrate 1.40 and its cyclization. 
 
    Under ground state oxidation conditions using CAN the cyclization reaction of 1.40 was 
finished within 10 min at room temperature. Because the cyclization products are somewhat 
volatile, the yields of the reaction were measured with GC using 1-iodooctane as the internal 
standard. The cyclization generated 65% of the desired product 1.41 as two diastereomers (trans 
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: cis = 1.3 : 1) and 7% of silylalkyne 1.42 as two diastereomers in 1 : 1 ratio. The overall yield 
was 72% of the desired product. 
    Two other ether groups were also incorporated into the cyclization substrates to replace octyl 
ethers. Methoxymethyl ether substrate 1.43 and silyl ether 1.44 (Scheme 1.25) were prepared 
using the same strategy employed to make allyl ether 1.40. Unfortunately, neither of them gave 
good cyclization yields. Silyl ether 1.44 gave ~9% yield of the product under ground state 
oxidation conditions using CAN and ~30% yield under photochemical conditions. As for MOM 
ether 1.43, practically no cyclization product was generated under either conditions. 
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Scheme 1.25. Substrates 1.43 and 1.44.  
 
1.2.5. Cascade cyclization involving C-C bond formation 
     Using a trisubstituted olefin as the nucleophile creates possibilities for initiating oxidative 
cascade cyclizations. To test this idea, we prepared substrate 1.4 (Scheme 1.26), which contains 
two nucleophiles: a hydroxyl group and an olefin. The trisubstituted olefin was synthesized using 
the protocol developed by Negeshi.46 A carboalumination of pent-4-yn-1-ol with Me3Al and 
Cp2ZrCl2 in the presence of H2O47 followed by a palladium catalyzed coupling reaction with 
allyl bromide generated alcohol 1.45 in 75% yield. Alcohol 1.45 was then transformed into 
iodide 1.46 with I2 in the presence of PPh3 and imidazole giving 87% yield. The iodide was 
treated with tert-butyl lithium,48 and the resulting alkyllithium species was transmetalated with 
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CeCl3. The resultant organocerium reagent added onto aldehyde 1.6 to afford 1.47 in 65% yield. 
Alkylation of 1.47 (90%) followed by hydroboration (46%) using disiamylborane49 provided 
cyclization substrate 1.4.  
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Ph
OC8H17
OH
O
H
OC8H17
MeO
Ph
OH
IHOHO
a b c
d, e f
1.45 1.46
1.47 1.4 1.48  
Reagent: a) Cp2ZrCl2, AlMe3, H2O, CH2Cl2; Pd(PPh3)4, CH2=CHCH2Br, 75%. b) PPh3, imid, I2, CH2Cl2,
87%. c) t-BuLi, Et2O, pentane, -78 oC to rt; CeCl3, THF, -78 oC; aldehyde 1.6, 65%. d) NaH, C8H17I, 120 oC, 
90%. e) Disiamylborane, THF; NaOH, H2O2, 46%. f) hν, NMQPF6, O2, DCE, NaOAc, Na2S2O3, 4 Å mol.
sieves, toluene, rt, 49%.  
Scheme 1.26. Cascade cyclization including C-C bond formation. 
     
    Under chemical oxidation conditions using CAN, the cyclization of substrate 1.4 took less 
than 5 minutes at room temperature and gave the desired product 1.48 in 32% yield. Under 
photochemical conditions, the reaction yield was improved to 49%. Under both conditions, 
product 1.48 was the only isomer that was isolated.  
 
1.2.6 Stereocontrol by ETIC reactions 
  ETIC reactions also provide opportunities to generate stereocontrol in C-C bond formations. 
As shown in Scheme 1.27, superior stereocontrol is expected for the 6-endo-pathway due to its 
strong preference for chair transition states and an (E)-configuration of the oxocarbenium ion. 
John Seiders in our lab has demonstrated that subjecting 1.49 to standard ETIC conditions (DCE, 
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NaHCO3, CAN, and CH3CN) at room temperature resulted in oxidative cleavage and cyclization 
to form tetrahydropyrone 1.50 with complete stereocontrol in 80% yield.50 
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H13C6
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Scheme 1.27. Stereocontrol of ETIC reactions. 
 
In consideration of the extensive presence of 2,4,6-trisubstituted tetrahydropyrans in 
biologically active natural products, many substrates have been synthesized by Seiders and 
subjected to oxidative cyclization conditions to test the generality of this method. As 
demonstrated by examples shown in Table 1.1, excellent yields and diastereoselectivity were 
obtained, proving the efficiency and generality of this method. A project aimed at the total 
synthesis of Leucascandrolide A51 with an ETIC reaction as the key step is currently under way.  
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Table 1.1. Using ETIC reactions to generate stereocontrol. 
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1.3 Discussion 
 
    Monobenzene substrate 1.12 (Scheme 1.28) did not give any cyclization product under 
chemical oxidation conditions using CAN. The isolated products are consistent with structures 
1.13 and 1.14, which were derived from C-Si bond cleavage. After single-electron oxidation, the 
resulting radical cation cleaves the C-Si bond, forming an allylic radical and a trimethylsilyl 
cation. The allylic radical can either abstract H· from solvent to form product 1.13 or be further 
oxidized to a carbocation. The carbocation then undergoes nucleophilic attack by a nitrate to 
form 1.14. The results showed that the cyclization does not proceed without proper tuning of the 
chemoselectivity and reactivity of the substrates.  
 
OC8H17
OMOM
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    -e-
OC8H17
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OC8H17
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CH3CN-e
-
CH2CN+
1.12
1.13
1.14
NO3
+ Si
 
Scheme 1.28. Decomposition of monobenzene substrate 1.12. 
 
    Under oxidation conditions using CAN, allene substrate 1.27 provided 81% yield of the 
alkyne product 1.28. And interestingly, silylalkyne 1.29 (Scheme 1.29) was isolated in 10% 
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yield. Product 1.29 is generated from proton loss of the cationic intermediate (Scheme 1.29). 
Silylalkyne 1.29 was converted to the desired product by treating it with TBAF. This cyclization 
showed that allenes, which can be readily made under Meyers’s conditions, with their continuous 
π-bonds can also serve as good nucleophiles in ETIC reactions to generate alkyne products. The 
cyclization did not provide good diastereoselectivity (1.2:1). In the transition state, the oxonium 
ion can reside either in an equatorial or axial position and the energy difference between these 
two conformations is small.  
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Scheme 1.29. Formation of 1.29 and the cleavage of the TMS group.  
 
    Benzyl ether substrate 1.32 and allyl ether 1.40 underwent cyclizations under oxidation 
conditions using CAN, showing that cleavable ethers can also serve as electron donating groups 
in these reactions, which allows further manipulation of the cyclization products.   
Methoxymethyl ether substrate 1.43 and silyl ether 1.44 were also subjected to cyclization 
conditions. It is an especially interesting point to test the silyl ether substrate, since it is a 
commonly used protecting group and easily accessible. Also, utilizing silyl ethers, if successful, 
could expand the reactivity adjusting group to silyl ethers. Unfortunately, neither substrate gave 
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good cyclization yields. The proposed decomposition mechanism of these two substrates is 
shown in Scheme 1.30. In the case of 1.43, the oxocarbenium ion intermediate generated from 
benzylic cleavage of the radical cation could decompose to an aldehyde and a new oxonium ion. 
The resulting oxonium ion could be attacked by external base such as acetate, to form the ester 
product. In a similar manner, the oxonium ion generated from 1.44 underwent cleavage at the 
weakened O-Si bond position to form a molecule of aldehyde and a stabilized silicon cation. The 
silicon cation could be captured by external base to form an ester product. In the crude NMR of 
the cyclization products of both substrates, evident aldehyde peaks were found. No extensive 
effort was put on the product separation, since the aldehyde was not the desired product. 
However, similar reactions were proven to be useful in traceless release of ketones and 
aldehydes from polymer supports as demonstrated recently by our group.52  
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Scheme 1.30. Possible decomposition pathways for substrates 1.43 and 1.44.  
 
 
The cyclization of 1.4 suggests that a cascade reaction involving π-bond nucleophile is 
feasible. Interestingly, the reaction generated the expected cyclization product as a single 
diastereomer with both methyl and octyloxy groups residing in axial positions. The reaction 
 31
appears to prefer taking a synclinal transition state to anti-periplanar TS. The result is consistent 
with literature precedents such as Johnson’s cyclization.53  
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Scheme 1.31. The cascade reaction.  
 
    In the cascade cyclization (Scheme 1.31), ring closure of A ring was 6-endo type and no 5-exo 
ring closure was observed, although either one is favored according to Baldwin’s rules. The 
reason may be that C5 supports a partial positive charge better than C4, since a methyl group 
resides on C5. This also suggests that combined with variant substituent patterns or stereocontrol 
factors, many interesting products can be designed. For example, the substrate shown in Scheme 
1.32, with the methyl group residing on C4, is expected to undergo cyclization and yield a 
product that contains two continuous 5-membered rings.  
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Scheme 1.32. Substrate designed to yield continuous 5-membered rings. 
 
    Because CAN is not soluble in DCE, it is necessary to use acetonitrile as co-solvent in the 
cyclizations. But in some cases, acetonitrile might also function as a nucleophile and lower the 
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cyclization yield. To avoid this problem and to increase the yield of the cascade cyclization, ceric 
bis(tetra-n-butylammonium) nitrate (CTAN), which is soluble in CH2Cl2, was made and used in 
the reactions. Substrates 1.1 and 1.4 (Scheme 1.33) were treated with CTAN under the same 
conditions as when CAN was used, but no cyclization occurred. After elongated time (5 h for 
1.1) and at elevated temperature (reflux in CH2Cl2 for 1.4), only a very small amount of desired 
products formed, and the majority of starting material was recovered. The reason for the different 
reactivities of CAN and CTAN could be that CAN has bare Ce(IV) cations that can coordinate 
onto the arene and facilitate the single electron oxidation. While for CTAN, cerium cations are 
surrounded by butyl groups and the coordination with arenes cannot occur. 
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Scheme 1.33. Substrates that were treated with CTAN. 
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1.4. Summary  
 
    ETIC reactions have been successfully expanded to the construction of carbon-carbon 
bonds after tuning the chemoselectivity and reactivity of the substrates. Table 1.2 summarizes 
the conditions and yields of the cyclizations that lead to C-C bond formation. In most cases, 
cyclizations gave good to excellent yields with short reaction times. The results clearly indicated 
that ETIC reactions are highly effective in constructing C-C bonds. Olefins and allenes with 
several different electron-donating groups served as good nucleophiles in the cyclization 
reactions to generate various carbocycles. Cascade cyclizations involving C-C bond formation 
were also proven to be successful, providing the desired chromene product as a single 
diastereomer. Several ether groups were incorporated into the cyclization substrates to replace 
octyl ethers, allowing for further manipulations of the cyclization products.  
The results also showed that in most cases, ground state oxidation conditions using CAN are 
preferable for C-C bond formation relative to photochemical conditions, which are relatively 
simple and do not require special equipment.  
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    a Ar = p-MeOPh. b ground state oxidation conditions: DCE, NaHCO3, 4 Å molecular sieves, CAN in CH3CN. c 
Photochemical conditions: hv, O2, DCE, toluene, NMQPF6, Na2S2O3, 4 Å molecular sieves, NaOAc.  
 
Table 1.2. C-C bond construction using ETIC reactions. 
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1.6 Experimental  
 
General Experimental: 
    Proton (1H NMR) and carbon (13C NMR) nuclear magnetic resonance spectra were recorded 
on Bruker Avance 300 spectrometers at 300 MHz and 75 MHz, respectively. The chemical shifts 
are given in parts per million (ppm) on the delta (δ) scale. The solvent peak or the internal 
standard tetramethylsilane were used as reference values. For 1H NMR: CDCl3 = 7.27 ppm, TMS 
= 0.00 ppm. For 13C NMR: CDCl3 = 77.23, TMS = 0.00. For proton data: s = singlet; d = 
doublet; t = triplet; q = quartet; p = pentet; dd = doublet of doublets; dt = doublet of triplets; ddt 
= doublet of doublet of triplets; ddq = doublet of doublet of quartets; br = broad; m = multiplet; 
app t = apparent triplet; app q = apparent quartet; app p = apparent pentet. 
    High resolution and low resolution mass spectra were recorded on a VG 7070 spectrometer.  
Infrared (IR) spectra were collected on a Mattson Gygnus 100 spectrometer.  
    Analytical thin layer chromatography (TLC) was performed on E. Merck pre-coated (25 nm) 
silica gel 60F-254 plates. Visualization was done under UV (254 nm). Flash column 
chromatography was performed using ICN SiliTech 32-63 60Å silica gel. Reagent grade ethyl 
acetate and hexanes (commercial mixture) were purchased from EM Science and used as is for 
chromatography. Reagent grade methylene chloride (CH2Cl2), dicholoroethane (C2H4Cl2), 
acetonitrile (CH3CN) and toluene were distilled from CaH2. Diethyl ether (Et2O) and 
tetrahydrofuran (THF) were distilled from sodium benzophenone ketyl prior to use.  Anhydrous 
(N,N)-dimthylformamide (DMF), methanol (MeOH), dimethyl sulfoxide (DMSO), acetone were 
purchased from Aldrich and used as is. 
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1-Methoxy-4-(2-methoxy-1-phenylvinyl)benzene (1.5) 
To a suspension of (methoxymethyl)triphenylphosphonium chloride (11.64 g, 
34.0 mmol) in THF (100 mL) at –78 °C was added LDA (34.0 mmol, 0.4 M 
in THF) dropwise. The color of the reaction changed to deep orange. After 0.5 h, a solution of 4-
methoxybenzophenone (5.15 g, 24.3 mmol) in THF (50 mL) was added and the resulting mixture 
was allowed to warm to rt. The reaction mixture was stirred for 2 h and was quenched with 
saturated NH4Cl (5 mL). The organic layer was separated, washed with water (10 mL) and brine 
(10 mL), then was dried over Na2SO4, filtered, and concentrated under reduced pressure. The 
resulting residue was dissolved in EtOAc (30 mL) and the solution was added to stirring hexanes 
(200 mL) dropwise. A precipitate formed and the suspension was filtered through a short pad of 
Celite. The filtrate was concentrated under reduced pressure and the resulting residue was 
purified by flash chromatography (4% EtOAc in hexanes) to give the desired product as a clear 
oil (3.83 g, 66%): 1H NMR (300 MHz, CDCl3) δ 7.22-7.40 (m, 6H), 7.14 (d, J = 8.2 Hz, 1H), 
6.83 (m, 2H), 6.41 (s, 50% of 1H), 6.39 (s, 50% of 1H), 3.82 (s, 3H), 3.77 (s, 3H); 13C NMR (75 
MHz, CDCl3) δ 158.6, 158.3, 145.8, 140.8, 138.1, 133.0, 131.1, 130.2, 129.9, 129.5, 128.3, 
128.0, 126.6, 126.5, 120.2, 120.1, 113.8, 113.5, 60.5, 55.3, 55.2; IR (neat) 3030, 2999, 2931, 
2834, 1631, 1606, 1510, 1493, 1441, 1286, 1229, 1172, 1104, 1035, 832, 765, 698 cm-1; HRMS-
EI (m/z) calcd for C16H16O2 [M+] 240.1150, found 240.1154. 
 
 (4-Methoxyphenyl)phenylacetaldehyde (1.6) 
To enol ether 1.5 (1.6 g, 6.7 mmol) in 1,4-dioxane (50 mL) were added NaI (7.6 
g, 50.9 mmol) and H2SO4 (2 M solution, 6 mL). The resulting mixture was 
heated at 50 °C overnight. The reaction mixture was concentrated on a rotary evaporator to 
MeO
Ph OMe
MeO
H
Ph
O
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remove most of the dioxane, and the resulting mixture was extracted with EtOAc (3 × 30 mL). 
The organic layers were combined and washed with water (10 mL), aqueous NaHCO3 (10 mL), 
and brine (10 mL), then were dried over Na2SO4, filtered and concentrated under reduced 
pressure. The resulting residue was purified by flash chromatography  (10% EtOAc in hexanes) 
to afford the desired product (1.29 g, 90%) as a colorless oil: 1H NMR (300 MHz, CDCl3) δ 9.93 
(s, 1H), 7.14-7.39 (m, 7H), 6.91 (d, J = 8.7 Hz, 2H), 4.85 (d, J = 2.2 Hz, 1H), 3.82 (s, 3H); 13C 
NMR (75 MHz, CDCl3) δ 198.6, 159.0, 136.7, 130.2, 129.0, 128.9, 128.2, 127.4, 114.4, 63.2, 
55.1; IR (neat) 2933, 2835, 1720, 1608, 1509, 1421, 1251, 1179, 1033, 828, 699 cm-1; HRMS-EI 
(m/z) calcd for C15H14O2 [M+] 226.0993, found 226.1001.  
 
1-(4-Methoxyphenyl)-1-phenylpent-4-en-2-ol (1.7) 
To a stirring solution of aldehyde 1.6 (1.0 g, 4.42 mmol) in THF (20 mL) at 
0 °C was added allylmagnesium bromide (1 M in THF, 14 mL, 14 mmol) 
dropwise. The reaction mixture was stirred at 0 °C for 0.5 h then was quenched with saturated 
NH4Cl solution (10 mL). The organic layer was separated, and the aqueous layer was extracted 
with EtOAc (3 × 15 mL). The organic layers were combined, washed with water (15 mL) and 
brine (15 mL), then were dried over Na2SO4, filtered and concentrated under reduced pressure. 
The resulting residue was purified by flash chromatography (15-30% EtOAc in hexanes) to 
furnish the desired product (0.565 g, 47%, 2 diastereomers) as a clear oil. Faster eluting 
diastereomer: 1H NMR (300 MHz, CDCl3) δ 7.27-7.43 (m, 7H), 6.88 (d, J = 6.8 Hz, 2H), 5.93 
(ddt, J = 9.6, 17.0, 7.4 Hz, 1H), 5.17 (dd, J = 9.1, 0.9 hz, 1H), 5.11 (dd, J = 17.0, 1.5 Hz, 1H), 
4.41 (dt, J = 3.5, 8.3 Hz, 1H), 3.93 (d, J = 8.3 Hz, 1H), 3.80 (s, 3H), 2.35-2.43 (m, 1H), 2.15-
2.25 (m, 1H); 13C NMR (75 MHz, CDCl3) δ 158.2, 141.8, 135.0, 134.5, 129.3, 128.8, 126.7, 
MeO
Ph
OH
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117.9, 114.1, 73.1, 57.2, 55.3, 39.6; IR (neat) 3453, 2906, 2822, 1510, 1248, 1178, 1034, 700 
cm-1; HRMS-EI (m/z) calcd for C18H20O2 (M+) 268.1463, found 268.1463. Slower eluting 
diastereomer: 1H NMR (300 MHz, CDCl3) δ 7.19-7.37 (m, 7H), 6.89 (d, J = 8.7 Hz, 2H), 5.94 
(ddt, J = 9.5, 17.1, 7.3 Hz, 1H), 5.14 (d, J = 9.5 Hz, 1H), 5.08 (dd, J = 17.1, 1.4 Hz, 1H), 4.41 (dt, 
J = 3.5, 8.3 Hz, 1H), 3.91 (d, J = 8.3 Hz, 1H), 3.80 (s, 3H), 2.33-2.36 (m, 1H), 2.17-2.20 (m, 1H); 
13C NMR (75 MHz, CDCl3) δ 158.6, 142.8, 135.1, 135.0, 133.4, 129.9, 128.8, 128.6, 128.3, 
126.7, 117.9, 114.3, 73.1, 57.2, 55.3, 39.7.  
 
1-Methoxy-4-(2-octyloxy-1-phenyl-pent-4-enyl)benzene (1.8) 
To neat alcohol 1.7 (0.56 g, 2.10 mmol) at rt were added NaH (60% in 
mineral oil, 0.36 g, 9.0 mmol) and 1-iodooctane (3.20 g, 13.3 mmol). The 
resulting mixture was heated to 120 °C and was stirred overnight at that temperature. The 
reaction mixture was cooled to 0 °C, diluted with 5 mL of hexanes, and quenched with an ice 
chunk. The resulting mixture was extracted with 50% EtOAc in hexanes (3 × 10 mL). The 
organic layers were combined, washed with H2O (10 mL) and brine (10 mL), then were dried 
over Na2SO4, filtered and concentrated under reduced pressure. The resulting residue was 
purified by flash chromatography (0-4% EtOAc in hexanes) to afford the desired product (0.75 g, 
95%) as a mixture of 2 diastereomers: 1H NMR (300 MHz, CDCl3) δ 7.13 -7.38 (m, 7H), 6.79-
6.83 (m, 2H), 5.84-5.93 (m, 1H), 4.95-5.07 (m, 2H), 3.91-3.99 (m, 2H), 3.74 (s, 50% of 3H), 
3.73 (s, 50% of 3H), 3.43 (app dt, J = 8.4, 6.3 Hz, 1H), 3.05 (app dt, J = 8.4, 6.3 Hz, 1H), 2.20-
2.35 (m, 2H), 1.10-1.40 (m, 12H), 0.92 (t, J = 7.0 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 158.2, 
143.4, 142.8, 135.2, 135.1, 134.4, 130.2, 129.6, 129.1, 128.6, 128.5, 128.2, 126.3, 126.2, 117.2, 
113.9, 113.6, 82.3, 82.2, 70.6, 55.2, 37.2, 37.0, 32.0, 30.2, 29.5, 29.4, 26.3, 22.8, 14.3; IR (neat) 
MeO
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3027, 2998, 2927, 2855, 1610, 1510, 1463, 1248, 1178, 1099, 699 cm-1; HRMS-EI (m/z) calcd 
for C23H31O2 [M – C3H5]+  339.2324, found 339.2312.  
 
5-(4-Methoxyphenyl)-4-octyloxy-5-phenylpentan-1-ol (1.15) 
To a stirring solution of olefin 1.8 (0.80 g, 2.10 mmol) in THF (8 mL) at 
0 °C was added BH3·THF (1 M in THF, 6.5 mL, 6.5 mmol) dropwise. 
The reaction mixture was stirred at 0 °C for 10 min and was quenched with NaOH (20% aqueous 
solution, 1.5 mL) and H2O2 (30%, 1.5 mL). The resulting mixture was stirred for 0.5 h and 
saturated Na2SO3 (10 mL) was added slowly. After additional 0.5 h, the organic layer was 
separated, and the aqueous layer was extracted with EtOAc (3 × 15 mL). The organic layers were 
combined, washed with H2O (10 mL) and brine (10 mL), then were dried over Na2SO4, filtered 
and concentrated under reduced pressure. The resulting residue was purified by flash 
chromatography (15-20% EtOAc in hexanes) to provide the desired product (0.44 g, 53%): 1H 
NMR (300 MHz, CDCl3) δ 7.14-7.37 (m, 7H), 6.81-6.85 (d, J = 8.7 Hz, 2H), 3.99-4.05 (m, 2H), 
3.76 (s, 3H), 3.54-3.66 (m, 2H), 3.40 (dt, J = 8.7, 6.5 Hz, 1H), 3.04 (dt, J = 8.7, 6.5 Hz, 1H), 
1.60-1.72 (m, 2H), 1.13-1.37 (m, 14H), 0.91 (t, J = 7.0 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 
157.9, 157.9, 143.0, 142.8, 134.6, 134.4, 129.8, 129.6, 129.3, 128.7, 128.3, 128.0, 126.1, 126.0, 
113.8, 113.1, 82.3, 82.2, 70.4, 62.6, 54.9, 54.6, 31.8, 29.9, 29.3, 29.2, 29.1, 28.3, 28.2, 25.9, 22.6, 
14.1; IR (neat): 3382, 2928, 1610, 1513, 1248, 1178, 1035, 910, 699 cm-1; HRMS-EI (m/z) calcd 
for C26H36O2 [M – H2O]+ 380.2715, found 380.2714.  
 
5-(4-Methoxyphenyl)-4
MeO
OH
Ph
OC8H17
MeO
H
Ph
OC8H17
O
-octyloxy-5-phenylpentanal (1.9) 
To a stirring mixture of alcohol 1.15 (445 mg, 1.12 mmol) and NaHCO3 
(235 mg, 2.8 mmol) in CH2Cl2 (10 mL) at 0 ˚C was added Dess-Martin 
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periodinane (458 mg, 1.35 mmol). The ice bath was removed and the reaction mixture was 
stirred at rt for 1 h. Saturated NaHCO3 (3 mL) and saturated Na2S2O3 (3 mL) were added to the 
reaction mixture. The resulting cloudy mixture was stirred at rt for 0.5 h. The organic layer was 
separated, and the aqueous layer was extracted with CH2Cl2 (3 × 10 mL). The organic layers 
were combined, washed with H2O and brine, then were dried over Na2SO4, filtered and 
concentrated under reduced pressure. The resulting residue was purified by flash 
chromatography (10% EtOAc in hexanes) to provide the desired product (380 mg, 88%): 1H 
NMR (300 MHz, CDCl3) δ 9.70 (s, 1H), 7.18-7.43 (m, 7H), 6.85-6.92 (m, 2H), 3.99 (br s, 2H), 
3.76 (2 singlets, 3H), 3.29 (dt, J = 8.3, 6.4 Hz, 1H), 2.99 (dt, J = 8.3, 6.4 Hz, 1H), 2.38-2.42 (m, 
2H), 1.93-2.00 (m, 1H), 1.69-1.77 (m, 1H), 1.17-1.38 (m, 12H), 0.93 (t, J = 7.0 Hz, 3H); 13C 
NMR (75 MHz, CDCl3) δ 202.0, 158.2, 158.2, 142.6, 134.3, 134.2, 129.8, 129.3, 128.7, 128.5, 
128.3, 128.1, 126.3, 126.2, 113.0, 113.5, 81.5, 81.4, 70.7, 70.6, 55.8, 54.9, 39.8, 39.7, 31.8, 29.9, 
29.3, 29.2, 25.9, 25.7, 25.6, 22.6, 14.1; IR (neat) 3061, 3028, 2999, 2926, 2855, 1723, 1610, 
1510, 1455, 1301, 1248, 1178, 1035, 700 cm-1; LRMS-CI (m/z) calcd for C26H36O3 397.27 [M + 
H]+, found 397.  
 
7-(4-Methoxyphenyl)-6-octyloxy-7-phenyl-2-trimethylsilylmethyl-hept-1-en-3-ol 
To a stirring solution of 2-bromo-3-(trimethylsilyl)propene (88 mg, 
0.45 mmol) in THF (1 mL) at -78 ˚C was added tert-butyllithium 
(1.35 M in pentane, 0.71 mL, 0.96 mmol) dropwise. The reaction mixture was stirred for 45 min 
at -78˚C and at -20˚C for 30 min. A solution of MgBr2 (0.45 mmol in 1 mL of Et2O) was added 
and the resulting cloudy mixture was allowed to warm to rt over 2 h. The resulting clear solution 
was added to a solution of aldehyde 9 (100 mg, 0.25 mmol) in THF (1 mL) at –78 ˚C. The 
MeO
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SiMe3
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reaction mixture was stirred for 15 min then was poured into a mixture of ether (20 mL) and 
saturated NH4Cl (10 mL). The organic layer was separated, and the aqueous layer was extracted 
with ether (3 × 10 mL). The combined organic layers were washed with H2O and brine, then 
were dried over Na2SO4, filtered and concentrated under reduced pressure. The crude product 
was used directly in the next step. A small amount of the unstable product was purified for 
characterization: 1H NMR (300 MHz, CDCl3) δ 7.14-7.38 (m, 7H), 6.80-6.83 (d, J = 8.5 Hz, 2H), 
4.87 (s, 1H), 4.64 (s, 1H), 3.98 (br s, 2H), 3.89 (br s, 1H), 3.77 (s, 3H), 3.34 (dt, J = 8.5, 6.5 Hz, 
1H), 3.02 (dt, J = 8.5, 6.5 Hz, 1H), 2.01 (br s, 1H), 1.74 (br s, 1H), 1.53-1.73 (m, 4H), 1.12-1.37 
(m, 12H), 0.87 (t, J = 6.8 Hz, 3H), 0.03 (s, 9H); LRMS-CI (m/z) calcd for C32H50O3Si 511.35 [M 
+ H]+, found 511.  
 
 [3-Methoxymethoxy-7-(4-methoxyphenyl)-2-methylene-6-octyloxy-7-phenylheptyl]-
trimethylsilane (1.1) 
To the crude 7-(4-methoxyphenyl)-6-octyloxy-7-phenyl-2-
trimethylsilylmethylhept-1-en-3-ol in DIPEA (1.5 mL) at 0 ˚C was added MOMCl (0.1 mL, 1.3 
mmol), followed by a small crystal of DMAP. The resulting mixture was warmed to 35 ˚C and 
was stirred at that temperature for 5 h. Saturated NH4Cl (1 mL) was added to the reaction 
mixture. The organic layer was separated and the aqueous layer was extracted with diethyl ether 
(3 × 5 mL). The organic layers were combined, washed with H2O (5 mL) and brine (5 mL), then 
were dried over Na2SO4, filtered and concentrated under reduced pressure. The resulting residue 
was purified by flash chromatography (EtOAc/CH2Cl2/hexanes = 3/10/87) to afford the desired 
product (55 mg, 40% over 2 steps): 1H NMR (300 MHz, CDCl3) δ 7.18-7.38 (m, 7H), 6.80-6.84 
(m, 2H), 4.84 (s, 1H), 4.71 (s, 1H), 4.56-4.59 (m, 1H), 4.41-4.46 (m, 1H), 3.92-3.98 (m, 2H), 
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3.76-3.78 (m, 4H), 3.36-3.40 (m, 1H), 3.28 (d, J = 2.2 Hz, 50% of 3H), 3.20 (d, J = 7.0 Hz, 50% 
of 3H), 3.04-3.07 (m, 1H), 1.47-1.62 (m, 4H), 1.15-1.40 (m, 14H), 0.89, (t, J = 6.7 Hz, 3H), 0.01 
(s, 9H); 13C NMR (75 MHz, CDCl3) δ 158.1, 146.1, 146.0, 143.4, 143.1, 142.9, 135.2, 134.9, 
134.6, 130.3, 130.1, 129.6, 129.2, 128.9, 128.7, 128.6, 128.2, 126.3, 126.2, 113.9, 113.6, 110.4, 
93.9, 82.7, 80.3, 80.1, 70.7, 70.4, 56.1, 55.6, 55.3, 32.0, 30.3, 29.6, 29.5, 29.0, 26.3, 22.9, 21.2, 
14.3, -0.8; IR (neat) 2928, 2855, 1511, 1464, 1248, 1098, 1035, 841, 698 cm-1; HRMS-EI (m/z) 
calcd for C32H49O2Si [M – OCH2OCH3]+ 493.3502, found 493.3523.  
 
1-Methoxymethoxy-2-methylene-4-octyloxycyclohexane (1.11) 
To allylsilane 1.1 (41 mg, 0.074 mmol) in DCE (3.0 mL) were added NaHCO3 (82 mg, 
0.98 mmol) and 4 Å molecular sieves (82 mg). The resulting mixture was warmed to 
40 ˚C, then a solution of CAN (101 mg, 0.185 mmol) in acetonitrile (0.9 mL) was 
added dropwise. After 10 min, the reaction mixture was filtered through a short plug of silica gel. 
The filtrate was concentrated under reduced pressure, and the resulting residue was purified by 
flash chromatography (3% EtOAc in hexanes) to afford the desired product (16.6 mg, 71%) as 2 
diastereomers (~1.7:1): 1H NMR (300 MHz, CDCl3) δ 4.98 (s, 1H, 63% of 1H), 4.94 (m, 37% of 
1H), 4.92 (m, 37% of 1H), 4.86 (m, 63% of 1H), 4.68 (d, J = 6.6 Hz, 63% of 1H, OCH2O), 4.63 
(d, J = 6.6 Hz, 63% of 1H, OCH2O), 4.65 (d, J = 6.6 Hz, 37% of 1H, OCH2O), 4.54 (d, J = 6.6 
Hz, 37% of 1H, OCH2O), 4.03-4.05 (m, 63% of 1H), 3.21-3.50 (m, 3H), 3.24-3.36 (m, 37% of 
1H), 3.38 (s, 63% of 3H, OCH3), 3.40 (s, 37% of 3H, OCH3), 2.57 (dd, J = 3.7, 13.1 Hz, 63% of 
1H), 2.41 (dd, J = 4.5, 11.3 Hz, 37% of 1H), 2.22-2.30 (m, 37% of 1H), 2.10-2.14 (m, 63% of 
1H), 1.94-2.07 (m, 2H), 1.69-1.83 (m, 1H), 1.46-1.59 (m, 4H), 1.26 (m, 10H), 0.86 (t, J = 6.6 
Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 144.9, 144.8, 112.8, 109.9, 94.7, 93.7, 77.4, 76.2, 74.3, 
OMOM
OC8H17
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68.6, 68.4, 55.6, 55.5, 38.6, 37.7, 32.1, 30.4, 30.3, 30.1, 30.0, 29.9, 29.7, 29.5, 28.6, 27.2, 26.4, 
22.9, 14.3; IR (neat) 2927, 2855, 1449, 1156, 1106, 1038 cm-1; HRMS (EI) calcd for C17H32O3 
[M+] 284.2351, found 284.2346.  
Cyclization of 1.1 under photochemical conditions:  
To allylsilane 1.1 (50 mg, 0.09 mmol) in DCE (5.0 mL) were added NMQPF6 (1.3 mg, 0.0045 
mmol), NaOAc (100 mg, 1.22 mmol), Na2S2O3 (100mg, 0.63 mmol), 4 Å molecular sieves (100 
mg) and toluene (1 mL).  The resulting mixture was stirred at rt while bubbling air gently and 
irradiating with a medium pressure mercury lamp at a distance of 4 cm. After 3 h, additional 3 
mg (0.01 mmol) of NMQPF6 was added and the reaction mixture was allowed to proceed for 
another 1 h. The reaction mixture was filtered through a short plug of silica gel, and the filtrate 
was concentrated under reduced pressure. The resulting residue was purified by flash 
chromatography (3% EtOAc in hexanes) to provide the desired product (12.9 mg, 50%) as 2 
diastereomers in ~1.7:1 ratio. 
 
(3-Methoxymethoxy-2-methylene-6-octyloxy-7-phenylheptyl)trimethylsilane (1.12) 
This substrate was prepared following the same sequence used to make 
allylsilane 1.1.  OC8H17
OMOM
SiMe3
1H NMR (300 MHz, CDCl3) δ 7.16-7.29 (m, 5H), 4.85-4.87 (m, 50% of 2H), 4.72-4.73 (m, 50% 
of 2H), 4.59 (dd, J = 1.5, 6.7Hz, 50% of 2H), 4.44 (dd, J = 2.0, 6.7Hz, 50% of 2H), 3.81-3.88 
(m, 1H), 3.35-3.54 (m, 3H), 3.31 (s, 50% of 3H), 3.28 (s, 50% of 3H), 2.81 (ddd, J = 4.6, 6.2, 
13.5 Hz, 1H), 2.65 (ddd, J = 3.1, 6.2, 13.5 Hz, 1H), 1.25-1.90 (m, 18H), 0.86 (t, J = 6.8 Hz, 3H), 
0.02 (s, 9H); IR (neat) 2924, 2852, 1250, 1091, 1029, 845 cm-1; HRMS (EI) calcd for 
C27H48O3Si [M+] 448.3372, found 448.3380.  
 47
CAN oxidation of 1.12: 
To a stirring mixture of 1.12 (40 mg, 0.89 mmol), NaHCO3 (83 mg, 1.0 mmol), and acetonitrile 
(3 mL) at rt was added CAN (97 mg, 0.177 mmol). The resulting mixture was stirred at rt for 1.5 
h, then was heated under reflux for 1 h. The reaction mixture was cooled to rt and additional 
CAN (64 mg) was added. The resulting mixture was heated at reflux for another 1 h. The 
reaction mixture was cooled to rt and was filtered through a short plug of silica gel. The filtrate 
was concentrated under reduced pressure, and the resulting residue was purified by flash 
chromatography (4-7% of EtOAc in hexanes). No cyclization product was detected. The two 
products obtained are consistent to alkane 13 and nitrate 1.14. 1.13: 1H NMR (300 MHz, CDCl3) 
δ 7.20-7.27 (m, 5H), 4.87-4.89 (2 singlets, 2H), 4.59 (d, J = 6.6 Hz, 1H), 4.45-4.47 (d, J = 6.6 
Hz, 1H), 3.91-3.96 (m, 1H), 3.36-3.45 (m, 3H), 3.32 (s, 50% of 3H), 3.26 (s, 50% of 3H), 2.82 
(ddd, J = 6.4, 9.6, 13.2 Hz, 1H), 2.66 (ddd, J = 6.0, 9.8, 13.2 Hz, 1H), 1.51-1.76 (m, 6H), 1.64 (s, 
3H), 1.20-1.30 (m, 10H), 0.86 (t, J = 6.6 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 144.2, 144.1, 
139.5, 139.4, 129.8, 129.7, 129.6, 128.4, 126.2, 120.6, 114.1, 114.0, 93.8, 81.0, 80.6, 80.4, 80.0, 
69.9, 69.8, 55.6, 41.2, 41.1, 32.0, 30.7, 30.3, 29.9, 29.7, 29.6, 29.4, 29.3, 26.4, 22.8, 22.5, 17.0, 
16.9, 14.3; IR (neat) 2927, 2855, 1449, 1097, 1033, 898, 699 cm-1; LRMS (EI) calcd for C22H35O 
[M – OCH2OCH3]+ 315, found 315. 1.14: 1H NMR (300 MHz, CDCl3) δ 7.19-7.27 (m, 5H), 
5.31-5.32 (2 singlets, 1H), 5.25-5.28 (2 singlets, 1H), 4.92 (d, J = 13.6 Hz, 1H), 4.85 (d, J = 13.6 
Hz, 1H), 4.57 (dd, J = 1.3, 6.8 Hz, 1H), 4.46 (d, J = 6.8 Hz, 1H), 4.04-4.09 (m, 1H), 3.37-3.45 
(m, 3H), 3.31 (s, 50% of 3H), 3.29 (s, 50% of 3H), 2.83 (dt, J = 7.2, 13.6 Hz, 1H), 2.63 (dt, J = 
7.2, 13.6 Hz, 1H), 1.50-1.65 (m, 6H), 1.20-1.30 (m, 10H), 0.86 (t, J = 6.6 Hz, 3H); 13C NMR (75 
MHz, CDCl3) δ 140.5, 140.4, 139.1, 129.6, 128.4, 126.2, 118.6, 94.3, 94.2, 80.7, 80.4, 77.9, 
78.2, 71.6, 71.5, 70.0, 69.9, 55.8, 41.1, 41.0, 32.0, 30.6, 30.3, 30.2, 30.1, 29.9, 29.6, 29.4, 26.4, 
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22.8, 22.5, 14.3; IR (neat) 2926, 2851, 1636, 1277, 1092, 1027, 843 cm-1; LRMS (EI) calcd for 
C22H34NO4 [M – OCH2OCH3]+ 376, found 376.  
 
3-[5-(4-Methoxyphenyl)-4-octyloxy-5-phenylpentyl]-pentane-2,4-dione (1.17) 
To a stirring mixture of alcohol 1.15 (1.53 g, 3.83 mmol) and 
triethylamine (1.55 g, 15.31 mmol) in CH2Cl2 (20 mL) at 0 ˚C was 
mol) dropwise. After 0.5 h, water was added to the reaction mixture. 
The organic layer was separated and the aqueous layer was extracted with CH
added MsCl (0.66g, 5.74 m
2Cl2. The organic 
layers were combined, washed with water, saturated NaHCO3 and brine, then were dried over 
Na2SO4, filtered and concentrated under reduce pressure. The resulting residue was dissolved in 
20 mL of acetone and NaI (2.87 g, 19.14 mmol) was added. The resulting mixture was heated at 
reflux for 1.5 h. The reaction mixture was cooled to rt and was concentrated under reduced 
pressure. The resulting residue was dissolved in water and ethyl acetate, the organic layer was 
separated and the aqueous layer was extracted with ether. The organic layers were combined, 
washed with water and brine, then were dried over Na2SO4, filtered and concentrated under 
reduced pressure. The resulting residue was purified by flash chromatography (8% EtOAc in 
hexanes) to provide iodide 1.16 (1.79 g, 92%). To a stirring mixture of iodide 1.16 (969 mg, 1.91 
mmol), 2,4-pentanedione (385 mg, 2.86 mmol), and anhydrous acetone (1 mL) was added 
potassium carbonate (403 mg, 2.02 mmol). The resulting mixture was heated at reflux for 22 h. 
The reaction mixture was cooled to rt and was filtered through Celite. The filtrate was 
concentrated under reduced pressure. The resulting residue was purified by flash 
chromatography (7-10% EtOAc in hexanes) to provide the desired product (514 mg, 56%) and 
unreacted starting material (389 mg, 40%). 1.17 exists as a ~1:1 mixture of dione and enol: 1H 
Ph
OC8H17
O
OMeO
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NMR (300 MHz, CDCl3) δ 7.17-7.37 (m, 7H), 6.80-6.84 (m, 2H), 3.87-3.95 (m, 2H), 3.77 (s, 
3H), 3.54 (t, J = 7.7 Hz, 50% of 1H, enone α-H), 3.30 (dt, J = 8.7, 6.7 Hz, 1H), 3.01 (dt, J = 8.7, 
6.7 Hz, 1H), 2.06 (s, 3H), 2.05 (s, 3H), 1.17-1.76 (m, 18H), 0.86 (t, J = 6.7 Hz, 3H); IR (neat) 
3466, 2924, 2851, 1698, 1608, 1509, 1458, 1359, 1247, 1174, 1359, 1032, 722, 688 cm-1; LRMS 
(EI) calcd for C23H27O3 [M – OC8H17]+ 351.2, found 351.  
 
8-(4-Methoxyphenyl)-3-meth
g mixture of dione 1.17 (637 mg, 1.32 mmol) and 
 
ylene-7-octyloxy-8-phenyloctan-2-one (1.18) 
To a stirrin
formaldehyde (37% aqueous solution, 0.33 mL, 4.1 mmol) in 1,4-
dioxane (1 mL) was added K2CO3 (500 mg, 3.6 mmol) in water (0.33 mL). The resulting mixture 
was stirred for 12 h at 35˚C. More water was added and the resulting mixture was extracted with 
ethyl acetate. The combined organic layers were washed with water and brine, then were dried 
over Na2SO4, filtered and concentrated under reduced pressure. The resulting residue was 
purified by flash chromatography (7-30% ethyl acetate in hexanes) to give the desired product 
(348 mg, 58%): 1H NMR (300 MHz, CDCl3) δ 7.17-7.39 (m, 7H), 6.80-6.84 (m, 2H), 5.96 (s, 
1H), 5.70 (s, 1H), 3.91-3.97 (m, 2H), 3.77 (s, 3H), 3.35 (dt, J = 8.7, 6.7 Hz, 1H), 3.01 (dt, J = 
8.7, 6.7 Hz, 1H), 2.30 (s, 3H), 2.16-2.30 (m, 2H), 1.47-1.57 (m, 4H), 1.13-1.44 (m, 12H), 0.87 (t, 
J = 6.8 Hz, 3H); 13C NMR (75 MHz, CDCl3) 199.8, 158.1, 149.2, 143.0, 135.2, 129.5, 129.0, 
128.6, 128.5, 128.2, 126.1, 124.8, 113.9, 82.4, 70.6, 32.5, 31.9, 30.6, 30.2, 29.8, 29.5, 29.3, 26.2, 
26.0, 24.0, 22.8, 14.2; IR (neat) 2927, 2855, 1678, 1610, 1454, 1248, 1100, 1035, 699 cm-1; 
LRMS (ESI) calcd for C30H42O3Na [M + Na]+ 473.3, found 473.3.  
 
Ph
OC8H17
O
MeO
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Acetic acid 6-(4-methoxyphenyl)-1-methylene-5-octyloxy-6-phenylhexyl ester (1.2) 
2 (4 mL) were added racemic trans-1,2-
2
3-Octyloxycyclohexanone (1.19) 
To enol acetate 1.2 (100 mg, 0.22 mmol) in DCE (8.0 mL) were added NaHCO3 
nd 4 Å molecular sieves (200 mg). The resulting mixture 
w 5
to the resulting
MeO To a stirring mixture of 4 Å molecular sieves (100 mg, flame dried 
under vacuum) and CH2Cl
OC8H17
(diamino)cyclohexane (0.57  M in CH2Cl2, 0.50 mL, 0.29 mmol) and SnCl4 (1 M in CH2Cl2, 0.29 
mL, 0.29 mmol). After the reaction mixture was cooled to 0 ˚C, bis(trimethylsilyl)peroxide (211 
mg, 1.0 mmol) was added, followed by a solution of enone 1.18 (117 mg, 0.26 mmol) in CH2Cl2 
(4 mL) after 7 min. The reaction mixture was stirred at rt for 40 h. Solid Na2S2O3 (~100 mg) was 
added and the resulting mixture was stirred for another 3 h. The reaction mixture was filtered 
through a short pad of Celite, and the filtrate was concentrated under reduced pressure. The 
resulting residue was purified by flash chromatography (5-10% EtOAc in hexanes) to provide 
the desired product (87 mg, 71%): 1H NMR (300 MHz, CDCl3) δ 7.24-7.34 (m, 7H), 6.87-6.91 
(m, 2H), 4.75-4.77 (m, 2H), 3.98-4.04 (m, 2H), 3.84 (s, 3H), 3.41 (dt, J = 8.7, 6.4 Hz, 1H), 3.09 
(dt, J = 8.7, 6.6 Hz, 1H), 2.21-2.29 (m, 2H), 2.18 (s, 3H), 1.59-1.66 (m, 4H), 1.26-1.50 (m, 12H), 
0.94 (t, J = 6.9 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 169.3, 158.1, 156.4, 143.0, 135.1, 129.5, 
129.0, 128.2, 126.2, 114.0, 101.4, 82.3, 70.6, 55.7, 55.3, 33.5, 32.2, 32.0, 30.2, 29.5, 29.4, 26.2, 
22.8, 22.2, 21.2, 14.3; IR (neat) 2927, 2854, 1756, 1511, 1248, 1199, 1178, 1101, 698 cm-1; 
LRMS (ESI) calcd for C30H42O4Na [M + Na]+ 489.3, found 489.3.  
 
(200 mg, 2.38 mmol) a
as heated to 0 ˚C. A solution of CAN (294 mg, 0.54 mmol) in acetonitrile (2.6 mL) was added 
 mixture dropwise. After 5 min, the reaction mixture was cooled to rt and was 
filtered through a short plug of silica gel. The filtrate was concentrated under reduced pressure, 
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O
O
O
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and the residue was purified by flash chromatography (4% EtOAc in hexanes) to afford the 
desired product (46 mg, 94%): 1H NMR (300 MHz, CDCl3) δ 3.65-3.75 (m, 1H), 3.38 (app t, J = 
6.6 Hz, 2H), 2.57 (dd, J = 14.0, 3.8 Hz, 1H), 2.41 (dd, J = 14.0, 7.3 Hz, 1H), 2.28 (app t, J = 6.4 
Hz, 2H), 1.93-2.05 (m, 2H), 1.78-1.82 (m, 1H), 1.65-1.69 (m, 1H), 1.48-1.55 (m, 2H), 1.26 (br s, 
10H), 0.85 (t, J = 6.3 Hz, 3H); 13C NMR (75 MHz, CDCl3) 210.1, 68.7, 47.9, 41.3, 32.0, 30.3, 
30.1, 29.6, 29.5, 26.4, 22.9, 20.9, 14.3; IR (neat) 2925, 2849, 1715, 1453, 1099 cm-1; HRMS (EI) 
calcd for C14H26O2 [M+] 226.1932, found 226.1923.  
Cyclization of 1.2 under photochemical conditions:  
To 1.2 (29.6 mg, 0.064 mmol) in DCE (5.0 mL) in a borosilicate flask were added NMQPF6 (0.9 
2O3 (60 mg, 0.38 mmol), 4 Å Molecular 
THF (4.6 mL) was added dropwise to dry CeCl3 solid (0.68 g, 
The resulting suspension was 
h
mmol) and magnesium ribbon 
mg, 0.0032 mmol), NaOAc (60 mg, 0.73 mmol), Na2S
sieves (60 mg) and toluene (1 mL). The resulting mixture was stirred at rt while bubbling air 
gently and irradiating with a medium pressure mercury lamp at a distance of 4 cm for 2 h. The 
reaction mixture was filtered through a short plug of silica gel, and the filtrate was concentrated 
under vacuum. The resulting residue was purified by flash chromatography (4% EtOAc in 
hexanes) to afford the desired product (11 mg, 75%). 
                
7,7-Diethoxy-1-(4-methoxyphenyl)-1-phenylheptan-2-ol (1.22) 
2.76 mmol) at 0 °C with stirring. 
subjected to sonication for 1 . A Grignard solution [made from bromide 1.20 (0.76 g, 3.17 
(76 mg, 3.17 mmol) in 5 mL of THF] was added to the CeCl3 
suspension dropwise at 0 °C. The reaction mixture turned yellow. After 1.5 h, a solution of 
aldehyde 1.6 (0.5 g, 2.4 mmol) in THF (2 mL) was added to the reaction mixture dropwise at 0 
°C. The resulting mixture was stirred for 50 min and was quenched with 10% acetic acid (10 
MeO
O
Ph O
OH
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mL). The organic layer was separated and the aqueous layer was extracted with EtOAc. The 
organic layers were combined, washed with H2O, saturated NaHCO3, and brine, then were dried 
over Na2SO4, and concentrated under reduced pressure. Purification of the resulting residue by 
flash chromatography (20-25% EtOAc in hexanes) provided the desired product (612 mg, 66%) 
as 2 diastereomers. Ketone product 1.23 (100 mg, 11%) was also isolated, which was reduced to 
the desired alcohol with NaBH4, giving a 77% overall yield: 1H NMR (300 MHz, CDCl3) δ 7.19-
7.38 (m, 7H), 6.81 (d, J = 6.6 Hz, 50% of 2H), 6.82 (d, J = 6.6 Hz, 50% of 2H), 4.43 (t, J = 5.7 
Hz, 1H), 4.28-4.32 (m, 1H), 3.81 (d, J = 8.3 Hz, 1H), 3.77 (s, 3H), 3.57-3.65 (m, 2H), 3.42-3.52 
(m, 2H), 1.40-1.61 (m, 4H), 1.30-1.40 (m, 4H), 1.17 (t, J = 7.0 Hz, 6H); 13C NMR (75 MHz, 
CDCl3) δ 158.4, 142.0, 134.8, 129.36, 129.0, 128.9, 128.4, 128.0, 126.6, 114.0, 103.1, 74.0, 61.1, 
61.0, 58.1, 55.4, 35.1, 33.8, 25.9, 24.9, 15.6; IR (neat) 3462, 2973, 2934, 1610, 1511, 1248, 
1177, 1036, 700 cm-1; LRMS (EI) calcd for C22H29O3 [M – OC2H5]+ 341.2, found 341. Also, 
HRMS (EI) calcd for C22H28O3 [M – OC2H5 – H]+ 340.2038, found 340.2021. Ketone product 
1.23: δ 7.22-7.35 (m, 7H), 6.84 (d, J = 6.6 Hz, 50% of 2H), 6.85 (d, J = 6.6 Hz, 50% of 2H), 4.43 
(t, J = 5.5 Hz, 1H), 3.82 (s, 1H), 3.79 (s, 3H), 3.58-3.64 (m, 2H), 3.41-3.51 (m, 2H), 2.52 (t, J = 
7.1 Hz, 2H), 1.55-1.64 (m, 2H), 1.25-1.36 (m, 4H), 1.18 (t, J = 7.0 Hz, 6H). 
 
 
1-(7,7-Diethoxy-2-octyloxy-1-phenylheptyl)-4-methoxybenzene  
To neat alcohol 1.22 (0.3 g, 0.78 mmol) at rt were added NaH 
mol) and 1-iodooctane (1.43 
m
temperature. The reaction mix
(60% in mineral oil, 123 mg, 3.11 m
g, 6.21 mmol). The resulting ixture was heated to 120 °C and was stirred overnight at that 
ture was cooled to 0 °C and was diluted with hexanes (5 mL). 
Water (2 mL) was added slowly to the resulting mixture. The organic layer was separated and 
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O
Ph O
OC8H17
 53
the aqueous layer was extracted with EtOAc. The combined organic layers were washed with 
water and brine, then were dried over Na2SO4, filtered and concentrated under reduced pressure. 
The resulting residue was purified by flash chromatography (5% EtOAc in hexanes) to provide 
the desired product (220 mg, 57%): 1H NMR (300 MHz, CDCl3) δ 7.17-7.40 (m, 7H), 6.81 (d, J 
= 8.6 Hz, 50% of 2H), 6.82 (d, J = 8.6 Hz, 50% of 2H), 4.41 (t, J = 5.6 Hz, 1H), 3.95 (d, J = 7.9 
Hz, 1H), 3.90-3.94 (m, 1H), 3.76 (2 singlets, 3H), 3.61-3.67 (m, 2H), 3.45-3.51 (m, 2H), 3.32-
3.40 (m, 1H), 3.00-3.06 (m, 1H), 1.17-1.60 (m, 20H), 1.21 (t, J = 6.7 Hz, 6H), 0.88 (t, J = 6.8 
Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 158.0, 143.5, 143.0, 135.2, 134.6, 130.1, 129.4, 128.9, 
128.5, 128.4, 128.1, 126.2, 126.1, 113.8, 113.5, 102.9, 82.6, 82.5, 70.5, 60.9, 55.7, 55.1, 33.6, 
32.9, 32.8, 31.9, 30.2, 29.4, 29.3, 26.2, 25.30, 25.1, 24.9, 22.7, 15.4, 14.2; IR (neat) 2924, 2847, 
1705, 1506, 1239 cm-1. 
 
7-(4-Methoxyphenyl)-6-octyloxy-7-phenyl-heptanal (1.24) 
To 1-(7,7-diethoxy-2-octyloxy-1-phenylheptyl)-4-methoxybenzene 
) at 0 °C was added 50% aqueous 
L
until no gas evolution wa
Ph O
(0.22 g, 0.44 mmol) in CHCl3 (8 mL
trifluoroacetic acid (4 m ). After 1.5 h, saturated NaHCO3 was added to the reaction mixture 
s seen. The organic layer was separated and the aqueous layer was 
extracted with EtOAc. The combined organic layers were washed with water and brine, then 
were dried over Na2SO4, filtered and concentrated under reduced pressure. The resulting residue 
(0.19 g, ~100%) was sufficiently pure to be used in the next step. 1H NMR (300 MHz, CDCl3) δ 
9.69 (s, 1H), 7.17-7.40 (m, 7H), 6.81 (d, J = 7.9 Hz, 2H), 3.95 (d, J = 7.9 Hz, 1H), 3.92 (br s, 
1H), 3.75 (s, 3H), 3.33 (dt, J = 8.1, 6.5 Hz, 1H), 3.03 (dt, J = 8.1, 6.5 Hz, 1H), 2.32 (t, J = 6.2, 
2H), 1.16-1.55 (m, 18H), 0.89 (t, J = 6.7 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 202.5, 158.0, 
MeO
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143.2, 142.8, 135.0, 134.4, 131.1, 130.0, 129.4, 128.9, 128.4, 128.1, 126.2, 126.0, 113.8, 113.5, 
82.3, 82.2, 70.6, 70.5, 55.6, 55.1, 43.7, 32.7, 32.5, 31.8, 30.1, 29.4, 29.3, 26.1, 24.9, 24.8, 22.7, 
22.1, 14.1; IR (neat) 2924, 2852, 1700, 1511, 1454, 1239 cm-1. 
 
9-(4-Methoxyphenyl)-8-octyloxy-9-phenyl-1-trimethylsilylnon-1-yn-3-ol (1.25) 
To a stirring solution of trimethylsilylacetylene (0.22 g, 2.25 
Li (1.6 M in 
o
resulting solution was added to a
 
Ph OH
mmol) in THF (5 mL) at 0 °C was added n-Bu
hexanes, 1.26 mL, 2.0 mmol) dr pwise. The reaction mixture was stirred at 0 °C for 45 min. The 
 solution of aldehyde 1.24 (190 mg, 0.44 mmol) in THF (3 mL) 
at 0 °C. After stirred at 0 °C for 1 h, the reaction mixture was quenched with saturated NH4Cl. 
The organic layer was separated and the aqueous layer was extracted with EtOAc. The combined 
organic layers were washed with water and brine, then were dried over Na2SO4, filtered and 
concentrated under reduced pressure. The resulting residue was purified by flash 
chromatography (10% EtOAc in hexanes) to afford the desired product (172 mg, 75%): 1H NMR 
(300 MHz, CDCl3) δ 7.18-7.40 (m, 7H), 6.81 (d, J = 8.6 Hz, 2H), 4.32 (t, J = 6.2 Hz, 1H), 3.97 
(d, J = 8.1 Hz, 1H), 3.90 (br s, 1H), 3.77 (s, 3H), 3.35 (dt, J = 8.6, 6.7 Hz, 1H), 3.01 (dt, J = 8.6, 
6.7 Hz, 1H), 1.89 (br s, 1H, OH), 1.60-1.68 (m, 2H), 1.14-1.5 (m, 18H), 0.90 (t, J = 6.7 Hz, 3H), 
0.18 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 158.1, 143.5, 143.0, 135.3, 134.7, 130.1, 129.5, 
129.0, 128.6, 128.5, 128.2, 126.2, 113.9, 113.6, 107.0, 89.4, 82.5, 70.7, 62.9, 62.9, 55.9, 55.3, 
37.8, 32.9, 32.0, 30.2, 29.5, 29.4, 26.2, 25.4, 25.3, 25.1, 22.8, 14.3, 0.1; IR (neat) 3429, 2926, 
2855, 2170, 1512, 1033, 1243, 835 cm-1; HRMS (EI) calcd for C32H47O3 [M – CH3]+ 507.3294, 
found 507.3302.  
MeO
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[9-(4-Methoxyphenyl)-8-octyloxy-9-phenylnona-1,2-dienyl] trimethylsilane (1.27) 
To a stirring solution of PPh3 (0.13 g, 0.49 mmol) in THF (2.5 
mL) at -10 °C was added DEAD (86 mg, 0.49 mmol). The 
in, and a 
solution of NBSH 1.26 (208 m
Ph
reaction mixture turned yellow. The reaction mixture was stirred at –10 °C for 10 m
solution of alcohol 1.25 (172 mg, 0.33 mmol) in THF was added. After another 10 min, a 
g, 0.82 mmol) in THF (2 mL) was added. The reaction 
temperature was allowed to increase to rt slowly. After 2.5 h, the reaction mixture was 
concentrated under reduced pressure. The resulting residue was dissolved in EtOAc (2 mL), and 
the resulting solution was added to stirring hexanes (50 mL) dropwise. A precipitate formed and 
the resulting suspension was filtered through a thin silica gel plug eluting with 5% EtOAc in 
hexanes. The filtrate was concentrated under reduced pressure, and the resulting residue was 
purified by flash chromatography (5% EtOAc in hexanes) to afford the desired product (140 mg, 
84%): 1H NMR (300 MHz, CDCl3) δ 7.18-7.37 (m, 7H), 6.7 (d, J = 8.5Hz, 2H), 4.84 (dt, J = 6.8, 
3.5 Hz, 1H), 4.69 (ddd, J = ~0.8, 6.8, 13.6 Hz, 1H), 3.93 (d, J = 7.8 Hz, 1H), 3.86 (br s, 1H), 3.77 
(2 singlets, 3H), 3.31 (dt, J = 8.7, 6.6 Hz, 1H), 2.97 (dt, J = 8.7, 6.6 Hz, 1H), 1.90 (br s, 1H), 
1.12-1.55 (m, 18H), 0.86 (t, J = 6.9 Hz, 3H), 0.08 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 210.1, 
158.0, 143.6, 135.4, 134.7, 130.2, 129.5, 129.1, 128.6, 128.4, 128.1, 126.2, 113.9, 113.5, 83.4, 
82.6, 70.6, 55.7, 55.3, 33.0, 31.9, 31.7, 30.2, 30.0, 29.5, 29.4, 28.0, 26.2, 25.1, 22.8, 14.2, -0.7; 
IR (neat) 2922, 2851, 1936, 1611, 1508, 1449, 1251, 1097, 1104, 851 cm-1; HRMS (EI) calcd for 
C33H50O2  [M+] 506.3580, found 506.3590.  
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1-Ethynyl-2-octyloxycyclohexane (1.28) 
To allene 1.27 (73 mg, 0.145 mmol) in DCE (4.0 mL) were added NaHCO3 (140 
mg, 1.67 mmol) and 4 Å molecular sieves (140 mg). The stirring mixture was 
(198 mg, 0.362 mmol) in acetonitrile (1.2 mL) was 
a s
The filtrate wa
OC8H17
heated to 40 ˚C, then a solution of CAN 
dded dropwi e. After 10 min, the reaction mixture was filtered through a short plug of silica gel. 
s concentrated under reduced pressure, and the resulting residue was purified by 
flash chromatography (20% toluene in hexanes) to afford the desired alkyne (28 mg, 81%, as 2 
diastereomers in 1.2:1 ratio) and silylalkyne 1.29 (4.4 mg, 10%). The latter was converted to the 
titled product by treating it with TBAF, which gave a 91% overall yield. cis-Isomer of 1.28 
(faster eluting diastereomer)1: 1H NMR (300 MHz, CDCl3) δ 3.50 (dt, J = 9.2, 6.7 Hz, 1H), 3.37 
(dt, J = 9.2, 6.7 Hz, 1H), 3.22 (app dt, J = 8.5, 4.1 Hz, 1H), 2.97 (br s, 1H), 2.07 (d, J = 2.4 Hz, 
1H), 1.70-1.75 (m, 1H), 1.26-1.70 (m, 19H), 0.86 (t, J = 6.6 Hz, 3H); 13C NMR (75 MHz, 
CDCl3) δ 85.0, 78.0, 70.6, 68.7, 32.8, 32.1, 30.2, 29.6, 29.5, 28.7, 26.4, 23.9, 22.9, 22.1, 14.3; IR 
(neat) 3310, 2930, 2847, 2114, 1457, 1366, 1100 cm-1; HRMS (EI) calcd for C16H28O [M+] 
236.2140, found 236.2141. trans-Isomer of 1.28 (slower eluting diastereomer)1: 1H NMR (300 
MHz, CDCl3) δ 3.49-3.57 (m, 2H), 3.19 (app dt, J = 3.9, 8.0 Hz, 1H), 2.38-2.45 (m, 1H), 2.06 (d, 
J = 2.4 Hz, 1H), 1.96-1.99 (m, 2H), 1.47-1.69 (m, 6H), 1.27 (br, 12H), 0.86 (t, J = 6.7 Hz, 3H); 
13C NMR (75 MHz, CDCl3) δ 87.0, 79.7, 69.6, 69.1, 35.0, 32.0, 30.5, 30.2, 29.8, 29.6, 29.4, 26.3, 
24.1, 23.4, 22.8, 14.2; IR (neat) 3306, 2926, 2855, 2166, 2114, 1449, 1362, 1104, 839 cm-1; 
HRMS (EI) calcd for C16H28O [M+] 236.2140, found 236.2149. Silylalkyne 1.29: 1H NMR (300 
MHz, CDCl3) δ 3.51 (dt, J = 9.1, 6.7 Hz, 1H), 3.37 (dt, J = 9.1, 6.5 Hz, 1H), 3.27 (app dt, J = 
8.7, 3.8 Hz, 1H), 2.90 (m, 1H), 1.26-1.76 (m, 20H), 0.86 (t, J = 6.7 Hz, 3H), 0.15 (s, 9H); HRMS 
(EI) calcd for C19H36OSi [M+] 308.2535, found 308.2533.  
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1-(2-Benzyloxy-7,7-diethoxy-1-phenylheptyl)-4-methoxybenzene  
To alcohol 1.22 (0.1 g, 0.26 mmol) in DMF (3 mL) at rt was 
added NaH (60% in min
Ph O
eral oil, 36 mg, 0.91 mmol). The 
 g, 1.55 mmol) was added 
c
separated and the aqueous lay
organic layers were washed w
(275 mg, 0.58 mmol) in CHCl3 (8 mL) at 0 °C was added 50% 
queous trifluoroacetic acid (4 mL). The reaction mixture was stirred at 0 °C for 1.5 h, then 
. The organic layer was separated 
reaction mixture was stirred for 10 min, then benzyl bromide (0.27
dropwise. After 1.5 h, an ice hunk was added to the reaction mixture. The organic layer was 
er was extracted with diethyl ether (3 × 5 mL). The combined 
ith water and brine, then were dried over Na2SO4, filtered and 
concentrated under reduced pressure. The resulting residue was purified by flash 
chromatography (8% EtOAc in hexanes) to provide the desired product (91 mg, 57%): 1H NMR 
(300 MHz, CDCl3) δ 7.22-7.49 (m, 10H), 7.00-7.10 (m, 2H), 6.87 (d, J = 8.7 Hz, 50% of 2H), 
6.83 (d, J = 8.7 Hz, 50% of 2H), 4.40 (dt, J = 1.1, 5.7 Hz, 1H), 4.31 (d, J = 10.9 Hz, 1H), 4.12 (d, 
J = 10.9 Hz, 1H), 4.04-4.10 (m, 2H), 3.79 (2 singlets, 3H), 3.55 (dq, J = 9.3, 7.1 Hz, 2H), 3.41 
(dq, J = 9.3, 7.1 Hz, 2H), 1.25-1.58 (br, 8H), 1.17 (t, J = 7.0 Hz, 6H); 13C NMR (75 MHz, 
CDCl3) δ 158.1, 143.2, 142.9, 138.6, 138.5, 134.9, 134.4, 130.1, 129.4, 129.0, 128.5, 128.2, 
127.9, 127.4, 126.2, 126.2, 113.9, 113.6, 102.9, 82.4, 82.3, 72.4, 61.0, 60.9, 55.7, 55.6, 55.1, 
33.6, 32.7, 32.6, 25.1, 15.0, 24.9, 15.4, 14.2;  IR (neat) 3060, 3028, 2972, 2937, 1610, 1510, 
1452, 1249, 1062, 698 cm-1; LRMS (EI) calcd for C27H28O2 [M – CH2Ph – H]+ 384.2, found 384.  
 
6-Benzyloxy-7-(4-methoxyphenyl)-7-phenylheptanal (1.30) 
To 1-(2-benzyloxy-7,7-diethoxy-1-phenylheptyl)-4-methoxybenzene 
a
saturated NaHCO3 was added until no gas evolution was seen
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and the aqueous layer was extracted with EtOAc. The combined organic layers were washed 
with water and brine, then were dried over Na2SO4, filtered and concentrated under reduced 
pressure. The resulting residue was purified by flash chromatography (15% EtOAc in 
hexanes) to provide the desired product (197 mg, 84%) as a mixture of 2 diastereomers: 1H 
NMR (300 MHz, CDCl3) δ 9.71 (2 singlets, 1H), 7.19-7.37 (m, 10H), 7.00-7.10 (m, 2H), 6.81 
(d, J = 8.8 Hz, 50% of 2H), 6.82 (d, J = 8.8 Hz, 50% of 2H), 4.30 (d, J = 10.9 Hz, 1H), 4.13 
(d, J = 10.9 Hz, 1H), 4.00-4.10 (m, 2H), 3.79 (2 singlets, 3H), 2.28-2.35 (m, 2H), 1.39-1.55 
(m, 6H); 13C NMR (75 MHz, CDCl3) δ 202.6, 158.2, 143.1, 142.8, 138.5, 134.8, 134.3, 
130.1, 129.4, 129.0, 128.5, 128.5, 128.2, 128.0, 127.5, 126.4, 126.3, 114.0, 113.7, 82.1, 82.0, 
72.6, 55.7, 55.2, 43.8, 32.6, 32.5, 24.8, 24.7, 22.1; IR (neat) 3027, 2932, 1716, 1509, 1250, 
1173, 1029, 698 cm-1; LRMS (CI) calcd for C20H23O3 [M – CH2Ph]+ 311.16, found 311. 
 
8-Benzyloxy-9-(4-methoxyphenyl)-9-phenyl-1-trimethylsilyl-non-1-yn-3-ol (1.31) 
Prepared following the procedure for 1.25. 1H NMR (300 
MHz, CDCl3) δ 7.19-7.36 (m, 10H), 7.00-7.09 (m, 2H), 
6.81-6.89 (m, 2H), 4.37 (d, J = 10.9 Hz, 1H), 4.16 (d, J = 10.9 Hz, 1H), 4.28-4.32 (m, 1H), 
4.00-4.10 (m, 2H), 3.79 (2 singlets, 3H), 2.00 (br s, 1H), 1.44-1.67 (m, 8H), 0.21 (s, 9H); 13C 
NMR (75 MHz, CDCl3) δ 158.1, 143.2, 142.9, 138.6, 138.6, 135.0, 134.5, 130.2, 129.5, 
129.1, 128.6, 128.3, 128.3, 128.1, 127.5, 126.4, 126.3, 114.0, 113.7, 107.0, 89.4, 82.4, 82.3, 
72.6, 62.8, 62.7, 55.9, 55.8, 55.3, 37.7, 32.9, 32.8, 25.4, 25.3, 25.0, 24.9, 0.1; IR (neat) 3431, 
2929, 2858, 2166, 1511, 1449, 1244, 1034, 845 cm-1; HRMS (EI) calcd for C32H40O3Si [M+] 
500.2746, found 500.2766.  
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[8-Benzyloxy-9-(4-methoxyphenyl)-9-phenylnona-1,2-
dienyl]trimethylsilane (1.32) 
 
Prepared following the procedure for 1.27. 1H NMR (300 MHz, CDCl3) δ 7.20-7.40 (m, 10H), 
7.00-7.10 (m, 2H), 6.82 (d, J = 8.5 Hz, 50% of 2H), 6.81 (d, J = 8.5 Hz, 50% of 2H), 4.85-4.90 
(m, 1H), 4.69 (app dq, J = 1.4, 6.8 Hz, 1H), 4.43 (d, J = 10.9 Hz, 1H), 4.20 (d, J = 10.9 Hz, 1H), 
9H); 13C 
5
128.6, 128.3, 128.0, 127.5, 126.3, 1
 40 °C, and a solution of CAN (203 mg, 0.37 mmol) in 
cetonitrile (1.5 mL) was added dropwise. After 10 min, the reaction mixture was filtered 
oncentrated under reduced pressure, and the 
re
the desired
4.01-4.06 (m, 2H), 3.78 (2 singlets, 3H), 1.89-1.93 (m, 2H), 1.27-1.58 (br, 6H), 0.09 (s, 
NMR (75 MHz, CDCl3) δ 210.1, 1 8.2, 143.4, 143.0, 138.7, 135.1, 134.5, 130.3, 129.5, 129.1, 
14.0, 113.7, 83.4, 82.6, 72.6, 55.8, 55.7, 55.3, 32.8, 32.6, 
29.9, 27.9, 25.0, 24.9, -0.6; IR (neat) 2929, 1936, 1510, 1247, 839, 697 cm-1; HRMS (EI) calcd 
for C32H40O2Si [M+] 484.2797, found 484.2806.  
 
 (2-Ethynyl-cyclohexyloxymethyl)benzene (1.33) 
To a stirring mixture of allene 1.32 (71 mg, 0.148 mmol) in DCE (5.0 mL) were 
added NaHCO3 (140 mg, 1.67 mmol) and 4 Å molecular sieves (140 mg). The 
resulting mixture was warmed to
OBn
a
through a short plug of silica gel. The filtrate was c
resulting sidue was purified by flash chromatography (0.5-2% EtOAc in hexanes) to provide 
 alkyne (16.5 mg, 52%) as 2 diastereomers in 1.3:1 ratio. Silylalkyne 1.34 (1.5 mg, 
3.5%) and unreacted starting material (11 mg, 15.5%) were also isolated. The overall yield was 
66% based upon unrecovered starting material. 1H NMR (300 MHz, CDCl3) δ 7.14-7.34 (m, 
5H), 4.62-4.49 (d, J = 12.3 Hz, ~50% of 1H), 4.59 (s, ~50% of 2H), 4.58 (d, J = 12.3 Hz, ~50% 
of 1H), 3.30-3.37 (m, 1H), 2.92 (br s, 43% of 1H), 2.41-2.48 (m, 57% of 1H), 1.94 (m, 1H, 
alkyne proton), 1.11-1.9 (m, 8H); 13C NMR (75 MHz, CDCl3) δ 139.1, 128.5, 127.9, 127.8, 
127.6, 87.0, 85.0, 79.4, 77.0, 71.4, 70.8, 70.2, 69.5, 35.2, 32.9, 30.6, 30.3, 29.9, 29.6, 28.6, 24.1, 
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23.7, 22.1; IR (neat) 3305, 2934, 2858, 2114, 1443, 1097, 735, 697 cm-1; HRMS (EI) calcd for 
C15H17O [M – H]+ 213.1279, found 213.1275.  
 
1-(4-Methoxyphenyl)-1-phenyl-7-(tetrahydropyran-2-yloxy)heptan-2-ol (1.37) 
Prepared following the procedure for 1.22. 1H NMR (300 MHz, 
CDCl3) δ 7.15-7.47 (m, 7H), 6.77 (d, J = 6.6 Hz, 50% of 2H), 6.78 
(d, J = 6.7 Hz, 50% of 2H), 4.50 (t, J = 3.5 Hz, 1H), 4.22-4.30 (m, 1H), 3.63-3.88 (m, 3H), 3.72 
, 3H), 3.40-3.46 (m, 1H), 3.27-3.35 (m, 1H), 1.13-1.70 (m, 14H); 13C NMR (75 MHz, CDCl3) 
δ 158.2, 142.0, 129.3, 128.9, 126.8, 11
26.4, 25.8, 25.8, 25.6, 19.8; IR (neat) 3452, 2939, 2858, 1603, 1506, 1454, 1250, 1173, 1116, 
mol) was added 
ropwise. The ice bath was removed and the reaction mixture was stirred at rt for 2.5 h. An ice 
 the aqueous layer 
c
were dried over Na2SO4, filtere
(s
4.1, 99.0, 73.9, 67.6, 62.5, 58.0, 55.3, 35.1, 30.9, 29.8, 
1075, 1029 cm-1. 
 
2-[6-Allyloxy-7-(4-methoxyphenyl)-7-phenyl-heptyloxy]tetrahydropyran 
To alcohol 1.37 (1.5 g, 3.77 mmol) in DMF (25 mL) at 0 °C was 
added NaH (60% in mineral oil, 452 mg, 11.31 mmol,). The 
reaction mixture was stirred for 10 min, then allyl bromide (2.28 g, 18.84 m
d
chunk was added to the reaction mixture. The organic layer was separated and
was extracted with ether. The ombined organic layers were washed with water and brine, then 
d and concentrated under reduced pressure. The resulting residue 
was purified by flash chromatography (15% EtOAc in hexanes) to afford the desired product: 1H 
NMR (300 MHz, CDCl3) δ 7.18-7.40 (m, 7H), 6.81 (d, J = 8.7 Hz, 50% of 2H), 6.82 (d, J = 8.7 
Hz, 50% of 2H), 5.64-5.69 (m, 1H), 5.01-5.10 (m, 2H), 4.55 (distorted t, 1H), 3.97-3.99 (m, 2H), 
MeO
Ph
OH
OTHP
MeO
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O
OTHP
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3.78 (2 singlets, 3H), 3.64-3.99 (m, 4H), 3.50-3.54 (m, 1H), 3.34-3.38 (m, 1H), 1.28-1.71 (m, 
14H); 13C NMR (75 MHz, CDCl3) δ 158.0, 143.2, 142.6, 135.2, 135.1, 134.9, 134.3, 130.0, 
129.3, 129.1, 128.9, 128.4, 128.2, 127.6, 126.0, 125.9, 115.9, 113.7, 113.4, 98.6, 82.3, 82.2, 71.4, 
71.3, 67.2, 61.9, 55.5, 55.4, 54.8, 32.9, 32.8, 30.6, 29.5, 26.2, 25.4, 25.1, 24.9, 19.5; IR (neat) 
2939, 2862, 1610, 1511, 1453, 1249, 1178, 1137, 1129, 1077, 1034, 990, 700 cm-1; LRMS (ESI) 
calcd for C28H38O4Na [M + Na]+ 461.27, found 461.2.  
 
6-Allyloxy-7-(4-methoxyphenyl)-7-phenylheptan-1-ol  
To 2-[6-allyloxy-7-(4-methoxyphenyl)-7-phenylheptyloxy]-
tetrahydropyran obtained above in methanol (20 mL) at rt was 
added para-toluenesulfonic acid (50 mg). The resulting mixture was stirred at rt for 5 h, then was 
oncentrated under reduced pressure. The resulting residue was purified by flash 
e desired product (1.12 g, 84% over 2 
D
(d, J = 8.6 Hz, 50% of 2H), 5.6
c
chromatography (30-45% EtOAc in hexanes) to afford th
steps): 1H NMR (300 MHz, C Cl3) δ 7.19-7.43 (m, 7H), 6.83 (d, J = 8.6 Hz, 50% of 2H), 6.84 
4-5.79 (m, 1H), 5.04-5.14 (m, 2H), 4.01 (br s, 2H), 3.81 (dd, J = 
5.5, 12.3 Hz, 1H), 3.75 (2 singlets, 3H), 3.61 (dd, J = 5.5, 12.3 Hz, 1H), 3.50 (t, J = 6.4 Hz, 2H), 
2.36 (br s, 1H), 1.38-1.51 (m, 6H), 1.14-1.20 (m, 2H); 13C NMR (75 MHz, CDCl3) δ 158.0, 
143.2, 142.7, 135.1, 135.0, 134.3, 130.1, 129.4, 129.0, 128.4, 128.4, 128.1, 126.2, 126.1, 116.3, 
113.8, 113.5, 82.3, 71.6, 71.6, 62.5, 55.6, 55.6, 55.1, 33.0, 32.9, 32.6, 25.8, 25.1, 25.0; IR (neat) 
3385, 2935, 2859, 1610, 1511, 1248, 1178, 1035, 700 cm-1; HRMS (EI) calcd for C20H24O2  [M 
– OC3H5 – H] + 296.1776, found 296.1774.  
6-Allyloxy-7-(4-methoxyphenyl)-7-phenylheptanal (1.38) 
To a stirring mixture of 6-allyloxy-7-(4-methoxyphenyl)-7-
MeO
Ph
O
OH
Ph O
MeO
H
O
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phenylheptan-1-ol (1.12 g, 3.16 mmol), NaHCO3 (796 mg, 9.48 mmol) and CH2Cl2 (20 mL) at 0 
°C was added Dess-Martin periodinane. After 1 h, saturated NaHCO3 and Na2S2O3 solutions 
were added to the reaction mixture. The resulting mixture was stirred at rt for another 0.5 h. The 
 EtOAc. The combined 
h
concentrated under red
95-5.07 (m, 2H), 4.30 (dd, J = 5.6, 
0.8 Hz, 1H), 3.99 (br s, 2H), 3.80 (ddd, J = 1.3, 5.7, 12.3 Hz, 1H), 3.75 (2 singlets, 3H), 3.61 
6H), 0.20 (s, 
13
129.46, 129.02, 128.49, 128.16, 
organic layer was separated and the aqueous layer was extracted with
organic layers were was ed with water and brine, then were dried over Na2SO4, filtered and 
uced pressure. The resulting residue was purified by flash 
chromatography (15% EtOAc in hexanes) to afford the desired product (858 mg, 77%): 1H NMR 
(300 MHz, CDCl3) δ 9.70 (m, 1H), 7.18-7.41 (m, 7H), 6.82 (m, J = 8.6 Hz, 2H), 5.62-5.77 (m, 
1H), 5.02-5.17 (m, 2H), 4.03 (br s, 2H), 3.79 (ddd, J = 1.2, 5.7, 12.3 Hz, 1H), 3.76 (s, 3H), 3.61 
(app dd, J = 5.7, 12.3 Hz, 1H), 2.33-2.38 (m, 2H), 1.27-1.60 (m, 6H); 13C NMR (75 MHz, 
CDCl3) δ 202.4, 158.1, 143.1, 142.6, 135.2, 135.1, 134.9, 134.2, 130.1, 129.5, 129.0, 128.5, 
128.5, 128.2, 126.3, 126.2, 116.4, 113.9, 113.6, 82.2, 82.2, 71.7, 71.7, 55.7, 55.6, 55.2, 43.7, 
32.9, 32.7, 24.9, 24.8, 22.1; IR (neat) 2936, 1722, 1510, 1248, 1033, 700cm-1; LRMS (EI) calcd 
for C20H22O3  [M – OC3H5 – H]+ 310, found 310.  
 
8-Allyloxy-9-(4-methoxyphenyl)-9-phenyl-1-trimethylsilyl-non-1-yn-3-ol (1.39) 
Prepared following the procedure for 1.25. 1H NMR (300 
MHz, CDCl3) δ 7.18-7.42 (m, 7H), 6.82 (d, J = 8.8Hz, 50% of 
2H), 6.83 (d, J = 8.8 Hz, 50% of 2H), 5.63-5.76 (m, 1H), 4.
MeO
Ph
O
OH
TMS
1
(ddd, J = 1.3, 5.7, 12.3 Hz, 1H), 2.46 (m, 1H), 1.60-1.68 (m, 2H), 1.30-1.50 (m, 
9H); C NMR (75 MHz, CDCl3) δ 158.02, 143.20, 142.70, 135.15, 135.01, 134.36, 130.12, 
126.25, 126.17, 116.49, 113.90, 113.59, 107.24, 89.04, 82.29, 
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71.74, 62.59, 55.73, 55.16, 37.60, 33.04, 32.93, 25,17, 25.03, 24.94, 0.01; IR (neat) 3416, 2941, 
2861, 1610, 1511, 1249, 1178, 1074, 1035, 843, 700 cm-1; HRMS (EI) calcd for C27H36O3Si [M 
– CH3 + H]+ 436.2433, found 436.2419.  
 
1
 [8-Allyloxy-9-(4-methoxyphenyl)-9-phenylnona-1,2-dienyl]trimethylsilane (1.40) 
Prepared following the procedure for 1.27. H NMR (300 MHz, 
CDCl3) δ 7.24-7.48 (m, 7H), 6.88 (d, J = 8.8 Hz, 50% of 2H), 
6.89 (d, J = 8.8 Hz, 50% of 2H), 5.70-5.84 (m, 1H), 5.08-5.24 (m, 2H), 4.95 (app dt, J = 6.8, 3.5 
Hz, 1H), 4.79 (app dq, J = 0.8, 6.8 Hz, 1H), 3.94-4.04 (m, 2H), 3.88 (ddd, J = 1.3, 5.7, 12.3 Hz, 
 1.52-1.58 
0
142.8, 135.3, 135.2, 134.4, 130
 
in, the reaction mixture was filtered through a short plug of silica gel eluting with CH2Cl2. The 
ng 1-iodooctane as the internal standard. The yield of 
NMR (300 MH
Ph
1H), 3.82 (2 singlets, 3H), 3.69 (ddd, J = 1.3, 5.7, 12.3 Hz, 1H), 1.99-2.02 (m, 2H),
(m, 4H), 1.41-1.46 (m, 2H), .19 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 210.1, 158.1, 143.4, 
.2, 129.5, 129.1, 128.6, 128.4, 128.2, 126.2, 126.2, 116.4, 113.9, 
113.6, 83.4, 82.6, 71.7, 55.7, 55.2, 33.0, 32.9, 29.9, 27.9, 25.1, 25.0, -0.7; IR (neat) 2934, 2852, 
1936, 1506, 1244, 835 cm-1; HRMS (EI) calcd for C28H38O2Si [M+] 434.2641, found 434.2661.  
 
1-Allyloxy-2-ethynylcyclohexane (1.41)  
To allene 1.40 (52 mg, 0.12 mmol) in DCE (3.0 mL) were added NaHCO3 (100 
mg, 1.19 mmol) and 4 Å molecular sieves (100 mg). To this stirring mixture at rt 
was added a solution of CAN (185 mg, 0.34 mmol) in acetonitrile (0.9 mL) dropwise. After 10
m
reaction yields were measured with GC usi
1.41 (trans/cis = 1.3/1) was 65%. cis-Diastereomer of 1.41 (faster eluting diastereomer)1: 1H 
z, CDCl3) δ 5.58-6.06 (m, 1H), 5.31 (app dq, J = 17.2, 1.6 Hz, 1H), 5.08-5.19 (m, 
1H), 4.03-4.16 (m, 2H), 3.33-3.39 (app dt, J = 8.2, 4.1 Hz, 1H), 2.96 (br s, 1H), 2.09 (d, J = 2.5 
O
MeO
O
• TMS
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Hz, 1H), 1.25-1.93 (m, 8H); 13C NMR (75 MHz, CDCl3) δ 135.7, 116.8, 84.9, 70.7, 69.6, 33.1, 
29.6, 28.6, 23.7, 22.1; IR (neat) 3308, 2936, 2859, 2591, 2115, 1444, 1084, 922 cm-1. trans-
Diastereomer of 1.41 (slower eluting diastereomer)1: 1H NMR (300 MHz, CDCl3) δ 5.84-6.01 
(m, 1H), 5.27 (app dq, J = 17.2, 1.6 Hz, 1H), 5.07 (app dq, J = 10.3, 1.6 Hz, 1H), 4.09 (app d, J = 
5.5 Hz, 2H), 3.28 (app dt, J = 3.7, 8.1 Hz, 1H), 2.40-2.48 (m, 1H), 2.08 (d, J = 2.3 Hz, 1H), 1.94-
1.99 (m, 2H), 1.62-1.71 (m, 2H), 1.23-1.48 (m, 4H); 13C NMR (75 MHz, CDCl3) δ 135.7, 116.6, 
86.9, 79.2, 70.5, 69.4, 35.1, 30.5, 30.4, 24.1, 23.4; IR (neat) 3308, 2934, 2859, 2602, 2100, 1659, 
1449, 1097, 1079, 922 cm-1; HRMS (EI) calcd for C8H11O [M – allyl group]+ 123.0809, found 
123.0808. Silylalkyne 1.42 (7%, 2 diastereomers in 1:1 ratio): 1H NMR (300 MHz, CDCl3) δ 
5.88-5.99 (m, 1H), 5.28 (app dd, J = 1.6, 17.2 Hz, 1H), 5.13 (app dd, J = 1.4, 10.4 Hz, 1H), 4.05-
4.15 (m, 2H), 3.36 (dt, J = 8.6, 3.7 Hz, ~50% of 1H), 3.26 (dt, J = 3.7, 8.1 Hz, ~50% of 1H), 
2.87 (app dt, J = 5.6, 2.8 Hz, ~50% of 1H), 2.41 (app dt, J = 4.1, 8.2 Hz, ~50% of 1H), 1.92-1.99 
(m, 2H), 1.60-1.71 (m, 4H), 1.32-1.44 (m, 2H), 1.23-1.41 (m, 4H), 0.15 (s, 9H); IR (neat) 2935, 
2858, 2166, 1244, 1075, 857, 841 cm-1; HRMS (EI) calcd for C11H19OSi [M – allyl group]+ 
195.1205, found 195.1201. 
 
[8-Methoxymethoxy-9-(4-methoxyphenyl)-9-phenylnona-1,2-dienyl]trimethylsilane (1.43) 
1H NMR (300 MHz, CDCl3) δ 7.26-7.48 (m, 7H), 6.88 (d, J = 
8.7 Hz, 2H), 4.94-4.97 (m, 1H), 4.79 (q, J = 6.8 Hz, 1H), 4.53 
(d, J = 6.9 Hz, 1H), 4.31-4.
MeO
Ph
OMOM
• TMS
45 (m, 2H), 4.07 (d, J = 8.5 Hz, 1H), 3.82 (2 singlets, 3H), 3.10 (2 
nglets, 3H), 1.97-2.02 (m, 2H), 1.50-1.80 (m, 4H), 1.35-1.45 (m, 2H), 0.18 (s, 9H); 13C NMR 
, 
si
(75 MHz, CDCl3) δ 210.1, 158.1, 143.0, 142.7, 134.8, 134.3, 130.2, 129.5, 129.1, 128.6, 128.3
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126.4, 126.3, 113.9, 113.7, 96.1, 96.0, 83.3, 82.6, 80.5, 80.4, 55.6, 55.4 55.3, 32.8, 32.6, 30.0, 
29.97, 29.90, 27.9, 24.4, 24.2, -0.81; IR (neat) 2935, 1936, 1511, 1248, 1148, 1036, 840 cm-1.  
 
1-[2-(tert-Butyldimethylsilyloxy)-1-phenyl-9-trimethylsilylnona-7,8-dienyl]-4-
methoxybenzene (1.44) 
1H NMR (300 MHz, CDCl3) δ 7.26-7.42 (m, 7H), 6.85 (d, J = 
8.4 Hz, 2H), 4.90-4.95 (m, 1H), 4.73 (q, J = 6.8 Hz, 1H), 4.31-4.34 (m, 1H), 3.98-4.02 (m, 1H), 
.78 (2 singlets, 3H), 1.93-1.97 (m, 2H), 1.33-1.54 (m, 6H), 0.83 (2 singlets, 9H), 0.15 (s, 9H), -
, 158.2, 142.7, 
142.8, 135.5, 134.1, 130.9, 129.8, 129.7, 128.9, 128.3, 128.2, 126.1, 113.8, 113.7, 83.4, 82.7, 
3
-1.53 (m, 2H), 1.26-1.34 (m, 
H), 0.90 (2 singlets, 9H), 0.09 (s, 6H); IR (neat) 2924, 2853, 2166, 1731, 1465, 1244, 835 cm-1.  
 
(
L, 2 mmol) in 5 mL of CH2Cl2 (made by adding AlMe3 solution slowly into the pentynol 
3
0.01 (2 singlets, 3H), -0.45 (2 singlets, 3H); 13C NMR (75 MHz, CDCl3) δ 210.2
76.3, 75.9, 55.9, 55.6, 55.3, 35.7, 5.5, 30.0, 28.0, 26.0, 24.3, 24.2, 23.9, 18.1, -0.6, -4.2, -5.3; IR 
(neat) 2929, 2852, 1936, 1511, 1248, 1096, 836, 698 cm-1.  
 
tert-Butyl-(2-ethynylcyclohexyloxy)dimethylsilane  
1H NMR (300 MHz, CDCl3) δ 3.76-3.80 (m, 50% of 1H), 3.61-3.65 (m, 50% of 1H), 
2.56-2.60 (m, 50% of 1H), 2.29-2.35 (m, 50% of 1H), 2.04 (d, J = 2.4 Hz, 50% of 1H), 2.01 (d, J 
= 2.4 Hz, 50% of 1H), 1.80-1.90 (m, 2H), 1.64-1.75 (m, 2H), 1.45
2
E)-4-Methylocta-4,7-dien-1-ol (1.45) 
To a stirring solution of Cp2ZrCl2 (0.69 g, 2.37 mmol) in CH2Cl2 (20 mL) at 
–23 °C was added AlMe3 (2 M in hexanes, 8.91 mL, 17.8 mmol) dropwise, followed by water 
(107 mg, 5.94 mmol). After 10 min, a mixture of 4-pentyn-1-ol (0.5 g, 5.94 mmol) and AlMe3 
(0.98 m
MeO
Ph
OTBS
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HO
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solution at 0 °C, the resulting mixture was then stirred at rt for 20 min.) was added to the reaction 
2
ol). After 30 min, saturated Na2SO3 was added to the reaction mixture. The 
rganic layer was separated and the aqueous layer was extracted with CH2Cl2. The organic layers 
rine, then were dried over Na2SO4, filtered and 
c r
mixture slowly at – 3 °C. The cold bath was removed and the reaction mixture was allowed to 
warm to rt slowly. After 5 h, a mixture of Pd(PPh3)4 (0.2 g, 0.178 mmol) and allyl bromide (0.72 
g, 5.94 mmol) in THF (10 mL) was added to the reaction mixture at rt. After 12 h, saturated 
K2CO3 (5 mL) was added to the reaction mixture at 0 °C cautiously. Some Na2SO4 solid was 
then added. The resulting thick mixture was stirred for 5 min and was filtered through a Celite 
pad. The filtrate was concentrated under reduced pressure. The resulting residue was purified by 
flash chromatography (15% EtOAc in hexanes) to afford the desired product (625 mg, 75%): 1H 
NMR (300 MHz, CDCl3) δ 5.72-5.86 (m, 1H), 5.18-5.23 (m, 1H), 4.92-5.04 (m, 2H), 3.53 (dt, J 
= 1.5, 6.6 Hz, 2H), 2.73 (t, J = 6.7 Hz, 2H), 2.06 (t, J = 7.5 Hz, 2H), 1.63-1.73 (m, 2H), 1.62 (s, 
3H); 13C NMR (75 MHz, CDCl3) δ 137.3, 136.1, 121.76, 114.2, 62.5, 35.9, 32.3, 30.8, 15.9; IR 
(neat) 3331, 2937, 1635, 1437, 1061, 908 cm-1; HRMS (EI) calcd for C9H16O [M+] 140.1201, 
found 140.1203.  
 
(E)-8-Iodo-5-methylocta-1,4-diene (1.46) 
To a stirring mixture of alcohol 1.45 (2.12 g, 15.16 mmol), PPh3 (5.57 g, 
21.22 mmol), imidazole (1.44 g, 21.22 mmol) and CH2Cl2 (50 mL) at 0 °C was added iodine 
(5.39 g, 21.22 mm
I
o
were combined, washed with H2O and b
oncentrated unde  reduced pressure. The resulting residue was purified by flash 
chromatography (straight hexanes) to provide the desired product (3.29 g, 87%): 1H NMR (300 
MHz, CDCl3) δ 5.71-5.85 (m, 1H), 5.20 (dt, J = 0.9, 7.2 Hz, 1H), 4.93-5.08 (m, 2H), 3.11 (t, J = 
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6.9 Hz, 2H), 2.72-2.77 (m, 2H), 2.08 (t, J = 6.8 Hz, 2H), 1.88-1.95 (m, 2H), 1.60 (s, 3H); 13C 
NMR (75 MHz, CDCl3) δ 137.01, 134.27, 122.89, 114.38, 40.08, 32.29, 31.60, 15.92, 6.59; IR 
(neat) 2975, 2932, 2842, 1637, 1429, 1217, 1166, 992, 909 cm-1; HRMS (EI) calcd for C9H15I  
[M+] 250.0218, found 250.0219. 
 
(E)-1-(4-Methoxyphenyl)-6-methyl-1-phenyldeca-6,9-dien-2-ol (1.47) 
To iodide 1.46 (3.29 g, 13.16 mmol) in 200 mL of mixed solvents 
of n-pentane/ether (3:2 by volume) at –78 °C was added t-BuLi 
(1.18 M in hexanes, 14.4 mL, 17.
MeO
Ph
OH
0 mmol) dropwise. The reaction mixture turned cloudy. After 5 
in, the reaction mixture was allowed to warm to 0 °C and stirred at 0 °C for 1.5 h, then at rt for 
n of anhydrous CeCl3 
H
was stirred at 0 °C for 40 mi
m
another 1.5 h. The resulting solution was cannulated into a suspensio
(3.244 g, 13.16 mmol) in T F (43 mL) at –78 °C. The reaction mixture was warmed to 0 °C and 
n. A solution of aldehyde 1.6 (1.98 g, 8.77 mmol) in THF (10 mL) 
was added dropwise at 0 °C. The resulting mixture was stirred at 0 °C for 10 min, warmed at rt 
for 30 min, then was quenched with 10% Acetic acid (30 mL). The organic layer was separated 
and the aqueous layer was extracted with EtOAc. The organic layers were combined, washed 
with H2O, saturated NaHCO3 and brine, then were dried over Na2SO4, filtered and concentrated 
under reduced pressure. The resulting residue was purified by flash chromatography (13% 
EtOAc in hexanes) to provide the desired product (1.99 g, 65%): 1H NMR (300 MHz, CDCl3) δ 
7.18-7.32 (m, 7H), 6.86 (d, J = 6.6 Hz, 50% of 2H), 6.85 (d, J = 6.6 Hz, 50% of 2H), 5.69-5.82 
(m, 1H), 5.07-5.13 (m, 1H), 4.90-5.01 (m, 2H), 4.28-4.33 (m, 1H), 3.81 (d, J = 8.2 Hz, 1H), 3.77 
(s, 3H), 2.68 (t, J = 6.4 Hz, 2H), 1.94 (t, J = 5.7 Hz, 2H), 1.55 (s, 3H), 1.41-1.67 (m, 4H); 13C 
NMR (75 MHz, CDCl3) δ 158.6, 143.0, 137.6, 136.6, 133.6, 130.0, 128.8, 128.3, 126.6, 121.6, 
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114.4, 114.3, 73.9, 58.1, 55.4, 39.6, 34.8, 32.4, 29.5, 24.2,16.0; IR (neat) 3559, 3446, 2933, 
1610, 1510, 1452, 1249, 1178, 1034, 700 cm-1; HRMS (EI) calcd for C24H30O2  [M+] 350.2245, 
found 350.2236.  
 
(E)-1-Methoxy-4-(6-methyl-2-octyloxy-1-phenyldeca-6,9-dienyl)benzene 
To alcohol 1.47 (1.98 g, 5.68 mmol) at rt was added NaH (60% in 
mineral oil, 0.8 g, 21 mmol). After 5 min, 1-iodooctane (6.82 g, 
28.4 mmol) was a
MeO
Ph
OC8H17
dded. The reaction mixture was heated to 120 °C and was stirred overnight at 
at temperature. The reaction mixture was cooled down to rt, diluted with hexanes, and was 
aqueous layer was 
m
dried over Na2SO4, filtered a
th
quenched with an ice chunk. The organic layer was separated and the 
extracted with ether. The co bined organic layers were washed with water and brine, then were 
nd concentrated under reduced pressure. The resulting residue was 
purified by flash chromatography (5% EtOAc in hexanes) to provide the desired product (2.35 g, 
90%): 1H NMR (300 MHz, CDCl3) δ 7.16-7.40 (m, 7H), 6.80 (d, J = 7.5 Hz, 2H), 5.70-5.83 (m, 
1H), 5.07-5.12 (m, 1H), 4.92-5.02 (m, 2H), 3.93 (d, J = 7.9, 1H), 3.86-3.90 (m, 1H), 3.77 (2 
singlets, 3H), 3.31 (dt, J = 8.6, 6.5 Hz, 1H), 2.99 (dt, J = 8.5, 6.5 Hz, 1H), 2.69 (t, J = 6.7 Hz, 
2H), 1.90 (t, J = 6.9 Hz, 2H), 1.54 (s, 3H), 1.13-1.54 (m, 16H), 0.85 (t, J = 6.9 Hz, 3H); 13C 
NMR (75 MHz, CDCl3) δ 158.0, 143.5, 143.1, 137.6, 136.5, 135.3, 134.8, 130.1, 129.5, 129.0, 
128.6, 128.4, 128.1, 126.2, 126.1, 121.48, 114.2, 113.8, 113.5, 82.5, 82.4, 70.6, 70.5, 55.7, 55.6, 
55.2, 39.7, 32.5, 32.3, 31.9, 30.2, 29.8, 29.5, 26.3, 26.2, 23.6, 22.8, 15.9, 14.2; IR (neat) 2928, 
2855, 1510, 1510, 1463, 1248, 1178, 1101, 1038, 699 cm-1; HRMS (EI) calcd for C32H46O2 [M+] 
462.3497, found 462.3491. 
(E)-10-(4-Methoxyphenyl)-5-methyl-9-octyloxy-10-phenyldec-4-en-1-ol (1.4) 
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To a stirring solution of 2-methylbutene (1.28 mL, 12.12 
mmol) in THF (12 mL) at –5 °C was added BH3·THF (1 M in 
THF, 6.1 mL, 6.1 mmol) dropwise. The reaction mixture was stirred for 45 min at –5 °C. The 
resulting solution was added to a solution of (E)-1-methoxy-4-(6-methyl-2-octyloxy-1-
eaction mixture 
a
added to the reaction mixture suc
(4R,8S,9R)-4-Methyl-8-ocyloxy-9-octahydrochromene (1.48) 
phenyldeca-6,9-dienyl)benzene (1.4 g, 3.03 mmol) in THF (12 mL) at 0 °C. The r
was stirred at 0 °C for 1.5 h. W ter (1 mL), NaOH (3 mL, 10%) and H2O2 (3 mL, 30%) were 
cessively. After 2 h, the organic layer was separated and the 
aqueous layer was extracted with EtOAc. The combined organic layers were washed with water 
and brine, then were dried over Na2SO4, filtered and concentration under reduced pressure. The 
resulting residue was purified by flash chromatography (15% EtOAc in hexanes) to afford the 
desired product (0.67 g, 46%): 1H NMR (300 MHz, CDCl3) δ 7.18-7.29 (m, 7H), 6.81 (d, J = 8.6 
Hz, 2H), 5.05 (t, J = 7.1 Hz, 1H), 3.95 (d, J = 9.5 Hz, 1H), 3.89-3.92 (m, 1H), 3.78 (2 singlets, 
3H), 3.59 (t, J = 6.3 Hz, 2H), 3.36 (dt, J = 8.3, 6.5 Hz, 1H), 3.03 (dt, J = 8.6, 6.5 Hz, 1H), 2.01 
(q, J = 7.2 Hz, 2H), 1.90 (t, J = 6.8 Hz, 2H), 1.55 (s, 3H), 1.15-1.70 (br, 18H), 0.85 (t, J = 6.9 
Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 158.1, 143.2, 135.9, 135.5, 129.6, 129.1, 128.3, 126.2, 
123.9, 144.0, 113.6, 82.5, 70.6, 62.9, 55.8, 55.4, 39.8, 32.9, 32.3, 32.0, 30.3, 29.6, 29.4, 26.3, 
24.3, 23.4, 22.9, 16.0, 14.3; IR (neat) 3368 (br), 2928, 2855, 1510, 1457, 1248, 1177, 1100, 
1036, 698 cm-1; LRMS (CI) calcd for C32H49O3 [M + H]+ 481, found 481. Also, LRMS (ESI) 
calcd for C32H48O3Na [M + Na]+ 503.4, found 503.5.  
 
 
 
MeO
Ph
OC8H17
OH
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To alcohol 1.4 (100 mg, 0.21 mmol) in DCE (6.0 mL) were added NMQPF6 (3.0 
mg, 0.01 mmol), NaOAc (200 mg, 2.44 mmol), Na2S2O3 (200 mg, 1.26 mmol), 4 Å 
olecular sieves (200 mg), and toluene (1 mL). The resulting mixture was stirred at rt while 
ubbling air gently and irradiating with a medium pressure mercury lamp at a distance of 4 cm. 
fter 80 min, additional NMQPF6 (1 mg, 0.0035 mmol) was added to the reaction mixture and 
 reaction mixture was filtered 
residue was
O
H
OC8H17
M
b
A
the reaction was allowed to proceed for another 20 min. The
through a plug of silica gel, and the filtrate was concentrated under vacuum. The resulting 
 purified by flash chromatography (3% EtOAc in hexanes) to afford the desired 
product (28.9 mg, 49%): 1H NMR (300 MHz, CDCl3) δ 3.77 (dt, J = 3.5, 11.9 Hz, 1H), 3.62 (app 
ddt, J = 5.2, 11.8, 1.4 Hz, 1H), 3.40 (dt, J = 9.0, 6.3 Hz, 1H), 3.30 (app dt, J = 2.5, 5.2 Hz, 1H), 
3.10 (dt, J = 9.0, 6.3Hz, 1H), 1.83-1.91 (m, 2H), 1.59-1.71 (m, 4H), 1.45-1.56 (m, 4H), 1.20-1.39 
(m, 13H), 1.35 (s, 3H), 0.87 (t, J = 6.7 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 79.2, 74.9, 69.6, 
61.3, 49.1, 40.7, 32.1, 30.4, 29.6, 29.5, 29.3, 27.8, 26.6, 23.4, 22.9, 19.5, 18.3, 14.3; IR (neat) 
2928, 2858, 1454, 1082 cm-1; HRMS (EI) calcd for C18H34O2 [M+] 282.2558, found 282.2563. 
 
References in experimental of Chapter 1: 
(1) Stereochemistry was assigned based on literature analogy. See: Wille, U.; Lietzau, L. 
Tetrahedron 1999, 55, 10119-10134. 
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Chapter 2. Ruthenium-catalyzed olefin hydroesterification: synthesis of 
lactones from allylic and homoallylic alcohols 
 
2.1 Introduction  
    Hydroesterification is an important reaction that converts olefins or alkynes into esters with 
carbon monoxide and alcohols catalyzed by transition metal catalysts (eq 1).1 It is one of the 
easiest ways to form new carbon-carbon bonds, to homologate olefins by one carbon, and to 
generate new functional groups. It also can be a very atom economic process since all the atoms 
in the starting material are incorporated into the product.  
 
R R
COOR'
R
COOR'CO, R'OH
Metal catalyst
+
         
eq 1
 
 
    Hydroesterification is the basis of many industrial processes and lab scale syntheses. Some 
important industrial products such as propionic acid and its esters, diethylketones, linear fatty 
acid esters, and 2-aryl propionic acids are synthesized using hydroesterification reactions.1-3 
BASF used a three-stage process with hydroesterification reactions as key steps in the synthesis 
of adipic acid (Scheme 2.1).4 In the first step, butadiene was treated under hydroesterification 
conditions to yield 3-pentenoic acid ester (2.1). In the second step, ester 2.1 was subjected to 
other hydroesterification conditions to undergo tandem isomerization (to give 4-pentenoic acid 
methyl ester) and hydroesterification to furnish dimethyl adipate (2.2), which was hydrolyzed to 
yield adipic acid.  
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adipic acid
O
OH
O
HO
+ CO + MeOH
HCo(CO)4, Py
120-140
300-1000 bar
CO2Me
HCo(CO)4, Py, CO, MeOH
150
150-170
-200 bar
MeO2C
CO2Me
hydrolysis
°C °C
2.2, 80%
90-95%2.1
CO2Me
4-Pentenoic acid methyl ester  
s. At the same 
e, many hydroesterification reagents other than toxic CO gas have been developed, which are 
particularly convenient for laboratory scale syntheses. Various olefins and alkynes were also 
tested under hydroesterification conditions to explore the substrate sc  hy roesterification 
reactions.  
2.1.1 Catalysts 
    There are an abundance of catalysts available for hydroesterification reactions. Commonly 
used are Pd, Rh, Ru, Pt, and Co catalysts. Among these catalysts palladium and rhodium are the 
most attractive because of their tolerance of many functional groups, mild reaction conditions 
(70-140 °C), and providing relatively high yields. Some representative Pd and Rh catalysts are 
PdCl2(PPh3)2, Rh6(CO)16, RhCl(dppb), RhCl(CO)(PPh3)2, RhCl3,  and RhCl(PPh3)3.
    Ruthenium and cobalt catalysts (e.g. Co2(CO)8, HCo(CO)4, Ru3(CO)12, Ru(cod)(cot), and 
RuCl2(PPh3)3) have seen increasingly frequent usage because of their relatively low cost. 
Ruthenium catalysts, such as Ru3(CO)12, are especially good at activating the C-H bond of 
formate.5 The disadvantage of these catalysts is the fairly harsh reaction conditions required. 
Scheme 2.1. BASF’s adipic acid synthesis. 
 
    Hydroesterification is most commonly carried out using CO and an alcohol under high 
temperature and high pressure in the presence of transition metal catalysts. In the past several 
decades, a variety of catalysts have been developed and applied in diverse system
tim
ope of d
 
4
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High temperature >140 °C and high pressure >100 atm are often necessary to activate the 
reactions.6  
    Other transition metal catalysts such as iron (e.g. H2Fe2(CO)8 and Fe2(CO)9), and nickel (e.g. 
Ni(CO)4) catalysts are also often seen to be used in hydroesterifications.7 Bimetallic or 
polymetallic catalysts that contain more than one metal species have been reported and many 
have shown enhanced reactivity and selectivity. Examples are platinum (e.g. H2PtCl6/SnCl2 and 
ed a branched ester (2.4) as the major product with an efficient conversion rate.  
 
PtCl2(DIOP)/SnCl2)8 and palladium (PdCl2-CuCl2)4 catalysts.  
Homogeneous catalysts can provide fast reaction rates but they are difficult to be recovered. 
Catalysts attached to solid or polymers have the advantage of being recyclable and have attracted 
increasing attention. Xia and co-workers reported the chitosan-SiO2 (CS) supported bimetallic 
catalyst system CS-PdCl2-NiCl2/SiO2, which showed good reactivity and regioselectivity in 
hydroesterification reactions.9 As shown in Scheme 2.2, hydroesterification of vinylnaphthalene 
(2.3) provid
2.3
H3CO
H3CO
CO2CH3
CH3
H3CO
CO2CH3
+
CO, CH3OH
CS-PdCl2-NiCl2/SiO2
100 °C, 4 Mpa
  
96% conversion
95 : 52.4  
Scheme 2.2. Hydroesterification using polymer-supported catalyst. 
 
    Alper reported polyamidoamine-SiO2 supported Pd(PPh3)2 catalyst, which has high reactivity 
and can be recycled and reused multiple times for hydroesterifications (Scheme 2.3).10 
O P
O
O
Si N
P
PdX2
 
Scheme 2.3. Polyamidoamin-SiO2 supported palladium catalyst. 
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2.1.2 Hydroesterification reagents  
The most commonly employed hydroesterification reagent is CO gas in combination with 
improved efficiency even in the 
ab
ally 
accepted mechanisms for this process have been proposed.8 As shown in Scheme 2.4, the 
catalytic cycle can start with the insertion of an olefin into M-H bond of a hydridometal species, 
followed by CO insertion and solvolysis.  This mechanism is believed to be a true catalytic cycle
and is supporte
 
alcohols. However, in consideration of the toxicity of CO gas, the use of nontoxic carbonyl 
sources such as formic acid, formate esters, and formamides would be desirable,11 especially on 
lab scale syntheses. Initial attempts employing these reagents still often require the presence of 
CO gas, although under lower pressures, to obtain satisfactory yields. After extensive research in 
the past two decades, many conditions have appeared with 
sence of CO gas.  
 
2.1.2.1 Hydroesterification using CO and its mechanism 
Using CO in combination with alcohols has the advantage of easy access of the inexpensive 
starting materials for industrial mass production, which has become the basis of many industrial 
processes. MeOH and EtOH are the alcohols that are usually used (eq 2). Two gener
 
d by ab initio MO calculations.12  
CO  +  CH2=CH2  +  CH3OH CH3CH2COOCH3
cat.
          eq 2      
[M]-H H2C CH2
[M]
H
CO[M]
H
COOR
CO  
Scheme 2.4. Catalytic cycle involves hydridometal species.  
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The hydridometal species can form in several ways. For example, in a palladium catalyzed 
system, hydrogen can be the hydride source by undergoing: Pd2+ + H2  [Pd-H]+ + H+. When 
an alcohol is used, a process involves Pd2+ + CH3OH  [Pd-OCH3]+ + H+ and [Pd-OCH3]+ → 
[Pd-H]+ + HCHO provides the hydride source. Water can also be used to serve this role.3  
Alternatively, the reaction may start from an alkoxycarbonylmetal species, which is generated 
from the insertion of an alcohol into an M-CO species (Scheme 2.5).  Insertion of an olefin into 
the metal-carbonyl bond of the alkoxycarbonylmetal, followed by acid cleavage of the metal-
alkyl bond results in the ester formation.3,12  
 
 
[M]-X
H2C CH2
COOR
[M]
COOR CO, ROH
HX
[M]-COOR
HX
6
 
Scheme 2.5. Catalytic cycle involves alkoxycarbonylmetal species. 
 
Chatani and co-workers discovered that 2-pyridylmethanol provides faster hydroesterifications 
than methanol (Scheme 2.6).  The accelerated reaction rate is explained by the coordination 
between the pyridyl nitrogen atom with rhodium catalyst to facilitate the reaction (Figure 2.6).6  
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O O
N
OH R
N
O R
+ 100 oC, 3 atm
Rh4(CO)12, CO
60-95%
N
O
R+
3 eq
N
 
OH RRh N OH N
Rh O
H
N
Rh O
RRh
N
Rh O
R
O
N
O
O
R
CO -Rh
 
Scheme 2.6. Hydroesterification using 2-pyridylmethanol and its mechanism.  
 
2.1.2.2 Formate esters 
Using formate esters in hydroesterification reactions was first reported by Sneeden et al. in 
1983. They described hydroesterification reactions of ethylene using methyl or ethyl formate and 
RuCl2(PPh3)3 under high pressure. Propionates were obtained in low yields (Scheme 2.7).13  
 
O
H2C CH2 + H OMe
O
OMe
+   CO
Cl3
190-200 °C
Ru
pressure       
Scheme 2.7. Formate esters as hydroesterification reagents.  
 
Grévin and Kalck reported the first palladium-catalyzed hydroesterification with formate 
esters (Scheme 2.8).14 The reaction was conducted at 130 °C in the presence of PdCl2(PBu3)2 and 
NaBH4. Complex [PdHCl(PBu)3)2] generated i  by reacting PdCl2(PBu3)2 with NaBH4 is 
proposed to be the actual catalyst. Up to 90% yield was reported. 
 
n situ
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CH2=CH2   +   HCOOCH3                                                    CH3CH2COOCH33.5 MPa, solvent, 130 °C
[PdCl2(PBu3)2], NaBH4
       
Scheme 2.8. Hydroesterifications with formate ester and Pd catalyst.  
 
Chang and co-workers found 2-pyridylmethyl formate (2.5) to be a superior 
hydroesterification reagent (Scheme 2.9).15 No carbon monoxide was needed and the reaction 
could be conducted under normal pressure. Good to excellent yields were obtained when olefins 
were used in excess. Exclusive linear ester formation was observed for substrates that have 
allylic branching. The reactions are believed to be facilitated by the nitrogen chelation with 
ruthenium ediates. 
 chelation complex of 2-pyridylmethanol with ruthenium has been crystallized and the structure 
 diffraction analysis.16  
, which minimizes destructive decarbonylation of activated acyl hydride interm
A
was confirmed by x-ray
 
O
O
N
H
+ O
O
N
+
Ru3(CO)12, 135 °C
O
O N
3 eq
87%
98 : 22.5
 
OO
N
N
R O N Ru3(CO)12
insertion
reductive
Ru O
oxidative
olefin
insertion
elemination
H
O
R
O H
O
Ru
Ru O
O
N
coordination
O
O
N
R
R
O NH
Ru
 
  Scheme 2.9. Chang’s hydroesterification and its proposed mechanism.  
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2.1.2.3 Formic acid and formamides  
    Hydrocarboxylation and hydroamidation are two types of reactions closely related to 
hydroesterification. The mechanisms and conditions of these reactions are very similar and 
products can be interconverted. When using formic acid as the carbonyl source, the process is 
called hydrocarboxylation. It has been widely used in industry in the preparation of highly 
branched C5 and C10 acids from alkenes.1  
Using a formamide as the carbonyl source, a process called hydroamidation, generates an 
amide ultimately. Kondo et al. demonstrated that reactions of olefins with formanilide afforded 
amides in high yields when catalyst [PPN][Ru3H(CO)11]  was used in the presence of PCy3 
(Scheme 2.10).5  
 
PhHN H
O O
PhHN
Ru3(CO)12, PCy3, 170 oC
[PPN][Ru3H(CO)11]
97%
+
3 eq     
 
Scheme 2.10. Hydroamidations with formanilides.  
 
Chang and co-workers described the hydroamidation of olefins with N-(2-pyridyl)formamide 
catalyzed by Ru3(CO)12. The reactions gave moderate to good yields ranging from 53-70% 
(Scheme 2.11).17  
 
PyHN
O
R PyHN
R
O
+
N N
H
N NH
H
O
Ru
H O
RRu3(CO)12
135 oC 53-76%
3 eq
    
Scheme 2.11. Hydroamidations with N-(2-pyridyl)formam de. 
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2.1.3 Co-catalyst 
    Many researchers reported a rate accelerating effect when co-catalysts are present in 
hydroesterification reactions. The co-catalysts reported to date include amine oxides, amines, and 
iodides.  
    Watanabe and co-workers reported the enhanced reactivity and efficiency of Ru3(CO)12 in the 
presence of  Me3NO·2H2O in comparison to when Ru3(CO)12 was used alone (Scheme 2.12).18 
Th
y Me3NO, therefore leaving free coordinating sites for the formate and olefin 
(Scheme 2.12). Similar effects have been observed for other ruthenium19 and osmium20 catalysts.  
e reaction of benzyl formate with 8 eq of cyclohexene gave 68% yield of the desired product 
when a co-catalyst was used, while the yield was only 31% without the co-catalyst. The 
mechanism of the rate acceleration was proposed. The carbonyl ligand on the metal can be 
oxidized to CO2 b
O
H O Ph
O Ph
O
68%
+
Ru3(CO)12-(CH3)3NO.2H2O
200 oC
8 eq  
        
[Ru]-CO
    Me3N + CO2
Me3NO
[Ru] COR
O
H
R'' O
COR
O
[Ru]H
OR[Ru]H
CO
[Ru] + CO + HOR
R' CH CH R''
CH CHR' 2
R''
[Ru]-OR
CO
CH2CH-CR'
R''
[Ru]-OR
O
CH2CHR'
R''
[Ru]-COR
O
or
CH2CHR' COR
 
Scheme 2.12. Rate acceleration by Me3NO and its mechanism.  
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Iodide was also observed to accelerate the hydroesterification reactions (Scheme 2.13).21 In 
the following reaction, MeI was found to be the best co-catalyst, which allowed as few as 1 
mol% of Rh catalyst to be used. No CO gas was necessary in the reaction.  
 
4 eq
O
H OH
OH
O
94%
190 °C
+ [RhCl(CO)2]2-MeI-P(Ph3)3
     
Scheme 2.13. Rate acceleration by iodide.  
In Hidai’s synthesis of ketones and esters from olefins using hydroesterifications (Scheme 
2.14),
 
to increase by 1200 times. It was proposed that iodide salts reacted with Ru3(CO)12 under the 
reaction conditions yielding [HRu3(CO)11]- and [Ru(CO)3I3]-, which are more reactive species 
and are responsible for the higher reactivity.  
 
 
22 iodides such as MeI, PhI, and I2 increased the reaction rate by 50-fold when used 
together with Ru3(CO)12. When using a 10:1 ratio of NaI/Ru3(CO)12, the reaction rate was found 
190 °C
H2C CH2 +    CO    +    MeOH
O
OMe
O
+Ru3(CO)12 or RuCl3
RI or Et3N
 
Scheme 2.14. Rate acceleration by iodide or amine.  
 
Rate accelerating effects by amines were also reported by Hidai.22 For example, in their 
hydroesterification reactions, using RuCl3 alone is 270 times faster then using Ru3(CO)12 alone, 
while a co f RuCl3 and Et3N was 520 times faster than using Ru3(CO)12 alone mbination o
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2.1.4 Hydroesterification substrates 
    Alkynes can undergo hydroesterifications to yield α,β-unsaturated esters.25,26 Alper found that 
treating alkynes with palladium catalyst in the presence of butyl formate, PPh3, PTSA, and 20 
atm CO afforded the desired esters in good yields (Scheme 2.15).25 Internal alkynes also undergo 
the same type of reactions. The ate 
ap
cheme 2.14). Similar effects were observed when Et3N23 or pyridine24 were used in 
hydroformylation reactions.  
 
regioselectivity is dependent on steric effects with the form
proaching from the less hindered end. When the steric difference is small, the regioselectivity 
is poor.  
Ph
Ph
COOBu Ph
COOBu
84 : 16
Pd(OAc) , dppb, PPh
THF, p-TsOH,
100 oC, 20 atm CO
+2 3
70%
+   HCOOBu
Scheme 2.15. Hydroesterifications of alkynes.  
 
Dienes are also suitable hydroesterification substrates. Chang and co-workers reported a 
selective hydroesterification of terminal double bonds in the presence of internal double bonds. 
The following reaction gave an excellent 70% yield with the formate 2.5 being the limiting 
reagent (Scheme 2.16)
10 eq
 
.26   
 
2.5
O
O
NRu3(CO)12, 135
3 eq
DMF, 70%
O
O
N
H
+ °C
      
Scheme 2.16. Selective hydroesterification of dienes.  
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α,β-Unsaturated esters were also reported to undergo hydroesterifications. Hidai and co-
workers described that α,β-unsaturated esters with various substitutents underwent facile 
hydroesterification and yielded a mixture of regioisomers. For example, methyl acrylate afforded 
alonate, together with 13% of dimethyl succinate (Scheme a 60% yield of the dimethyl methylm
2.17).27  
 
7 eq
COOMe
Ru3(CO)12, benzene
20 atm CO, 170°C
COOMe HCOOMe COOMe
MeOOC+
60% 13%
COOMe+
 
2.1.5 Enantioselective hydroesterification  
Introducing enantioselectivity will certainly make hydroesterifications even more powerful, 
especially in the context of the synthesis of natural products, pharmaceuticals, and other fine 
chemicals. However, because of the harsh reaction conditions and complex reaction pathways, it 
is often difficult to achieve enantioselectivity and only a few examples have been reported. Alper 
and Hamel reported the enantioselective hydrocarboxylation of aromatic olefins in the presence 
of (S)- or (R)-1,1’-binaphthyl-2-2’-diyl hydrogen phosphate (BNPPA). Optical yields of 55-91% 
were achieved (Scheme 2.18).28  
 
 
 Scheme 2.17. Hydroesterifications of α,β-unsaturated esters. 
Ar +  CO  +  H2O
O2, THF, (S)- or (R)-BNPPA
PdCl2-CuCl2, RT, 1 atm Ar COOH
CH3
*
55-91% ee     
Scheme 2.18. Enantioselective hydroesterifications. 
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Zhou et al. reported asymmetric hydroesterification using mixed catalyst PdCl2-CuCl2 and a 
biphosphine ligand. The hydroesterification of styrene yielded methyl 2-phenylpropionate in 
94% yield and 97% ee (Scheme 2.19).29  
 
CO2Me
CO, MeOH, PdCl2-CuCl2
O
O
PPh2
Ph2P
H H
Me
94%, 97% ee
80 °C, 6 Mpa
 
Scheme 2.19. Asymmetric hydroesterifications. 
 
As demonstrated from above examples, hydroesterifications are a powerful class of reactions 
but with limitations. The harsh reaction conditions have restricted its application to mostly 
simple substrates with few functional groups. Under the reaction conditions, extensive olefin 
isomerization often occurs and an olefin has to be used in excess amount, with the carbonyl 
reagent (e.g. formate) as the limiting reagent. However, many times the olefin may be less 
accessible than the carbonyl reagent. Finding milder hydroesterification conditions to minimize 
olefin isomerization will be one major task for the researchers in this area. Its fulfillment will 
help to expand the scope of this reaction to more complex olefins and to maximally execute its 
potential.  
 
2.1.7 Converting homoallylic alcohols into lactones 
     Homoallylic alcohols represent a class of valuable starting materials. They can be easily 
synthesized from the allylation of aldehydes. Moreover, asymmetric allylation is a thoroughly 
studied reaction, which provides easy access to enantiomerically pure homoallylic alcohols. The 
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alc
on components of natural products and many 
harmaceuticals. Converting homoallylic alcohols into lactones is a practical way of accessing 
these more advanced intermediates. 
    While many syntheses of lactones from homoallylic alcohols have been reported, most of 
them require multi-step sequences. One-carbon homologation of olefins in the synthesis of δ-
lactones is often the most difficult step to accomplish and many solutions have been developed, 
such as a Wittig reaction.   
In Suzuki’s synthesis of protomycinolide IV, the authors used a five-step sequence to convert 
a homoallylic alcohol into a lactone.  As shown in Scheme 2.20, alcohol 2.6 was first protected 
with a THP group. Hydroboration of the resulting olefin followed by oxidation afforded a lactol 
(2.7), which underwent a Horner-Emmons reaction with Mikolaiczyk reagent to give the ketene 
dithioacetal (2.8). Cyclization under mild acidic conditions followed by hydrolysis of the 
dithoacetal afforded the lactone 2.9.  
 
ohol and olefin functional groups on homoallylic alcohols allow various transformations, 
which make them desirable substrates for the synthesis of more advanced products.  
      Lactones, on the other hand, are comm
p
30
 
OH
R
OH 1) DHP, PPTS/CH2Cl2, 94%
2) c-Hex2BH/THF; H2O2, 97%
3) Swern oxidation; H+, 84%
R
O
R
OH
S
S
S
S
P(OEt)2
O
KH
O
1) trace HCl/dioxane
2) HgCl2/CH3CN-THF, PH 7 buffer
70%
O
R
90%
2.6 2.7 2.8
2.9  
Scheme 2.20. Suzuki’s lactone synthesis.  
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The most commonly used sequence is shown in Scheme 21.31,32 Homoallylic alcohols are 
subjected to a 5-step sequence, including dihydroxylation, oxidation, Wittig reaction, 
hydrogenation, and lactonization to afford the desired lactone.  
 
OH
OTBS
Me
OTBS
Me
OH
MeO2C
OO
H
OTBS1) OsO , NMO4 1) H2, 5% Pd-C
2) aq. NaIO4
3) Ph3P=CHCO2Me
2) PPTS, CH2Cl2
         reflux Me
73%
 
   
rs (Scheme 2.22).33  
 
Scheme 2.21. Typical Lactone Synthesis Sequence in the Literature. 
 A powerful reaction, ring closing metathesis, was also applied in the transformation of 
homoallylic alcohols into lactones. In Cossy’s synthesis of (+)-methynolide, a homoallylic 
alcohol was first converted into an ester (2.10) with methacryloyl chloride. The resulting diene 
then underwent ring closing metathesis in the presence of Grubbs’ II catalyst to afford an 
enelactone, which was reduced under hydrogenation conditions to yield the desired lactone 
(2.11) as a 1:1 mixture of diastereome
2.10 2.11
OHTBSO OTBSO
O
OTBSO
OO
Cl
Et3N, DMAP, CH2Cl2
80%
1) Grubbs' II (15 mol%), 
    CH2Cl2, 98%
2) PtO2, H2 (4 atm), EtOH
 
Scheme 2.22. Lactone synthesis using ring closing metathesis.  
 
Later, Cossy and co-workers developed a general protocol using a tandem cross-
metathesis/hydrogenation/cyclization reaction to synthesize lactones from homoallylic alcohols. 
In the same reaction vessel, both the cross metathesis catalyst and the hydrogenation catalyst 
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we
talysts and providing low yields. 
Also, undesired hydrogenation often occurs before cross metathesis and shuts down the desired 
reaction pathway.  
 
re present. Cross metathesis between the homoallylic/allylic alcohol and acrylic acid occurred 
first, followed by hydrogenation and cyclization to afford the lactones in 35-70% yields (Scheme 
2.23).34 The method has the drawbacks of using expensive ca
N N
RuCl
OH
R
R'
HO
O
O
O
R'
R
OH
R
R'
+ +
PtO2/H2, 1 atm
Cl
O
CH2Cl2
( )n ( )n
( )n
 
Scheme 2.23. Cossy’s one-pot lactone synthesis.  
 
Wuts and co-workers developed a protocol using a hydroformylation followed by an oxidation 
2
(350 psi) and high temperature (100 °C) in the presence of Rh catalyst and PPh3 to generate a 
needs special equipment, large amounts of CO gas, and expensive catalysts.  
 
(Scheme 2.24).35 A homoallylic alcohol was treated with CO and H  gas under high pressure 
lactol, which was then oxidized to a lactone in excellent overall yield. This method, however, 
O
OH
Rh2(OAc)4, PPh3, EtOAc
350 psi CO/H2, 100° C
PCC, CH2Cl2
80-86%
O
R
Me
R
OH
Me
O
R
Me  
Scheme 2.24. Lactone formation under high pressure. 
 
Kalck and co-workers used a palladium catalyzed hydroesterification to convert isopulegol 
(2.12) into its lactone. In the presence of CO gas at 97 °C, lactone 2.13 was obtained in 53-62% 
 87
yield (Scheme 2.25).36 Because a palladium catalyst was used, the reaction could be conducted at 
fairly mild 97 °C. However, this method has the drawback of using CO gas under high pressure. 
Also, the scope of this reaction was not studied since this is the only example in this report. The 
mechanism of the reaction was also proposed (Scheme 2.25).36  
2.12 2.13
OH O
O
PdCl2(PPh3)2, MeOH, 
 CO, 4 MPa, 97 °C
53-62%
  
[Pd]-H OH
O
O
OH
OH
[Pd]-H
[Pd]
OH
[Pd]
O
CO  
Scheme 2.25. Palladium-catalyzed lactonization of isopulegol.  
 
Alper and co-workers found that when 2-allylphenols were treated with CO under 600 psi in 
the presence of palladium catalyst, a mixture of 5-, 6- and 7-membered lactones was formed 
(Scheme 2.26).37 Changing the reaction conditions, substitution patterns on the arom
and reagents lead to various ra
yield to 7-membered lactone 2.15 (Scheme 2.26). However, too often the yields are poor and the 
selec
atic ring, 
tios among the products. Allylphenol 2.14 gave an excellent 95% 
tivity is low. The substrate scope is limited to allylphenols.  
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solvent, CO, 600 psi, 
      100-150 °C
Pd(II), dppb,R1
OH
R3
R2 R1
R1
O
R2
O
R3
R1
O O
R2 R3
R2 R3
+
O
O
+
 
  
tol, CO/H2, 600 psi, 
 100-150 °C, 95%
O
HO
O
O
O
Pd(OAc)2, dppb,
2.14 2.15  
Scheme 2.26. Lactone formations from allylphenols.  
 
    As summarized above, the transformation of homoallylic alcohols into lactones often needs 
multiple steps when not using hydroesterification conditions. The operation is lengthy and the 
cost of reagents is high. Using hydroesterification can shorten the sequence greatly; however, the 
reactions need to be performed under high pressure and high temperature involving the use of 
CO gas. Therefore, expensive equipment is needed.  
     Our goal, in c system that can 
fu ill the transformation of homoallylic alcohols into lactones with low cost and without 
re
onsideration of but not limited to lab scale synthesis, is to find a 
lf
sorting to special equipment. Developing mild conditions is another goal, which will broaden 
the tolerance of functional groups and the scope of this transformation. Applying 
hydroesterification reactions with new carbonyl-bearing reagents will be one way to achieve 
these goals. 
 89
2.2 Results 
    In our study of total synthesis of integramycin, we sought a transformation that enables the 
conversion of homoallylic alcohol 2.16 into lactone 2.17 (Scheme 2.27). Hydroesterification is 
an excellent way to realize this goal but the existing reaction conditions are often too harsh 
because high pressure CO gas at high temperature is needed. We conceived that the 
hydroesterification conditions recently developed by Chang15 would provide the opportunity of 
achieving this goal under milder conditions. 
O
OH
O
TBSO
TBSO
2.16 2.17          
on of our hypothesis, furnished the desired 
 in a combined ~10% yield. Ester byproducts 2.20 and 2.21 were isolated in 13% 
and 1% yields, respectively.      
 
Scheme 2.27. Converting homoallylic alcohols to lactones.  
     
2.2.1 Initial results 
Treatment of alcohol 2.16 with 2-pyridylmethyl formate 2.5 (3 eq) and a catalytic amount of 
Ru3(CO)12 (5 mol%) at 135 ºC for 4 h, as a validati
lactone 2.17 in 36% yield (Scheme 2.28).38 When using 5 equivalents of 2.5 and elongated 
reaction time (4 h at 135 ºC and 11 h at 125 ºC), the yield was slightly improved to 40%. A 
careful separation of the reaction mixture and NMR spectroscopy analysis revealed the identities 
of the side products of the reaction (Table 2.1). γ-Lactone 2.18 was isolated in a significant 18% 
yield with a 1:2.3 ratio to the desired lactone. Starting material 2.16 and its formate ester 2.19 
were isolated
 90
O2.16 2.17
5 mol% Ru3(CO)12
formate 2.5, 135 °C
36-40%
OH O
TBSO TBSO
 
Scheme 2.28. Lactonization of 2.16. 
 
product ayield (%)
4
18
4
12.21
2.18
2.17
starting material
O
O
0
TBSO
O
TBSO
O
O
CH3
CH3
TBSO
O
H
5
13
2.19
2.20
O
TBSO
O H
O
O
N
TBSO
OH O
O
N
2.16
 conditions: a mixture of 2.16, 5 eq of 2-pyridylmethyl formate, and 5 mol% of 
Ru (CO)12 was stirred at 135 ºC for 4 h, and at 125 ºC 11 h. 
Table 2.1. Product distribution of the hydroesterification/lactonization reaction. 
 
    a All yields were isolated yields. Reaction
3
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Even though the reaction yield is modest, the reaction indeed shows advantages over literature 
precedents. The reaction conditions are much simpler and the ruthenium catalyst is relatively 
inexpensive. Moreover, the two ester byproducts promise a better yield s ey can be 
hydrolyzed to the desired lacto
 
2.2.2 Improved conditions 
     The ester byproducts 2.20 and 2.21 can be converted to the desired lactone under acidic 
conditions. However, the TBS protecting group would not survive acidic conditions and needed 
to be changed. We then synthesized homoallylic alcohol 2.22 with a para-methoxylphenyl 
(PMP) protecting group on the primary alcohol, which is robust and allows acidic hydrolysis. 
After hydroesterification at 135 ºC for 4 h, the reaction mixture was subjected to various acidic 
conditions to cyclize the ester byproducts. Heating the reaction mixture in HOAc/THF/H2O 
(3:1:1) at 85 °C was found to be the best hydrolysis conditions. Indeed, this one-pot 
hydroesterification followed by acidic hydrolysis protocol converted homoallylic alcohol 2.22 
into lactone 2.23 in an improved 53% yield (Scheme 2.29).38  
 
ince th
ne under acidic conditions.  
PMPO
OH O
O
PMPO
N
HO
O
2) HOAc, THF, H2O,  85°C
1)               , 5 mol% Ru3(CO)12, 135°C
53%2.22 2.23  
Scheme 2.29. One-pot protocol of hydroesterification followed by hydrolysis. 
 
In the hydroesterification
formed in 18% yield, which is higher than 
/lactonization reaction of 2.16 (Scheme 2.28), the γ-lactone 2.18 
expected according to Chang’s observation of 
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ex
plex (Scheme 2.30). A compelling 
recedent for a coordinating group causing a regiochemical reversal in hydrometalation reactions 
he Evans group’s studies on metal-catalyzed hydroborations.39  
clusive linear product formation in the presence of a branching group at the allylic position.  
We rationalized this by invoking a coordinating effect of the free hydroxyl group with the 
ruthenium catalyst to generate a kinetically favored 5-membered intermediate, which lowers the 
barrier of the formation of the branched alkylmetal com
p
has been provided through t
 
N
Ru3(CO)12
Ru O
H
O
O
O
NH
R
OH
O
O
N
R
HO Ru
CH3
CH3O
R CH3
O
O
H
Ru
H
R
ON
O
R
OH
 
Scheme 2.30. Coordination facilitated γ-lactone formation. 
 
    To suppress coordination, the hydroxyl group was protected as a silyl ether. Silyl ether 2.24 
(Scheme 2.31) was treated under hydroesterification conditions followed by acidic hydrolysis, 
and afforded the desired lactone in an improved 68% yield. While requiring one additional step 
relative to the one-pot lactone synthesis, the incr
oallylic alcohols that are difficult to access. 
ease in efficiency should prove to be useful for 
hom
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NHO
OTES OO1)               , 5 mol% Ru3(CO)12, 135°C
2) HOAc, THF, H2O,  85°C
O
68%
PMPO PMPO
2.24 2.23  
 
2.2.3 Rate acceleration by addition of co-catalyst 
Scheme 2.31. Improved efficiency of silyl ethers. 
t is known that amine oxide such as Me3NO can facilitate metal-catalyzed 
hydroesterifications.18 N-methyl morpholine N-oxide (NMO) was also observed to promote 
cobalt-catalyzed Pauson-Khand reactions in Schreiber’s study.40  
We investigated the effect of addition of NMO in our hydroesterification reactions. To our 
delight, a significant rate accelerating effect was observed when NMO was applied in the 
reactions.41 For example, in the presence of NMO, the hydroesterification of 2.22 went to >98% 
conversion at 135 oC in less then 1.5 h. While in the absence of NMO, it took 12 h for the 
reaction to reach this conversion. The addition of NMO also enables reduction of the reaction 
temperature to as lo e 2.32.), which 
extends the substrate scope of this method to compounds that do not tolerate extreme heat. The 
I
w as 90-95 oC without affecting the reaction yield (Schem
new conditions also enhance the reaction rate for sterically hindered substrates at 135 oC and 
facilitate large scale reactions. Using these conditions, 100 mmol scale reactions have been 
conducted in our lab without significant loss of yield.42  
OO
O
C6H13
O
C6H13
OH
N
HO
O
2) HOAc, THF, H2O, 85°C
(CO)12, 
 95°C
55% 23%
+
1)                  5 mol% Ru3
                    , 15% NMO,
2.25 2.26 2.27
C6H13
 
Scheme 2.32. Enhanced reaction rate by addition of NMO. 
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2.2.4 Scope 
    To gauge the scope of this reaction with functionalized olefins as limiting reagents and to 
assess the potential of hydroxyl coordination to alter the regiochemical outcom  of the 
hydroesterification reaction, we prepared several substrates and exposed them to 
hydroesterification conditions (Table 2.2).  Homoallylic alcohol 2.28 (entry 1), in which the 
ental to the formation of 
th
 to reverse the regiochemical 
ou
one formation from allylic alcohols.  
1,1-Disubstituted alkene 2.42 (entry 6) reacted efficiently, albeit slowly, to form lactone 2.43 
as a 1:1 mixture of diastereomers in 72% yield. Hindered neopentyl and tertiary alcohols proved 
to be very suitable substrates. Disubstitution at the allylic position (entry 7) actually resulted in 
quantitative hydroesterification, though the linear to branched ratio was only approximately 2:1.  
e
41
absence of branching at the allylic carbon was expected to be less detrim
e branched product relative to substrate 2.22, indeed provided γ-lactone 2.29 (48%) as a 
diastereomeric mixture and δ-lactone 2.30 (25%). This result, while not immediately useful in a 
synthetic sense, demonstrates that coordination has the capacity
tcome of hydroesterification reactions. As expected, hydroesterification of silyl ether 2.31 
(entry 2) provided a mixture of linear ester 2.32 and branched ester 2.33 in an approximately 3:1 
ratio. The major product in this reaction was olefin isomer 2.34. In the presence of an allylic 
group, however, the olefin isomerization was suppressed and a linear ester (2.36) was obtained in 
an excellent 80% yield (entry 3).  
 Allylic alcohol 2.37 (entry 4) only provided a moderate yield of the γ-lactone 2.38 (45%), with 
ketone 2.39 generated from starting material isomerization as the major byproduct. The 
destructive isomerization can be suppressed by protecting the allylic alcohol with a silyl group 
(entry 5). Ether 2.40 underwent facile hydroesterification and gave the ester product 2.41 in 78% 
yield, ultimately providing an excellent method for γ-lact
 95
C6H13
OTBS C6H13
TBSO
O
Py
O C6H13
TBSO
O Py
O
C6H13
OTBS
2.32 (28%) 2.33 (9%) 2.34 (33%)
HO
HO
O
O
O O
O
O
C6H13
OH
O
C
O
6H13
C H6 13
OH
O
C6H13
O
O
C H
O
6 13
C6H13
OTBS C H6 13
TBSO
O
O
Py
entry substratea
1
3
2
4 C6H13
products (yield)
OH
OC6H13 O C6H13
O
5
6
6 13
7
C H
OH
OC6H13 O
O
C6H13
O
OTBS
C H6 13
O
HO
O
OCH Py2
HO
PMPO
OTBS
PMPO
O
O Py
2.36 (80%)
2.28 2.29 (48%)b 2.30 (25%)
2.31
2.39 (28%)2.37
2.35
2.38 (45%)
2.40 2.41 (78%)
8
9
2.44 2.45 (65%) 2.46 (35%)
2.47 2.48 (76%)
2.51 (19%) 2.52 (20%)
2.39 (5%)
2.42 2.43 (72%)b,c
2.49 2.50 (21%)
2
c
Table 2.2. Scope of tandem hydroesterification/lactonization reactions. 
2.53 (37%)  
aGeneral conditions: substrate, Ru3(CO)12 (5 mol%), and NMO (5-15 mol%) were stirred at 100-135 oC in 2-pyridylmethyl 
formate for 1.5-12 h. HOAc/THF/H O was added to complete lactonization when necessary. bIsolated as 1:1 mixture of 
diastereomers. Yield at 89% conversion.  
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Hindered substrates reacted most efficiently in sealed tubes, most likely because the substrates 
are somewhat volatile and can be lost upon prolonged heating. 
Spirolactones, common components of some natural products,43 can also be synthesized under 
our conditions. Notably, menthone derivatives 2.47 and 2.49, which were poor substrates for 
Cossy’s34 metathesis-based lactonization strategy, were converted to spirolactones 2.48 and 2.50 
in satisfactory yields. Allylic alcohol 2.47 (entry 8) afforded lactone 2.48 in a good 76% yield, 
while 2.49 (entry 9) gave a mixture of products including lactone 2.50 (21%) and ester 2.53 
(37%). Although ester 2.53 cyclized only reluctantly under thermal conditions, it can be 
converted to lactone 3.50 in quantitative yield by treatment with NaH in THF.  
Internal olefins were also tested under the reaction conditions. After 12 h heating, olefin 2.54 
only produced small amounts of the lactone products 2.55 and 2.56. When the alcohol was 
protected with a silyl group, the reactivity was not improved. The reaction also only provided 
low yields to the lactones (Scheme 2.33). These results showed that internal homoallylic alcohols 
are much less reactive than terminal homoallylic alcohols under our conditions.  
C6H13
OH
O
C6H13
O
O
C6H13
O
2.54 2.55 (10%)
2.57
2.56 (16%)
O
C6H13
O
C6H13
OTES
O
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O
2.55 (10%) 2.56 (10%)
N
HO
O
2) HOAc, THF, H2O, 85°C
1)                  5 mol% Ru3(CO)12, 
                    , 15% NMO, 135°C
N
HO
O
2) HOAc, THF, H2O, 85°C
1)                  5 mol% Ru3(CO)12, 
                    , 15% NMO, 135°C
+
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Scheme 2.33. Low reactivity of internal olefins. 
 
2
ic methyl group appeared to play important roles in determining 
the reaction 2, entry 2), 
.2.5 Mechanistic study  
     The hydroxyl group and allyl
efficiency and regioselectivity. For example, compound 2.31 (Table 2.
 97
which does not have an allylic Me group or free OH, gave the linear ester 2.32 in a 28% yield 
and the branched ester 2.33 in a 13% yield, with starting material isomer 2.34 as the major 
pr
 with deuterium 
NMR. In these experiments we define α-deuteration as deuterium incorporation on the carbon 
bearing the ester group and β-deuteration as deuterium incorporation on the adjacent carbon. 
Exclusive β-deuteration would be expected if product regiochemistry were solely dictated by the 
initial hydrometalation step, whereas a mixture of α- and β-deuteration would be expected if 
hydrometalation were reversible. 
 
oduct (33%). This is in sharp contrast to 2.35 (Table 2.2, entry 3), which gave 80% yield of the 
linear product; it is also in contrast to 2.28 (Table 2.2, entry 1), which give a 73% overall 
hydroesterification yield.  
The formation of varying amounts of olefin isomers of the starting materials (Table 2.2, 
entries 2&9) and ketone 2.39 (Table 2.2, entry 4) suggests that β-hydride elimination can be 
competitive with reductive elimination, thereby challenging our original hypothesis of product 
selectivity being set in the hydrometalation step (Scheme 2.30). 
 To obtain a clearer image of the reaction pathways and the roles of hydroxyl and methyl 
groups, mechanistic study applying deuterium labeling was conducted. Deuterium labeled 2-
pyridylmethyl formate 2.58, prepared by a reaction from commercially available DCO2D as 
shown in Scheme 2.34 was used as the mechanistic probe in the hydroesterification reactions. 
After the reactions were completed, the products were separated and analyzed
O O
N
O
D D D O CH3
O OH3C O CH3
HO O
O
N
D
2.58  
Scheme 2.34. Deuterated 2-pyridylmethyl formate. 
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     Compounds 2.22, 2.24, 2.59 and 2.60 were subjected to the reaction conditions and the results 
are listed in Table 2.3. A striking observation from this work is that little or no selectivity is 
observed in the site of deuterium incorporation in most of the reaction products. Also noteworthy 
is that stopping the hydroesterification of 2.24 prior to complete conversion resulted in the 
isolation of starting material in which deuterium was incorporated at both vinylic positions. 
These results strongly indicate that hydrometalation is reversible and that regiochemical 
preferences in this step cannot be the sole determinant in the partitioning between linear and 
branched products for this series of compounds.  
 
 
O
2.58
PMPO
X
Y
D O
N+ Ru3(CO)12, NMO
Δ
X=OH, OTES; Y=H, Me
products
 
 
Products and deuterium distribution   
Entry Substrate a
 
Branched product Linear porduct Starting material or 
its isomer 
 
1 
 
PMPO
OTES
 
 
2.59 
PMPO
OTES
O
N
D
O
D
6.3
1.0
2.61 
PMPO O
OD
D
TESO
1.5
1.0
Py
 
2.62 
2.8
1.0
PMPO OTES
D
D
 
3.63 
 
 
 
2 b PMPO
OH
 
 
2.60 
O
O
D
D
10.0
1.0
PMPO  
2.64 
O
O
D
D
1.0
1.3PMPO  
 
2.65 
PMPO
OH D
D
1.5
1.0
 
2.66 
 
 
3 
 2.0
1.0
PMPO
OTES
PMPO  
 
2.24 
 
Not isolated O
OD
D
TESO
Py
TESO
PMPO
D
D 2.5
1.0
 
 
2.68 2.67 
 
4 
 
PMPO
OH
 
 
2.22 
O
O
D
D >10.0
1.0
PMPO  
2.69 
O
O
D
D
1.0
1.2PMPO
 
 
2.70 
 
Not isolated 
 
a General procedure: substrate, Ru3(CO)12 (5 mol %), and NMO (5-15 mol %) were stirred at 135 °C in deuterated 2-
pyridylmethyl formate for 1.5-12 h. b Reaction conducted at 100 °C.  
 
Table 2 oducts. .3. Deuterium distribution of deuterioesterification pr
 99
    Scheme 2.35 shows a revised mechanism that is consistent with the deuteration patterns shown 
in Table 2.3. Hydrometalation proceeds with no selectivity, even with substrates that are 
branched at the allylic position. β-Hydride elimination is, in most cases, rapid relative to 
reductive elimination. Internal olefin formation by β-hydride elimination accounts for starting 
material isomerization. As discussed above, these products undergo hydroesterification reactions 
only very slowly under our conditions. Allylic branching suppresses starting material 
isomerization, leading to enhanced efficiency for ester formation for all substrates except allylic 
alcohols. The selectivity for linear products thus arises from reductive elimination being more 
ficient for primary alkylruthenium species than for secondary species, either through having an 
inherently lower energy of activation or through β-hydride elimination being significantly faster 
for secondary alkylruthenium compounds. Branching provides a further drive for linear product 
rmation. This can be attributed to steric hindrance disfavoring the branched isomer as the 
ediate β-hy on. 
 
ef
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Scheme 2.35. 
 elim
Mechanistic pathways for hydroesterification. 
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    The conspicuous diminution of α-deuteration in the branched products of entries 2 and 4 
provides compelling evidence for the role of heteroatom coordination (Scheme 2.36). These data 
indicate that the primary alkylruthenium species undergoes reductive elimination in nearly 
exclusive preference to β-hydride elimination. This result is most economically ascribed to the 
hydroxyl group occupying the coordination site that is required for β-hydride elimination. By 
analogy, coordination must slow β-hydride elimination to a sufficient extent in branched 
intermediates for reductive elimination to become a competitive pathway. Although this analysis 
explains improved efficiency for branched product formation, it does not explain its preference 
from 2.28. In this reaction we postulate that branched hydrometalation is favored over linear 
hydrometalation, possibly resulting from hydroxyl coordination, thereby increasing the 
concentration of the secondary alkylruthenium species and promoting branched product 
formation. 
 
R
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stable toward β-hydride
elimination  
Scheme 2.36. Role of coordination in hydroesterification.  
 
 Finally, a complete image of the reaction mechanism is described in Scheme 2.37. Ruthenium 
initially coordinates to the nitrogen atom of 2-pyridylmethyl formate 2.5, then undergoes 
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oxidative insertion into the C-H bond, generating a 6-membered chelate. Olefin insertion into the 
Ru-H bond results in a linear alkyl-Ru complex and a branched alkyl-Ru complex. Both 
complexes can undergo β-hydride elimination to afford either starting material or its isomer. The 
two complexes can also undergo reductive elimination to give the corresponding esters, which 
then undergoes transesterification to provide the δ- and γ-lactones.  
The competition between hydrometalation, β-hydride elimination, and reductive elimination 
determines the efficiency and regioselectivity of the reaction. The allylic methyl group and free 
OH dictate the winner of the competition. Realizing the factors influencing the reaction pathways 
will help to design conditions and formate reagents to improve the reaction efficiency. It will 
also help in the design of substrates suitable for hydroesterifications. 
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Scheme 2.37. Mechanism of the tandem hydroesterification/lactonization. 
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2.3 Summary 
We have developed a general protocol for synthesizing lactones from allylic and homoallylic 
alcohols. The lactone synthesis only requires one step (for allylic alcohols) or two steps (for 
homoallylic alcohols) that can be conducted in one pot. The experimental procedure is simple 
and the efficiency is considerably improved compared to that of multi-step sequences.  
hat, whereas the hydroxyl 
group might very well influence the regiochemistry of the hydrometalation step, the partitioning 
of products between linear and branched isomers is dependent upon the relative rates of 
reductive elimination between primary and secondary alkylruthenium species. The hydroxyl 
group serves to slow β-hydride elimination of the secondary alkylruthenium species to an extent 
that allows reductive elimination to be a viable process. 
Application of hydrometalation/reductive elimination processes to complex molecule 
synthesis will ultimately require an understanding of the effects of remote functional group on 
regiochemistry and efficiency. Elucidating the consequences of heteroatom coordination through 
mechanistic studies of the type described herein will prove to be beneficial in the design of 
procedural variants that expand the scope of this useful reaction class.  
We have demonstrated that hydroesterification reactions of functionalized olefins can proceed 
efficiently even when the olefin is used as the limiting reagent. These processes proceed most 
effectively when branching is present at the allylic position to suppress olefin isomerization. 
Homoallylic hydroxyl groups promote the formation of branched esters to a modest extent. 
Mechanistic studies with deuterated pyridylmethyl formate show t
 103
2.4 References 
 
(4
. J. Organomet.Chem. 1997, 542, 185-
(16) Ko, S.; Lee, C.; Choi, M.-G.; Na, Y.; Chang, S. J. Org. Chem. 2003, 68, 1607-1610.  
(17) Ko, S.; Han, H.; Chang, S. Org. lett. 2003, 5, 2687-2690.  
(18) Kondo, T.; Yoshii, S.; Tsuji, Y.; Watanabe, Y.; J. Mol. Catal. 1989, 50, 31-38.  
(1) Kiss, G. Chem. Rev. 2001, 101, 3435-3456.  
(2) Alper, H.; Hamel, N. J. Am. Chem. Soc. 1990, 112, 2803-2804.  
(3) Vavasori, A.; Cavinato, G.; Toniolo, L. J. Mol. Catal. A: Chem. 2001, 176, 11-18.  
) Beller M.; Cornils, B.; Frohning, C. D.; Kohlpainter, C. W. J. Mol. Catal. A: Chem. 1995, 
104, 17-85.  
(5) Kondo, T.; Okada, T.; Mitsudo, T. Organometallics 1999, 18, 4123-4127.  
(6) Yokota, K.; Tatamidani, H.; Fukumoto, Y.; Chatani, N. Org. Lett. 2003, 5, 4329-4331.  
(7) Bird, C. W. Chem. Rev. 1962, 62, 283-302.  
(8) Ojima, I. Chem. Rev. 1988, 88, 1011-1030.  
(9) Zhang, J.; Xia, C.-G. J. Mol. Catal. A: Chem., 2003, 206, 59-65.  
(10) Reynhardt, J. P. K.; Alper, H. J. Org. Chem. 2003, 68, 8353-8360.  
(11) Wiedemann, S. H.; Bergman, R. G.; Ellman, J. A. Org. Lett. 2004, 6, 1685-1687.  
(12) Kawana, M.; Nakamura, S.; Watanabe, E.; Urata, H
189.  
(13) Isnard, P.; Denise, B.; Sneeden, R. P. A.; Cognion, J. M.; Durual, P. J. Organomet. Chem. 
1983, 256, 135-139.  
(14) Grevin, J.; Kalck, P. J. Organomet. Chem. 1994, 476, C23-C24.  
(15) Ko, S.; Na, Y.; Chang, S. J. Am. Chem. Soc. 2002, 124, 750-751.  
 104
(19) Johnson, B. F. G.; Lewis, J.; Pippard, D. J. Organomet. Chem. 1978, 145, C4-C6.  
0) Rankin, J.; Benyei, A. C.; Poole, A. D.; Cole-Hamilton, D. J. J. Chem. Soc., Dalton Trans., 
.  
(24 . F.; Mirbach, M. J. J. Mol. Catal. 1985, 32, 59-75.  
. Mol. Catal. A: Chem. 1995, 95, 129-133. 
0, 112, 2803-2804.  
et. Chem. 1997, 543, 227-
hem. Soc. 
(31 upe, A. N.; Hutton, C. A.; Lilly, M. J.; Mann, R. K.; Mcrae, K. J.; McRae, K. J.; 
(32 . J. Chem. Soc., Chem. Commun. 2002, 2066-2067.  
 (b) Cossy, J.; Bauer, D.; 
on Lett. 1984, 25, 4051-4054.  
(2
1999, 3771-3782. 
(21) Simonato, J.-P. J. Mol. Catal. A: Chem. 2003, 197, 61-64.  
(22) Hidai, M.; Koyasu, Y.; Chikanari, K.; Uchida, Y. J. Mol. Catal. 1987, 40, 243-254
(23) Isnard, P.; Denise, B.; Sneeden, R. P. A. J. Organomet. Chem. 1982, 240, 169-177.  
) Mirbach, M
(25) Ali, B. E.; Alper, H. J. Mol. Catal. A: Chem. 1995, 96, 197-201.  
(26) Na, Y. Ko, S.; Hwang, L. K.; Chang, S. Tetrahedron Lett. 2003, 44, 4475-4478.  
(27) Suzuki, Y.; Katoh, H.; Ishii, Y.; Hidai, M. J
(28) Alper, H.; Hamel, N. J. Am. Chem. Soc. 199
(29) Zhou, H.; Hou, J.; Cheng, J.; Lu, s.; Fu, H.; Wang, H. J. Organom
228.   
(30) Suzuki, K.; Tomooka, K.; Katayama, E.; Matsumoto, T.; Tsuchihashi, G. J. Am. C
1986, 108, 5221-5229.  
) Cuzz
Zammit, S. C.; Rizzacasa, M. A. J. Org. Chem. 2001, 66, 2382-2393.  
) Wipf, P.; Reeves, J. T
(33) (a) Cossy, J.; Bauer, D.; Bellosta, V. Synlett 2002, 5, 715-718.
Bellosta, V. Tetrahedron 2002, 58, 5909-5922.  
(34) Cossy, J.; Bargiggia, F.; BouzBouz, S. Org. Lett. 2003, 5, 459-462.  
(35) Wuts, P. G. M.; Obrzut, M. L.; Thompson, P. A. Tetrahedr
(36) Chenal, T.; Cipres, I.; Jenck, J.; Kalck, P. J. Mol. Catal. 1993, 78, 351-366.  
 105
(37) El Ali, B.; Okuro, K.; Vasapollo, G.; Alper, H. J. Am. Chem. Soc. 1996, 118, 4264-4270.  
(39 Fu, G. C.; Hoveyda, A. H. J. Am. Chem. Soc. 1992, 114, 6671-6679.  (b) 
, 114, 6679-6685.  
 Agric. Food Chem. 2002, 
, 3510-
y, E. 
ato, T.; Inoue, K.; Takagi, 
 
 
 
 
(38) Wang, L.; Floreancig, P. E. Org. Lett. 2004, 6, 569.  
) (a) Evans, D. A.; 
Evans, D. A.; Fu, G. C.; Anderson, B. A. J. Am. Chem. Soc. 1992
(40) Shambayati, S.; Crowe, W. E.; Schreiber, S. L. Tetrahedron Lett.1990, 31, 5289.  
(41) Wang, L. Floreancig, P. E. Org. Lett. 2004, 6, 4207.  
(42) Seiders, J. R., II; Floreancig, P. E. unpublished results.  
(43) (a) Caloprisco, E.; Fourneron, J.-D.; Faure, R.; Demarne, F.-E. J.
50, 78-80. (b) Johnson, W. S.; Dumas, D. J.; Berner, D. J. Am. Chem. Soc. 1982, 104
3511. (c) Anjaneyulu, A. S. R.; Venugopal, M. J. R. V.; Sarada, P.; Clardy, J.; Lobkovsk
Tetrahedron Lett. 1998, 39, 139-142. (d) Yamaki, M.; Bai, L.; K
S.; Yamagata, Y.; Tomita, K. Phytochem. 1993, 6, 1497-1498. 
 
 
 
 
 
 
 
 106
2.5 Experimental  
 
2-pyridylmethyl formate (2.5)1  
To stirring acetic anhydride (6.5 mL, 69 mmol) at 0 °C was added formic acid (2.6 O
mL, 99%, 69 mmol) dropwise. The reaction mixture was stirred at room 
O
N
H
temperature for 2 h. The resulting formic acetic anhydride was cannulated to a stirring mixture of 
l), and THF (23 mL). After stirring 
The
was
con
chr uct (6.1 g, ~100%): 1H NMR 
00 MHz, CDCl3) δ 8.60 (d, J = 5.6 Hz, 1H), 8.20 (s, 1H), 7.76 (dt, J = 1.8, 7.7 Hz, 1H), 7.41 
, J = 7.7 Hz, 1H), 7.30 (dd, J = 5.2, 7.7 Hz, 1H), 5.20 (s, 2H).   
eneral information for olefin hydroesterification: 
or small scale reactions, sample vials with screw cap can be used. In cases when the starting 
aterial is volatile, sealed pressure tubes are suitable. For large scale reactions, flasks equipped 
ith condensers can be used. CAUTION: While the authors never met any situation where the 
ressure was sufficiently high to cause an explosion, placing the reaction vessels behind blast 
ield is recommended. 
 
2-pyridylmethanol (5 g, 46 mmol), NaHCO3 (5.7 g, 69 mmo
at rt for 1 h, saturated aq NaHCO3 was added to the reaction mixture until gas evolution stopped. 
 resulting mixture was extracted with EtOAc (3x). The organic layers were combined and 
hed with H2O, saturated aq NaHCO3, and brine, then were dried over Na2SO4, filtered, and 
centrated under reduced pressure. The resulting residue was purified by flash 
omatography (40% EtOAc in hexanes) to give the desired prod
(3
(d
 
G
F
m
w
p
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Representative hydroesterification procedure: To the substrate (1.0 mmol) in a pressure tube 
ere added Ru3(CO)12 (32 mg, 0.05 mmol), NMO (17 mg, 0.15 mmol), and 2-pyridylmethyl 
he tube was flushed with argon, sealed, then placed behind a 
blast shield. T
5
ide (4.68 g, 41.7 mmol, dried 
under vacuum overnight at 80 °C) in THF (50 mL) at –78 °C was added trans-
.56 M in hexanes, 26.7 mL, 42.7 mmol) 
 min, a solution of aldehyde 3-(tert-butyldimethylsilyloxy)-propanal3 
.1 g, 37.6 mmol) in THF (20 mL) was added slowly. The resulting viscous mixture was stirred 
for 2 h at –78 °C. NaOH (3 N, 50 mL) and H2O2 (30%, 30 mL) were added to the reaction 
TBSO
w
formate 2.5 (408 mg, 3 mmol). T
he reaction mixture was heated to 135 °C with stirring over 20-30 min. After 
 °C for 2-18 h, the reaction mixture was cooled to 0 °C. The cap was removed with 
caution. The reaction mixture was purified by flash chromatography. 
 
Representative hydrolysis procedure: Upon completion of the hydroesterification, the reaction 
mixture was dissolved in THF (2 mL), HOAc (6 mL), and H
stirring at 13
2O (2 mL). The resulting mixture 
was heated at 85 °C for 12 h then concentrated under reduced pressure. The resulting residue was 
purified by flash chromatography.  
 
(3R, 4S)-1-tert-Butyldimethylsilyloxy-4-methylhex-5-en-3-ol (2.16)2 
To a stirring mixture of potassium tert-butoxOH
2-butene (7.5 mL, 83.3 mmol) via cannula. n-BuLi (1
was added dropwise over 40 min. The reaction mixture turned orange. The resulting mixture was 
stirred at –48 °C for 15 min then cooled to –78 °C again. A solution of (-)-B-
methoxydiisopinocampheylborane (1 M in THF, 50 mL, 50 mmol) was added at a speed of ~1 
mL/min. The reaction mixture was stirred for 0.5 h and BF3·Et2O (6.67 mL, 55.8 mmol) was 
added dropwise. After 5
(7
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mixture. Cold bath was removed and the reaction mixture was stirred at rt for 30 min. The 
organic layer was separated and the aqueous layer was extracted with ether. The combined 
organic layers were washed with water and brine, then were dried over Na2SO4, filtered and 
concentrated. The resulting residue was purified by flash chromatography (2% acetone in 
hexanes) to give the desired product (6.14 g, 67%) as a colorless oil: [α]23D –6.7º (c = 1.80, 
CHCl3); [α]23D –3.4º (c = 1.30, CH2Cl2); 1H NMR (300 MHz, CDCl3) δ 5.77 (m, 1H), 5.02-5.08 
, 2H), 3.74-3.94 (m, 2H), 3.65-3.69 (m, 1H), 3.23 (s, 1H, OH), 2.17 (m, 1H), 1.60 (m, 2H), 
yran-2-one (2.17) 
T
(
(m
1.02 (d, J = 5.2 Hz, 3H), 0.89 (s, 9H), 0.07 (s, 6H); 13C NMR (75 MHz, CDCl3) δ 140.9, 115.3, 
75.2, 62.9, 44.2, 35.8, 26.1, 18.4, 15.9, -5.3; IR (neat) 3452, 2956, 2929, 2858, 1471, 1463, 1255, 
1087, 836, 776 cm-1; HRMS (EI) calcd for C9H21O2Si [M – CH3CHCH2=CH2]+ 189.1311, found 
189.1316.  
 
(5S,6R)-6-[2-(tert-Butyldimethylsilyloxy)ethyl]-5-methyltetrahydrop
o a mixture of olefin 2.16 (0.5 g, 2.05 mmol) and 2-pyridylmethyl formate 2.5 
1.39 g, 12.23 mmol) in a sample vial was added Ru3(CO)12 (65 mg, 0.102 
mmol). Nitrogen gas was flushed into the vial to remove air and then the sample vial was 
capped. The reaction mixture was heated to 135 °C with stirring over 30 min. The reaction 
mixture was stirred at 135 °C for 4 h then at 125 °C for 12 h. The reaction mixture was cooled to 
0 °C. The cap of the sample vial was removed. The reaction mixture was purified by flash 
chromatography (20-35% EtOAc in hexanes) to afford the desired product (222 mg, 40%): [α]23D 
+48.0º (c = 2.04, CHCl3); 1H NMR (300 MHz, CDCl3) δ 4.07 (dt, J = 2.3, 9.5 Hz, 1H), 3.75-3.87 
(m, 2H), 2.57-2.67 (m, 1H), 2.41-2.53 (m, 1H), 1.87-2.05 (m, 2H), 1.70-1.77 (m, 2H), 1.49-1.62 
(1H), 1.01 (d, J = 6.5 Hz, 3H), 0.89 (s, 9H), 0.06 (s, 6H); 13C NMR (75 MHz, CDCl3) δ 171.6, 
O
O
TBSO
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82.6, 58.6, 36.7, 32.5, 29.5, 27.8, 25.92, 18.2, 17.5, -5.4; IR (neat) 2956, 2929, 2856, 1738, 1252, 
1208, 1090, 836, 776 cm-1; HRMS (EI) calcd for C10H19O3Si [M – C(CH3)3]+ 215.1108, found 
215.1109. 
 
(5S,6R)-6-[2-(4-Methoxyphenoxy)ethyl]-5-methyltetrahydropyran-2-one (2.23) 
Hydroesterification was conducted using 3.22 (120 mg, 0.51 mmol), 
Ru3(CO)12 (13 mg, 0.02 mmol) and 2-pyridylmethyl formate 2.5 (207 mg, 1.52 
mmol) at 135 °C for 3 h. Hydrolysis was followed. Purification by flash chromatography (35-
40% EtOAc in hexanes) gave the desired product (72 mg, 53%): [α]23D  +63.6º (c = 1.23, 
CH2Cl2); 1H NMR (300 MHz, CDCl3) δ 6.80 (s, 4H), 4.00-4.20 (m, 3H), 3.72 (s, 3H), 2.54 (ddd, 
J = 4.7, 6.9, 17.8 Hz, 1H), 2.39 (ddd, J = 6.9, 9.6, 16.7 Hz, 1H), 2.13-2.26 (m, 1H), 1.84-1.97 (m, 
H), 1.67-1.79 (m, 1H), 1.49-1.58 (m, 1H), 1.01 (d, J = 6.6 Hz, 3H); 13C NMR (75 MHz, CDCl3) 
1732, 
 
Triethyl{(1R,2S
O
O
PMPO
1
δ 171.5, 153.8, 152.8, 115.4, 114.6, 82.6, 63.9, 55.6, 33.4, 32.6, 29.5, 27.8, 17.2; IR (neat) 
1508, 1232, 1037 cm-1; HRMS-EI (m/z) calcd for C15H20O4 [M+] 264.1362, found 264.1362. 
)-1-[2-(4-methoxyphenoxy)ethyl]-2-methylbut-3-enyloxy}silane (2.24) 
 To a stirring solution of alcohol 2.22 (162 mg, 0.68 mmol) and imidazole 
(102 mg, 1.5 mmol) in CH2Cl2 (7 mL) at room temperature was added 
chlorotriethylsilane (0.21 mL, 1.23 mmol) dropwise. The resulting mixture was stirred for 1 h 
and saturated NH4Cl solution (2 mL) was added. The organic layer was separated and the 
aqueous layer was extracted with ether (2x). The organic layers were combined and washed with 
brine, then were dried over Na2SO4, filtered and concentrated. The resulting residue was purified 
by flash chromatography (1-3% EtOAc in hexanes) to afford the desired product (224 mg, 94%): 
PMPO
OTES
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[α]23D +12.8º (c = 0.98, CH2Cl2); 1H NMR (300 MHz, CDCl3) δ 6.84 (s, 4H), 5.83-5.92 (m, 1H), 
5.06-5.13 (m, 2H), 3.96-4.03 (m, 3H), 3.79 (s, 3H), 2.36-2.47 (m, 1H), 1.79-1.97 (m, 2H), 1.09 
(d, J = 7.0 Hz, 3H), 0.98 (t, J = 7.8 Hz, 9H), 0.60 (q, J = 7.8 Hz, 6H); 13C NMR (75 MHz, 
DCl3) δ 153.8, 153.3, 140.7, 115.3, 114.9, 114.7, 72.4, 65.4, 55.7, 43.8, 33.0, 14.6, 7.1, 5.3; IR 
(neat) 2950, 2873, 1
 
H
C
508, 1231, 1045 cm-1; HRMS-EI (m/z) calcd for C20H34O3Si [M+] 350.2277, 
found 350.2274.  
 111
O
C6H13
O
2.28 2.29 2.30
6 13C
OH
O
O
O
C HC6H13 6 13
O
+
 
Hydroesterification was conducted using 2.28 (100 mg, 0.64 mmol), Ru3(CO)12 (20 mg, 0.03 
mmol), NMO (3.8 mg, 0.03 mmol), and 2-pyridylmethyl formate (261 mg, 1.9 mmol) at 135 °C 
for 2 h. Hydrolysis was followed. The reaction mixture was analyzed by GC using n-C8H17I as 
the internal standard to get the yields (2.29: 48%; 2.30: 25%). The reaction mixture was 
concentrated and the resulting residue was also purified by flash chromatography (20-25% 
tOAc in hexanes) to give the desired products. 
5-Hexyl-3-methyld
 1H 
E
 
ihydrofuran-2-one (2.29) 
NMR (300 MHz, CDCl3) δ 4.41-4.47 (app tt, J = 5.2, 7.4 Hz, 50% of 1H), 
4.24 (ddt, J = 5.2, 7.3, 10.3 Hz, 50% of 1H), 2.56-2.63 (m, 1H), 2.40 (ddd, J = 
5.4, 8.5, 13.4 Hz, 50% of 1H), 2.05 (ddd, J = 4.9, 8.9, 12.8 Hz, 50% of 1H), 1.96 (td, J = 7.5, 
12.8 Hz, 50% of 1H), 1.18-1.50 (m, 13.5H), 0.80 (t, J = 7.0 Hz, 3H); 13C NMR (75 MHz, 
CDCl3) δ 180.1, 179.6, 78.7, 78.5, 37.4, 35.9, 35.6, 35.5, 34.1, 31.7, 29.05, 29.02, 25.4, 25.3, 
 112
O
C6H13
O
22.5, 15.9, 15.1, 14.1; IR (neat) 1772, 1460, 1188 cm-1; HRMS-EI (m/z) calcd for C11H21O2 [M 
+ H]+ 185.1541, found 185.1548.  
 
6-Hexyltetrahydropyran-2-one (2.30)4
1H NMR (300 MHz, CDCl3) δ 4.19-4.27 (m, 1H), 2.49-2.57 (m, 1H), 2.36-2.45 (m, 
1H), 1.43-1.99 (m, 4H), 1.15-1.35 (m, 10H), 0.81 (t, J = 6.9 Hz, 3H); 13C NMR (75 
MHz, CDCl3) δ 172.3, 80.7, 35.9, 31.7, 29.5, 29.1, 27.8, 24.9, 22.6, 18.5, 14.1; IR (neat) 1736, 
506, 1224 cm-1.  
 
1
O
O
C6H13 OTBS
O
N
O
C6H13
OTBS
C6H13 OTBS
O
N
C6H13
TBSO
O
C6H13N
OTBS
+ +
2.32 (73 mg, 
8%), 2.33 (23 mg, 9%), and 2.34 (57 mg, 33%).  
5-(tert-Butyldimethylsiloxy)undecanoic acid
2.31                                            2.32 2.33                      2.34  
Hydroesterification was conducted using 2.31 (172 mg, 0.64 mmol), Ru3(CO)12 (20 mg, 0.03 
mmol), NMO (11 mg, 0.1 mmol), and 2-pyridylmethyl formate (261 mg, 1.9 mmol) at 135 °C 
for 2.5 h. The reaction was continued for another 2 h after additional Ru3(CO)12 (20 mg, 0.03 
mmol), NMO (11 mg, 0.1 mmol), and 2-pyridylmethyl formate (261 mg, 1.9 mmol) were added. 
Purification by flash chromatography (4→20→25% EtOAc in hexanes) afforded 
2
 
 pyridin-2-ylmethyl ester (2.32) 
1H NMR (300 MHz, CDCl3) δ 8.58 (d, J = 4.1 Hz, 1H), 7.67 (t, J = 7.7 Hz, 
1H), 7.22 (d, J = 7.7 Hz, 1H), 7.20 (dd, J = 5.8, 6.6 Hz, 1H), 5.23 (s, 2H), 3.61 
(app p, J = 5.6 Hz, 1H), 2.37 (t, J = 7.4 Hz, 2H), 1.66-1.82 (m, 2H), 1.41-1.52 
 113
41, 1255, 1152 cm-1; HRMS-EI (m/z) calcd for C19H32NO3Si 
 – t-Bu]+ 350.2151, found 350.2138. 
(m, 1H), 1.73 (br, 1H), 1.42-1.55 (m, 4H), 
.22-1.30 (m, 9H), 0.88 (br, 12H), 0.04 (br, 6H); IR (neat) 1741, 1465 cm-1.  
 
tert-Butyldimethyl-(1-propenylheptyloxy)silane (2.34) 
1H NMR (300 MHz, CDCl3) δ 5.32-5.56 (m, 2H), 4.36 (dd, J = 7.5, 12.6 Hz, 20% 
(m, 4H), 1.26 (br, 8H), 0.88 (br, 12 H), 0.03 (s, 6H); 13C NMR (75 MHz, CDCl3) δ 173.4, 156.2, 
149.6, 136.9, 123.0, 121.9, 72.1, 66.8, 37.3, 36.6, 34.6, 32.0, 29.7, 26.1, 25.4, 22.8, 21.0, 18.3, 
14.3, -4.2; IR (neat) 2927, 2852, 17
[M
 
4-(tert-Butyldimethylsiloxy)-2-methyldecanoic acid pyridin-2-ylmethyl ester (2.33) 
1H NMR (300 MHz, CDCl3) δ 8.50 (d, J = 3.6 Hz, 1H), 7.65 (t, J = 7.7 
Hz, 1H), 7.34 (d, J = 7.7 Hz, 1H), 7.16 (dd, J = 5.7, 6.5 Hz, 1H), 5.24 (s, 
2H), 3.65-3.73 (m, 1H), 2.70-2.77 (m, 1H), 1.90-1.96 
1
of 1H),  3.98 (dd, J = 6.0, 12.4 Hz, 80% of 1H), 1.66 (d, J = 5.2 Hz, 80% of 3H), 1.62 (d, J = 5.4 
Hz, 20% of 3H), 1.27-1.57 (m, 10 H), 0.86-0.90 (m, 12H), 0.02-0.05 (4 singlets, 6H); 13C NMR 
(75 MHz, CDCl3) δ 135.3, 124.9, 122.9, 73.9, 68.6, 38.7, 32.1, 29.5, 26.2, 26.1, 25.6, 22.8, 18.5, 
17.8, 14.3, 13.5, -4.0, -4.5; IR (neat) 1460, 1250, 1081, 835 cm-1; HRMS-EI (m/z) calcd for 
C13H29OSi [M – C3H5]+ 229.1987, found 229.1989.  
 
2.39
O
C6H13
O
C6H13
OH
C6H13
O
2.38
+
2.37  
n was conducted using 2.37 (142 mg, 1.0 mmol), RuHydroesterificatio
mmol), NMO (17 mg, 0.15 mmol), and 2-pyridylmethyl formate (408 mg, 3 mmol) at 135 °C for 
C6H13
3(CO)12 (32 mg, 0.05 
TBSO
O
N
O
C6H13
OTBS
2 h. Purification by flash chromatography (10→30→60% ether in pentane) afforded 2.28 (68 
mg, 40%) and 2.29 (40 mg, 28%). 
 
5-Hexyldihydrofuran-2-one (2.28)5 
      1H NMR (300 MHz, CDCl3) δ 4.43 (p, J = 7.0 Hz, 1H), 2.49 (dd, J = 7.1, 9.3 Hz, 2H), 
2.26 (hextet, J = 6.6 Hz, 1H), 1.50-1.88 (m, 3H), 1.20-1.40 (m, 8H), 0.85 (t, J = 7.1 Hz, 
4.2.  
3H).  
O
3H); 13C NMR (75 MHz, CDCl3) δ 177.6, 81.3, 35.7, 31.8, 29.2, 29.0, 28.2, 25.3, 22.7, 1
 
Nonan-3-one (2.29)6 
1H NMR (300 MHz, CDCl3) δ 2.37 (q, J = 7.3 Hz, 2H), 2.34 (t, J = 7.4 Hz, 2H), 1.52-
1.64 (m, 2H), 1.22-1.37 (m, 6H), 1.03 (t, J = 7.5 Hz, 3H), 0.84 (t, J = 6.8 Hz, 
 
C6H13
OTBS
C6H13
O
C6H13
OTBS
O
O
N
2.39
Hydroesterification was conducted using 2.40 (150 mg, 0.58 mmol), Ru (CO)  (18.7 mg, 0.03 
mmol), NMO (10 mg, 0.089 mmol), xylenes (0.15 mL), and 2-pyridylmethyl formate (238 mg, 
1.7 mmol) at 135 °C for 12 h. Purification by flash chromatography (0.5→10→30% EtOAc in 
hexanes) afforded 2.39 (4 mg, 5%) and 2.41 (181 mg, 78%).  
 
2.41
+
2.40  
3 12
tert-Butyldimethylsiloxy)decanoic acid pyridin-2-ylmethyl ester (2.41) 
1H NMR (300 MHz, CDCl3) δ 8.54 (d, J = 4.7 Hz, 1H), 7.62 (dt, J = 1.6, 
7.7 Hz, 1H), 7.29 (d, J = 7.7 Hz, 1H), 7.15 (dd, J = 4.9, 6.9 Hz, 1H), 5.29 
(s, 2H), 3.58 (app q, J = 5.5 Hz, 1H), 2.42 (t, J = 7.4 Hz, 2H), 1.61-1.88 (m, 2H), 1.22-1.39 (m, 
O
 4-(
C6H13
C6H13
O
O
C6H13
OTBS
O
N
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10H), 0.84 (br, 12H), 0.00 (s, 6H); 13C NMR (75 MHz, CDCl3) δ 173.6, 156.2, 149.5, 136.7, 
122.8, 121.8, 71.2, 66.8, 37.1, 31.9, 31.8, 30.0, 29.5, 26.0, 25.2, 22.7, 18.2, 14.2, -4.3, -4.5; IR 
(neat) 1742, 1255, 1160 cm-1; HRMS-EI (m/z) calcd for C22H38NO3Si [M – H]+ 392.2621, found 
392.2632.  
 
OH
OC6H13
C6H13
O
2.432.42  
Hydroesterification was conducted using 2.42 (170 mg, 1.0 mmol), Ru3(CO)12 (32 mg, 0.05 
mol), NMO (17 mg, 0.15 mmol), and 2-pyridylmethyl formate (408 mg, 3 mmol) at 135 °C for 
s continued for another 6 h after additional Ru3(CO)12 (32 mg, 0.05 mmol), 
NMO (17 mg, 0.15 mmol), and 2-
 
2.42 (19 mg, 11%) and 2.43 (127 mg, 72% at 89% conversion). 
 
6- Hexyl-4-methyltetrahydropyran-2-one (2.43)  
           1H NMR (300 MHz, CDCl3) δ 4.29-4.38 (m, 50% of 1H), 4.19-4.27 (m, 50% of 1H), 
2.48-2.68 (m, 1H), 1.85-2.18 (m, 3H), 1.40-1.80 (m, 4H), 1.20-1.37 (m, 7H), 1.04 
(d, J = 6.0 Hz, 50% of 3H), 0.98 (d, J = 5.5 Hz, 50 % of 3H), 0.82 (t, J = 6.6 Hz, 3H); C NMR 
(75 MHz, CDCl3) δ 172.6, 171.7, 30.7, 77.4, 38.1, 37.5, 37.0, 36.1, 35.6, 35.1, 31.7, 29.1, 26.8, 
25.2, 24.8, 23.9, 22.6, 21.7, 21.5, 14.1; IR (neat) 1731, 1239 cm-1; HRMS-EI (m/z) calcd for 
C12H23O2 [M + H]+ 199.1698, found 199.1696.  
 
m
12 h. The reaction wa
pyridylmethyl formate (200 mg, 1.5 mmol) were added. 
Hydrolysis was followed. Purification by flash chromatography (10-15-20% EtOAc in hexanes)
gave unreacted 
13
O
C6H13
O
 115
OC6H13
O
 116
C H6 13
OH
O
C6H13
O
2.45 2.46
+
2.44  
Hydroesterification was conducted using 2.44 (184 mg, 1.0 mmol), Ru3(CO)12 (32 mg, 0.05 
mmol), NMO (17 mg, 0.15 mmol), and 2-pyridylmethyl formate (408 mg, 3 mmol) at 135 °C for 
18 h. Hydrolysis was followed.  The reaction mixture was analyzed by GC using nC8H17I as 
internal standard to get the yields (2.45: 65%; 2.46: 35%). The reaction mixture was also 
concentrated and the resulting residue was purified by flash chromatography (10-25% EtOAc in 
hexanes) to give the products. 
 
 
5
50% of 3H); 13C NMR (75 MHz, CDCl3) δ 179.6, 179.0, 88.1, 87.9, 47.5, 44.9, 42.7, 41.1, 31.8, 
O
6-Hexyl-5,5-dimethyltetrahydropyran-2-one (2.45) 
              1H NMR (300 MHz, CDCl3) δ 3.88 (dd, J = 3.6, 9.2 Hz, 1H), 2.46-2.53 (m, 2H), 
1.43-1.73 (m, 6H), 1.20-1.35 (m, 6H), 0.96 (s, 3H), 0.90 (s, 3H), 0.82 (t, J = 6.6 Hz, 
3H); 13C NMR (75 MHz, CDCl3) δ 172.1, 87.9, 34.5, 32.0, 31.8, 30.1, 29.2, 27.5, 26.6, 26.2, 
22.6, 19.6, 14.1; IR (neat) 1735, 1467, 1215, 1041 cm-1; HRMS-CI (m/z) calcd for C13H25O2 [M 
+ H]+ 213.1854, found 213.1855. 
C6H13
O
 
5-Hexyl-3,4,4-trimethyldihydrofuran-2-one (2.46)
O
1H NMR (300 MHz, CDCl3) δ 4.03 (dd, J = 5.9, 7.3 Hz, 50% of 1H), 3.87 (dd, J = 
0% of 1H), 2.31 (q, J = 7.1 Hz, 50% of 1H), 2.30 (q, J = 7.4 Hz, 50% of 1H), 1.26-
1.52 (m, 10H), 1.09 (t, J = 7.4 Hz, 50% of 3H), 1.05 (t, J = 7.1 Hz, 50% of 3H), 1.06 (s, 50% of 
3H), 1.02 (s, 50% of 3H), 0.98 (s, 50% of 3H), 0.85 (2 triplets, both J = 6.0 Hz, 3H), 0.77 (s, 
4.2, 8.6 Hz, 
O
C6H13
30.0, 29.3, 28.7, 27.0, 26.6, 23.5, 22.7, 22.4, 15.7, 14.2, 9.5, 8.1; IR (neat) 1774, 1465 cm-1; 
HRMS-EI (m/z) calcd for C13H25O2 [M + H]+ 213.1854, found 213.1855.  
 
HO
O
O
2.482.47  
Hydroesterification was conducted using 2.47 (182 mg, 1.0 mmol), Ru3(CO)12 (32 mg, 0.05 
mmol), NMO (17 mg, 0.15 mmol), and 2-pyridylmethyl formate (408 mg, 3 mmol) at 135 oC for 
18 h. Purification by flash chromatography (10-20% EtOAc in hexanes) provided 2.48 (161 mg, 
76%).  
 
 (5S,6S,9R)-6-Isopropyl-9-methyl-1-oxaspiro[4.5]decan-2-one (2.48)7 
[α]23D -7.8º (c = 1.84, CHCl3); 1H NMR (300 MHz, CDCl3) δ 2.45-2.65 (m, 2H), 
.01 (m, 1H), 1.73-1.85 (m, 4H), 1.48-1.60 
H
O O
2.26 (ddd, J = 8.2, 9.9, 13.2 Hz, 1H), 1.90-2
(m, 2H), 1.07-1.26 (m, 2H), 0.92 (d, J = 6.6 Hz, 3H), 0.84 (d, J = 6.0 Hz, 3H), 0.80 (d, J = 7.1 
0-1.00 (m, 1H); z, 3H), 0.8 13C NMR (75 MHz, CDCl3) δ 177.3, 89.6, 49.9, 49.5, 34.7, 31.4, 
29.2, 28.7, 26.5, 24.0, 22.1, 21.8, 18.0; IR (neat) 1773, 1216, 1139 cm-1; HRMS-EI (m/z) calcd 
for C13H22O2 [M+] 210.1619, found 210.1613.  
 
OH
O OO OO
OH
O
N + +
OH+
2.50 2.512.53 2.522.49  
Hydroesterification was conducted using 2.49 (196 mg, 1.0 mmol), Ru3(CO)12 (32 mg, 0.05 
mmol), NMO (17 mg, 0.15 mmol), and 2-pyridylmethyl formate (408 mg, 3 mmol) at 135 oC for 
 117
12 h. Purification by flash chromatography (5→10→15→20→40% EtOAc in hexanes) gave 
2.53 (123 mg, 37%), 2.50 (46 mg, 21%), 2.51 (42 mg, 19%), and 2.52 (39 mg, 20%). 
 
(6S,7S,10R)-7-Isopropyl-10-methyl-1-oxaspiro[5.5]undecan-2-one (2.50) 
[α]23D +14.6º (c = 1.04, CHCl3); 1H NMR (300 MHz, CDCl3) δ 2.48 (ddd, J = 4.4, 
4.9, 18.1 Hz, 1H), 2.38 (ddd, J = 7.7, 9.9, 18.1 Hz, 1H), 2.07 (dt, J = 4.9, 12.6 Hz, 
2H), 1.93-2.02 (m, 2H), 1.76-1.85 (m, 3H), 1.63 (dt, J = 2.7, 13.2 Hz, 1H), 1.41-1.54 (m, 2H), 
1.12-1.17 (m, 2H), 0.90-1.02 (m, 1H), 0.91 (d, J = 7.1 Hz, 3H), 0.83 (d, J = 7.1 Hz, 3H), 0.81 (d, 
J = 8.2 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 171.8, 85.7, 50.4, 47.5, 34.9, 30.6, 30.0, 27.4, 
S,5R)-1-Hydroxy-2-isopropyl-5-methylcyclohexyl]-butyric acid pyridin-2-ylmethyl 
ester (2.53) 
 1H), 7.79 (t, J = 7.4 Hz, 
1
2.10-2.19 (
-2.83 (m, 1H), 2.47 (t, J = 12.0 Hz, 50% of 1H), 
1.65-2.13 (m, 6.5 H), 1.49-1.65 (m, 3H), 1.26 (d, J = 7.1 Hz, 50% of 3H), 1.25 (d, J = 
6.0 Hz, 50% of 3H), 1.00-1.20 (m, 2H), 0.93 (d, J = 7.1 Hz, 3H), 0.84 (d, J = 8.2 Hz, 3H), 0.79 
26.1, 23.9, 22.4, 20.4, 17.7, 16.7; IR (neat) 1731, 1249 cm-1; C14H24O2 [M+] 224.1776, found 
224.2768.   
 
4-[(1S,2
        1H NMR (300 MHz, CDCl3) δ 8.68 (d, J = 3.8 Hz,
H), 7.42 (d, J = 7.7 Hz, 1H), 7.32 (d, J = 6.9 Hz, 1H), 5.32 (s, 2H), 2.51 (t, J = 6.9 Hz, 2H), 
m, 1H), 1.46-1.86 (m, 10H), 1.10-1.24 (m, 2H), 0.96 (d, J = 7.1 Hz, 3H), 0.95 (d, J = 
6.9 Hz, 3H), 0.94 (d, J = 6.3 Hz, 3H).  
 
6-Isopropyl-3,9-dimethyl-1-oxaspiro[4.5]decan-2-one (2.51)  
   1H NMR (300 MHz, CDCl3) δ 2.7O
O O
O
OH
O
N
O
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(d, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 180.2, 179.7, 87.3, 86.8, 51.3, 51.0, 48.1, 
41.6, 38.6, 36.0, 34.8, 34.5, 29.1, 28.4, 26.9, 26.2, 24.0, 23.9, 22.2, 22.1, 21.4, 18.0, 17.7, 15.8; 
IR (neat) 1768, 1212 cm-1; HRMS-EI (m/z) calcd for C14H24O2 [M+] 224.1776, found 224.2785. 
J = 6.6 Hz, 
H), 0.85 (d, J = 6.0 Hz, 3H), 0.84 (d, J = 6.6 Hz, 3H).  
 
 (1S,2S,5R)-2-Isopropyl-5-methyl-1-propenylcyclohexanol (2.52) 
  1H NMR (300 MHz, CDCl3) δ 5.61-5.70 (m, 1H), 5.43 (d, J = 15.4 Hz, 1H), 1.95-2.00 
(m, 1H), 1.65-1.80 (m, 5H), 1.40-1.52 (m, 4H), 1.04-1.28 (m, 2H), 0.86 (d, 
OH
3
 
2.502.53
OH
O
O
N
O O
 
To ester 2.53 (40 mg, 0.12 mmol) in THF (2 mL) at 0 oC was added NaH (10 mg, 60% in 
mineral oil, 0.24 mmol). The ice bath was removed and the reaction mixture was stirred at rt for 
20 min. Saturated aq NH4Cl (1 mL) was added. The resulting mixture was extracted with ether 
(2x). The organic layers were combined and washed with brine, then were dried over Na2SO4, 
ltered and concentrated. The resulting residue was purified by flash chromatography (15% fi
EtOAc in hexanes) to afford 2.50 (26 mg, ~100%).  
 
OPMP
OTES
O
N D
O
D
6.3
OPMP
1.0
O
O
D
D
2.8 DOTESOTES
1.5
1.0
+ +
OPMP
N 1.0
PMPO OTES
D
2.59                                      2.61 2.62    2.63  
Hydroesterification was conducted using 2.59 (150 mg, 0.45 mmol), Ru3(CO)12 (14 mg, 0.022 
e-d (183 mg, 1.34 mmol) at 135 
linear pr
 
= 1.6, 7.7 Hz, 1H), 7.32 (d, J = 7.9 Hz, 1H), 7.19 (dd, J = 4.9, 6.9 
), 2.42 (t, J = 7.4 Hz, 2H), 
7.9 Hz, 
 34.5, 20.9, 7.1, 5.2; HRMS-ESI (m/z) 
alcd for C26H39NO5SiNa [M + Na]+ 496.2495, found 496.2490.  
     
2H NMR (300 MHz, CHCl3) δ 2.52 (area: 1.0), 1.83 (area: 1.5). 
 
mmol), NMO (7.8 mg, 0.07 mmol), and 2-pyridylmethyl format
oC for 3 h. Purification by flash chromatography (4→25→30% EtOAc in hexanes) gave the 
oduct 2.61 (61 mg, 29%), the branched product 2.62 (17 mg, 8%), and 2.63 (22 mg, 
15%). 
 
7-(4-Methoxyphenoxy)-5-triethylsiloxyheptanoic acid pyridin-2-ylmethyl ester (2.61) 
 1H NMR (300 MHz, CDCl3) δ 8.58 (d, J = 4.1 Hz, 1H), 7.61 (dt, J
PMPO
Hz, 1H), 6.82 (s, 4H), 5.24 (s, 2H), 3.94-4.01 (m, 3H), 3.76 (s, 3H
1.86-1.94 (m, 2H), 1.72-1.78 (m, 2H), 1.53-1.60 (m, 2H), 0.90 (t, J = 7.9 Hz, 9H), 0.57 (q, J = 
6H); 13C NMR (75 MHz, CDCl3) δ 173.3, 156.1, 153.8, 153.3, 149.6, 136.9, 123.0, 
121.9, 115.4, 114.8, 69.0, 66.9, 65.1, 55.9, 37.2, 36.7,
c
6-(4-Methoxyphenoxy)-2-methyl-4-triethylsiloxyhexanoic acid pyridin-2-ylmethyl ester 
(2.62)  
1H NMR (300 MHz, CDCl3) δ 8.58 (d, J = 4.4 Hz, 1H), 7.68 (t, J = 
7.7 Hz, 1H), 7.36 (dd, J = 3.3, 7.7 Hz, 1H), 7.23 (dd, J = 5.5, 7.1 Hz, 1H), 6.82 (s, 4H), 5.23 (s, 
2H), 3.97-4.04 (m, 3H), 3.77 (s, 3H), 2.66-2.75 (m, 1H), 1.89-2.11 (m, 3H), 1.54-1.65 (m, 1H), 
OTES
O
O
N
PMPO
TESO O
O
1.5
1.0
D
N
D
PMPO
TESO
O
N
O
 120
1.24 (d, J = 8.2 Hz, 3H), 0.90 (2 triplets, J = 7.7 Hz, 9H), 0.53 (2 quartets, J = 7.9 Hz, 6H); 
HRMS-ESI (m/z) calcd for C26H39NO5SiNa [M + Na]+ 496.2495, found 496.2502. 
    
PMPO
OTES
O
N
D
O
D
6.3
1.0  H NMR (300 MHz, CHCl2
 25% of 1H), 4.30 (app q, J = 6.4 Hz, 75% of 1H), 3.89-4.03 (m, 2H), 3.78 (s, 3H), 1.88-
.95 (m, 2H), 1.68 (d, J = 6.0 Hz, 75% of 3H), 1.63 (d, J = 5.2 Hz, 25% of 3H), 0.92 (q, J = 7.7 
Hz, 9H), 0.58 (t, J = 7.9 Hz, 
3) δ 2.66 (area: 1.0), 1.20 (area: 6.3).  
 
Triethyl-{1-[2-(4-methoxyphenoxy)ethyl]but-2-enyloxy}silane (2.63) 
1H NMR (300 MHz, CDCl3) δ 6.82 (s, 4H), 5.44-5.67 (m, 2H), 4.74 (app q, J = 
7.0 Hz,
PMPO
OTES
1
6H).  
2.8
1.0PMPO
TESO
D
D    2H NMR (300 MHz, CHCl3) δ 5.59 (area: 1.0), 1.62 (area: 2.8).  
 
PMPO
OH
10.0 1.0
PMPO
1.0 1.3
OH D
D
1.5
1.0
100 oC +O
O
D
D
PMPO
O
O
D
PMPO D
+
2.60                                          2.64 2.65               2.66  
Hydroesterification was conducted using 2.60 (115 mg, 0.52 mmol), Ru3(CO)12 (16 mg, 0.026 
mmol), NMO (9 mg, 0.077 mmol), and 2-pyridylmethyl formate-d (212 mg, 1.55 mmol) at 100 
 flash chromatography (15oC for 3 h. Purification by →25→35→50% EtOAc in hexanes) 
5 (20 mg, 16%), and 2.66 (18 mg, 15%). 
 
 
2.6provided 2.64 (22 mg, 17%), 
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5-[2-(4-Methoxyphenoxy)ethyl]-3-methyldihydrofuran-2-one (2.64) 
00 MHz, C1H NMR (3 DCl3) δ 6.84 (s, 4H), 4.76 (tt, J = 5.5, 7.1 Hz, 50% of 
1H), 4.58 (t
  2H NMR (300 MHz, CHCl3) δ 2.66 (area: 1), 1.28 (area: 10).  
 
6-[2-(4-Methoxyphenoxy)ethyl]tetrahydropyran-2-one (2.65) 
 1H NMR (300 MHz, CDCl3) δ 6.84 (s, 4H), 4.55 (dddd, J = 2.7, 5.5, 7.7, 10.4 
Hz, 1H), 4.01-4.19 (m, 2H), 3.78 (s, 3H), 2.57 (td, J = 6.3, 17.6 Hz, 1H), 2.42 
(ddd, J = 7.1, 8.2, 17.6 Hz, 1H), 1.86-2.16 (m, 5H), 1.56-1.69 (m, 1H); HRMS-EI (m/z) calcd for 
14 18 4 ] 250.1205, found 250.1208.  
O
t, J = 6.3, 12.1 Hz, 50% of 1H), 4.00-4.14 (m, 2H), 3.78 (s, 3H), 
2.66-2.77 (m, 50% of 1H), 2.54-2.63 (m, 50% of 1H), 2.20 (ddd, J = 5.2, 8.8, 12.9 Hz, 1H), 2.01-
2.14 (m, 3H), 1.28 (d, J = 6.8 Hz, 50% of 3H), 1.30 (d, J = 7.4 Hz, 50% of 3H); HRMS-EI (m/z) 
calcd for C14H18O4 [M+] 250.1205, found 250.1202.  
 
C H O  [M+
1.0
O
1.3
O
D
DPMPO    H NMR (300 MHz, CHCl3) δ 2.40-2.50 (area: 1.0), 1.89 (area: 1.3).  
1-(4-Methoxyphenoxy)hex-4-en-3-ol (2.66) 
  1H NMR (300 MHz, CDCl3) δ 6.85 (s, 4H), 5.70 (qd, J = 6.3, 15.4 Hz, 1H), 
5.58 (ddd, J = 1.6, 6.9, 15.4 Hz, 1H), 4.37 (dd, J = 6.6, 12.9 Hz, 1H), 4.08 (td, J = 6.0, 9.6 Hz, 
1H), 4.04 (td, J = 6.0, 9.6 Hz, 1H), 3.78 (s, 3H), 1.97 (app q, J = 6.0 Hz, 2H), 1.71 (d, J = 5.8 Hz, 
3H).  
2
 
PMPO
OH D
D
1.5
1.0
H NMR (300 MHz, CHCl     2
O
3) 5.70 (area: 1.0), 1.70 (area: 1.5).  
PMPO
O
10.0
1.0
O D
D
O
O
PMPO
PMPO
OH
PMPO
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OTES
PMPO
TESO
PMPO
D
D
1.02.0
1.0
PMPO O
OD
D
TESO
Py + 2.5
2.24                                2.67      2.68  
ydroesterification was conducted using 2.24 (124 mg, 0.35 mmol), Ru3(CO)12 (11 mg, 0.018 
mol), NMO (6 mg, 0.05 mmol), and 2-pyridylmethyl formate-d (145 mg, 1.1 mmol) at 135 oC 
anes) provided 2.67 (67 
mg, 37%) and 2.
 
Cl3) δ 8.60 (d, J = 4.9 Hz, 1H), 7.69 (t, J = 
J = 7.9 Hz, 1H), 7.22 (dd, J = 4.9, 6.6 Hz, 1H), 6.82 (s, 4H), 5.24 (s, 2H), 
2 ), 1.74-1.88 
, 3H), 1.59-1.70 (m, 1H), 1.42-1.55 (m, 1H), 0.89-0.95 (m, 12H), 0.55 (q, J = 7.9 Hz, 6H).  
rea:1.0), 1.73 (area: 1.0),  1.42 
Cl3) δ 6.84 (s, 4H), 5.83-5.92 (m, 1H), 5.06-5.13 (m, 
2H), 3.96-4.03 (m, 3H), 3.79 (s, 3H), 2.36-2.47 (m, 1H), 1.79-1.97 (m, 2H), 
1.09 (d, J = 7.0 H
 
2H NMR (300 MHz, CHCl3) δ 5.79 (area: 1.0), 5.03 (area: 2.5).  
1.0
H
m
for 2 h. Purification by flash chromatography (10→25% EtOAc in hex
68 (44 mg, 35%).  
7-(4-Methoxyphenoxy)-4-methyl-5-triethylsiloxyheptanoic acid pyridin-2-ylmethyl ester 
(2.67) 
1H NMR (300 MHz, CD
OTES
7.9 Hz, 1H), 7.33 (d, 
3.95 (t, J = 6.0 Hz, H), 3.88 (app p, J = 4.0 Hz, 1H), 3.76 (s, 3H), 2.36-2.58 (m, 2H
(m
2H NMR (300 MHz, CHCl3) δ 2.44 (a2.0
(area: 1.0). 
Triethyl-{1-[2-(4-methoxyphenoxy)ethyl]-2-methylbut-3-enyloxy}silane (2.68) 
 
1H NMR (300 MHz, CD
z, 3H), 0.98 (t, J = 7.8 Hz, 9H), 0.60 (q, J = 7.8 Hz, 6H). 
PMPO O
OD
D
TESO
Py
TESO
PMPO
D
D 2.5
1.0
PMPO
OTES
PMPO O
N
O
PMPO
OH O
O
D
D
O
O
D
D >10.0
1.0 1.2
1.0
PMPO
PMPO
+
esterification was conducted using 2.22 (100 mg, 0.42 mmol), Ru3(CO)12 (13 mg, 0.021 
mmol), NMO (7 mg, 0.06 mmol), and 2-pyridylmethyl formate-d (174 mg, 1.3 mmol) at 135 oC 
for 2 h. Purificati provided the 
2.69 (44 mg, 40%) and 2.70 (18 mg, 16%).  
 
         5-[2-(4-Methoxyphenoxy)ethyl]-3,4-dimethyldihydrofuran-2-one (2.69) 
2H NMR (300 MHz, CHCl3) δ 2.67 (area: 1.0), 1.15 (area: >10). 
hyltetrahydropyran-2-one (2.70) 
 M 3
H NMR (300 MHz, CHCl3
 
 
O
2.22                          2.69   2.70  
Hydro
on by flash chromatography (20→30→40% EtOAc in hexanes) 
O
1H NMR (300 MHz, CDCl3) δ 6.84 (s, 4H), 4.31 (ddd, J = 3.7, 6.0, 9.3 Hz, 1H), 
4.05-4.09 (m, 2H), 3.77 (s, 3H), 2.72 (app p, J = 7.7 Hz, 1H), 2.37 (app hextet, J = 7.0 Hz, 1H), 
2.13 (dddd, J = 3.7, 7.4, 11.0, 14.4 Hz, 1H), 1.95 (app tt, J = 4.9, 9.3 Hz, 1H), 1.17 (d, J = 7.6 
Hz, 3H), 1.05 (d, J = 7.1 Hz, 3H).  
PMPO
O
 
6-[2-(4-Methoxyphenoxy)ethyl]-5-met
1H NMR (300 Hz, CDCl ) δ 6.80 (s, 4H), 4.00-4.20 (m, 3H), 3.72 (s, 3H), 2.54 
(ddd, J = 4.7, 6.9, 17.8 Hz, 1H), 2.39 (ddd, J = 6.9, 9.6, 16.7 Hz, 1H), 2.13-2.26 
(m, 1H), 1.84-1.97 (m, 2H), 1.67-1.79 (m, 1H), 1.49-1.58 (m, 1H), 1.01 (d, J = 6.6 Hz, 3H). 
 
  2 ) δ 2.47-2.61 (area: 1.2), 1.57-1.91 (area: 1.0).  
 
O
O
D
D 1.2
1.0
PMPO
O
O
PMPO
O
D
D >10.0
1.0
PMPO
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Chapter 3. The synthesis of the C16-C35 fragment of integramycin 
 
    Since the first diagnosed AIDS case reported in 1981, AIDS has brought devastating impact to 
numerous individuals and families. In the past two decades, more than 20 million people have 
died of AIDS and there are estimated 38 million people living with HIV in the whole world.  In 
the United States, about 1 million people are living with HIV, and in the year of 2003 alone, 
about 14,000 Americans died of AIDS.   
The fight against AIDS in the past two decades has yielded important successes that can 
prolong life and reduce the physical effects of HIV infection. In the year 2004, there were 17 
anti-HIV drugs approved by the FDA and available on the market, 16 of which targeted viral 
replication (reverse transcriptase and protease) and 1 of which targeted cell fusion.2 Combination 
therapies using two types of drugs also emerged and showed their strength.  However, these 
therapies are often limited by the issues of regimen compliance, adverse side effects, and the 
emergence of mutated viral strains that are drug resistant.4 The plasticity of HIV viruses often 
makes the existing therapies become less effective in the long term.2 A cure of AIDS is still 
elusive. Identifying new therapeutic targets at different stages of the viral life cycle and 
developing new inhibitory agents will be one of the essential solutions.5  
 
3.1.1 HIV-1 integrase 
HIV-1 integrase is an enzyme responsible for the integration of the HIV genome into the host 
genome. Integration is an essential sequence in the replication cycle of HIV and other 
 
3.1 Introduction 
1
3
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retrovi igure 
.1).4,6,7 
integrase first recognizes the four nucleotide CAGT sequence at the termini of the viral 
inal 3' GT dinucleotide at both ends of the viral DNA, leaving a 
mpleted, the viral DNA is bound onto the host DNA 
co
ruses. It contains three steps: 3'-end processing, strand transfer, and DNA repair (F
3
    HIV-1 
DNA. It then removes the term
recessed CA with a free 3' hydroxyl group and an overhanging 5'-AC on the strand. This step is 
called 3'-end processing (3'-P).  
     In the second step, integrase cleaves the target DNA, and binds the 3' hydroxyl groups at both 
ends of the viral DNA onto the phosphate backbone of the target DNA. This step is termed 
strand transfer (ST). After this step is co
valently.  
     Finally, catalyzed by host repair enzymes, the irreversible incorporation of the HIV-1 genome 
into the host genome is completed by DNA gap filling and repair, which involves a series of 
DNA polymerization, dinucleotide excision, and ligation reactions to yield new viral progeny 
and the infection cycle is completed.  
 
 
Figure 3.1. HIV-1 integration. 
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     The development of chemotherapeutic agents for the treatment of HIV-1 infection has been 
focused on inhibitors of reverse transcriptase (catalyzes the conversion of viral RNA into DNA) 
eans that the inhibition of integrase may be very selective and 
rocess and there is much more to be explored.2  
 of compounds that show good activity and selectivity. 
ly screened more than 250,000 compounds and found that most of the 
potent compounds have a diketo acid functional group. Some examples are listed below; they 
demonstrate good to excellent potency against the integrase strand transfer reaction (Figure 3.2).9   
 
and protease (hydrolyzes viral polyproteins into functional proteins). However, the unique nature 
of the integration process provides potential chemotherapeutic intervention safely targeting on 
integrase, which appears to be absent from the host. Furthermore, there is no known human 
homologue to integrase, which m
present minimal toxicity to the human beings.7 More than a decade of research in this area 
resulted in two drug candidates in clinical trials currently, and there are no drugs that act on HIV-
1 integrase available on the market yet, indicating that we are just at the beginning of a 
discovering p
 
3.1.2 Synthetic HIV-1 integrase inhibitors 
    Numerous compounds have been found to have biological activity against integrase.2,8 Among 
them, diketo acids constitute a class
Merck scientists random
O O
O
OHBnO
OBn
L-708,906 IC50 = 0.10 μΜ
O
O
OHO
N
F
L-731,988 IC50 = 0.05 μΜ
O
O
OHO
N
( )3
L-731,927    IC50 = 0.50 μΜ 
Figure 3.2. Diketo acids as HIV-1 integrase inhibitors. 
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5CITEP is an analog of diketo acid. It shows slightly superior potency to its diketo acid 
equivalent DKA1 (Figure 3.3).10 The tetrazole group of 5CITEP is considered as an isosteric acid 
replacement. A complex of HIV-1 integrase with 5CITEP has been crystallized and the crytal 
structure demonstrated that 5CITEP bound to the core domain of HIV-1 integrase.11  
O O
O
OH
HN
Cl
DKA1      IC50 = 0.5 μΜ (ST)
O O
N N
N
NH
HN
Cl
5CITEP   IC50 = 0.65 μΜ (ST)
IC50 = 35 μΜ (3'-P) IC50 = 65 μΜ (3'-P) 
Figure 3.3. Diketo acid inhibitors of HIV-1 integrase. 
 
S-1360 is a diketo acid derivative developed by Shionogi & Co. Ltd based on above findings. 
50 value of 0.02 μM. This compound has proceeded It demonstrates excellent potency with an IC
to phase I/II clinical trial phase. Merck’s L-870,810, which is called napthyridine carboxamide, 
has an IC50 value of 0.01 μM and has entered phase I clinical trial (Figure 3.4).2      
S
O
O
N
NH
N
F
OH
S-1360    IC50 = 0.02 μΜ (ST)
N
N
N
OHO
N
H
F
O
O
L-870,810   IC50 = 0.01 μΜ (ST) 
Figure 3.4. Compounds in clinical trials against HIV-1 integrase. 
 
A second group of HIV-1 integrase inhibitors can be classified as polyhydroxylated 
compounds. Caffeic acid phenylethyl ester (CAPE) (Figure 3.5), a nontoxic apiary product, 
demonstrated moderate inhibitory activities with IC50 values of 19 and 220 μM against 3'-end 
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pr
r toxicity.14 
It is of particular interest to observe increased inhibitory activity in cell culture for these 
compounds, which would be very valuable in clinical trials.2  
 
ocessing and strand transfer reactions.12 Many analogs of CAPE have been prepared and tested 
against HIV-1 integrase. Digalloyl derivative 3.1 shows increased activity with an IC50 value of 
4.7 μM against 3'-P,13  dicaffeoyl-D,L-isoserine 3.2 has an improved IC50 of 0.37 μM,14 and 
biscatechol acid 3.3 has an IC50 value of 0.23 μM, which also shows decreased cellula
OH OH
O
O
HO
HO
CAPE IC50 = 19 μΜ (3'-P)
O
O
HO
HO
H
OH
O
O
OH
OH
H
N
Dicaffeoyl-D,L-isoserine 3.2
OO
O O
OO
OHHO
OHHO
OH
IC50 = 0.37 μΜ (3'-P)
IC50 = 4.7 μΜ (3'-P)Digalloyl derivative 3.1
O
OH
OH
HO
O
HO OH
OH
Biscatechol acid 3.3  IC50 = 0.23 μΜ (3'-P)  
Figure 3.5. Polyhydroxylated compounds as HIV-1 integrase inhibitors. 
     
A large num onucleotides,5 
eptides,5 and sulfates16 were also found to demonstrate inhibitory properties against HIV-1 
in
ber of other types of compounds, such as mononucleotides,15  olig
p
tegrase. For example, Maurer and co-workers synthesized a new class of sulfate compounds 
that inhibit both integrase and reverse transcriptase. This character will be very desirable 
considering that two therapies can be combined by using a single drug. The parent system 
 130
carbonyl J has an IC50 value of 4 μM (Figure 3.6).16 After modification, compound 3.4 showed 
good activities against 3'-P and ST reactions with IC50 values of 0.2 and 0.33 μM.  
 
N
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N
H
OH OH
SO3O S3
N
H
O
N
H
OH OH
SO3O3S
N
N
N
N
SO3
O3S
F
F
F
F F
F
F
F
3.4
IC50 = 0.2 μΜ for 3'-P
 ST
IC50 = 0.33 μΜ for ST  
Figure 3.6. Carbonyl J and its derivative as HIV-1 integrase inhibitors. 
 
3.1.3 Natural product as HIV-1 integrase inhibitors 
    Nature provides an enormous collection of natural products with complex structures and new 
properties. For thousands of years, natural products have been the main source of medicines. In 
modern drug discovery, natural products still play a crucial role by providing new motifs in 
search of new drugs. From 1981 to 2002, 49% of the small-molecule New Chemical Entities 
(NCEs) introduced were natural products, semi-synthetic natural product analogues, or synthetic 
compounds based on natural products.17  Novel structures of natural products may lead to the 
discovery of inhibitors of HIV-1 integrase that suppress quick drug resistance developed by HIV 
viruses. The investigation of natural products and their analogs will greatly expand the scope of 
HIV-1 integrase inhibitor candidate pool and provide new insights in the design of drugs with 
novel properties.  
Carbonyl J IC50 = 4 μΜ for both 3'-P and
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Many natural products have been isolated and tested against HIV-1 integrase. Several 
examples are shown in Figure 3.7.18 These compounds show moderate to good anti-HIV1 
integrase activities. Among these compounds, integramycin is of particular interest to us.  
Integramycin was isolated from Actinoplanes sp by Singh et al. in 2002.18d It contains a novel 
hexacyclic structure and inhibits the recombinant HIV-1 integrase strand transfer reaction with 
an IC50 value of 4 μM. The structure itself presents an intriguing target for synthetic organic 
chemist. There is no reported total synthesis of integramycin yet. Moreover, it has a diketo acid 
moiety (F ring) and a polyhydroxylated aromatic ring (A ring), two motifs often seen in integrase 
inhibitors but not often in the same molecule. The combination of these two motifs may be 
responsible for its biological activity.  
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R = COCH3 Integracin A IC50 = 32 μΜ (ST)
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HO OSO3
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O
HO
HO
OH
OH
OH
OH
COOHO
COOH
ermic acid B IC50 = 0.37 μΜ (ST) Integramycin IC50 = 4 μΜ (ST)  
Figure 3.7. Natural product inhibitors of HIV-1 integrase. 
Lithosp
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ibition 
of
ment with the cis-decalin unit 3.6, and the side chain 
yrrolidinedione 3.7 (Scheme 3.1). Each subtarget has a functional group on its terminus which 
will allow connection between them. This strategy allows the reduction of this complex molecule 
into three easier individual syntheses. Eventual connection of the three molecules will allow the 
completion of the total synthesis convergently.  
Integramycin may serve as a lead structure in the search for new anti-HIV drugs. The 
synthesis of integramycin and its analogs may lead to drug candidates with stronger potency. The 
study of its structure-activity relationship will help to understand the mechanism of its inh
 HIV-1 integrase, which will further facilitate the design of new drugs in the future. A potent 
derivative of integramycin, if discovered, could be used in new therapeutic methods in the 
treatment of AIDS, which can be applied alone or in combination with other existing methods.18d  
 
3.1.4 Retrosynthetic analysis of integramycin 
Integramycin was reduced into three subtarget molecules: the C16-C35 fragment with the 
spiroketal unit 3.5, the C6-C17 frag
p
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O
O
H
H
H
OH N
H
O
O
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1
3
5
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15
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35
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30 18
20
33 3424
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H
H
OH
OMe
O+
OH
PO
OP
O
O
H
HO
A
B
C
D
E
F
A
B
C D
E
F
N
O
OHO
H
+
3.73.5 3.6  
Scheme 3.1. Synthetic strategy. 
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        Numerous ways have been developed to synthesize spiroketals, the key feature of the C16-
C35 fragment of integramycin. For example, in the synthesis of spirofungins A and B by Dias, a 
coupling reaction of a hydrazone 3.8 and an alkyl iodide 3.9 followed by a hydrolysis provided a 
ketone product 3.10. Removal of the TBS group on 3.10 promoted spontaneous spiroketal 
formation furnishing 3.11 in 78% yield (Scheme 3.2).19a  
 
ONHMe2 I
PMBO
OTBS
PMBO
OTBS
OTBS
O
O
OTBS
3.91) n-BuLi, THF, HF-pyr, THF
78%2) SiO2, CH2Cl2
OPMB87%
3.8 3.10 3.11  
Scheme 3.2. Spiroketal synthesis by Dias. 
 
      Similarly, in Ley’s synthesis of spongistatin 1, deprotection of the TES and acetal groups on 
ketone 3.14 was followed by a simultaneous cyclization to afford spiroketal 3.15 in 85% yield. 
The ketone was prepared from an aldehyde (3.12) and an alkyne (3.13) in several steps (Scheme 
3.3).  
 
PMBO OTES
O O O O O
O
HO
H
H
OPMB
OH
SS
10% HClO4(aq),
MeCN/CH2Cl2
85%
SS
TES
PMBO
O O O
OTES
TESO
+
3.12 3.13
3.14 3.15  
Scheme 3.3. Spiroketal synthesis by Ley. 
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In Cohen’s two-pot enantioselective synthesis of spiroketal pheromone, a dicerium species 
(3.17), generated from a phenylthio ether (3.16) underwent a carbonyl addition onto lactone 
(3.18). The resulting product, upon acidic aqueous workup, furnished spiroketal (3.19) in 75% 
yield (Scheme 3.4). Although this method was employed to a fairly simple system, it provides 
one of the most efficient approaches to spiroketals.19c  
 
PhS
OH
O
O
O
O1) n-BuLi, THF, -78 °C
2) LDBB
3) CeCl3
Cl2Ce
OCeCl2
H3O+
75%3.16 3.17
3.18
3.19  
S . 
 
iroketal formation is expected to be spontaneous upon acidic treatment of the coupling 
3.20 and 3.21 as demonstrated in Cohen’s example.19c The spiroketal, once formed, 
should take the desired configuration because of the double anomeric effect (Scheme 3.6).19c If 
not, acid-catalyzed conditions should drive the spiroketal to the thermodynamically favored 
configuration taking the alkoxy groups in axial positions on both rings.20  
cheme 3.4. Cohen’s spiroketal construction
    To minimize protecting group manipulations, we envisioned that the C16-C35 fragment of 
integramycin 3.5 can be accessed by a coupling reaction of two fragments: a dianion species 3.20 
carrying the aromatic ring and a lactone 3.21 bearing a protected hydroxyl group (Scheme 3.5). 
The sp
product of 
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Scheme 3.5. Retro synthesis of the C16-C35 fragment of integramycin. 
 
Ar
OTBS
O
O Ar
OTBS
O
 
Scheme 3.6. The desired configuration of the spiro etk al. 
 
    The dianion species 3.20 can be generated from an alcohol 3.22 bearing a phenylthio group 
via a reduction reaction.19c Alcohol 3.22 can be synthesized from homoallylic alcohol 3.24 
through a radical reaction with PhSH.19c Lactone 3.21 is accessible by methylation of lactone 
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3.23, which can be obtained from homoallylic alcohol 3.25 using the strategy developed in 
Chapter 2.  
    Homoallylic alcohols 3.24 and 3.25 can be prepared from asymmetric crotylation reactions of 
aldehydes 3.26 and 3.28 employing the same (E)-crotylmetallic reagent 3.27. Various 
asymmetric crotylating reagents are available, such as Brown’s crotyldiisopinocampheyl-
boranes,21 Roush’s crotylboronates,22 Denmark’s crotyltrichlorosilane catalyzed with 
bisphosphoramide,23 and Hafner’s crotyltitanium taddolate reagent.24  
 As an alternative approach to lactone 3.21, Myers’ pseudoephedrine25 chiral auxiliary can be 
used (Scheme 3.7). In the forward sense, pseudoephedrine amide 3.30 can be methylated under 
Myers conditions to set up the α-stereocenter with excellent stereoselectivity to yield 3.29. The 
protecting group on the secondary alcohol of product 3.29 can be selectively removed and the 
resulting product should cyclize under acidic conditions to furnish lactone 3.21. Amide 3.30 can 
be obtained from  
amide alcoholysis.  
 
 homoallylic alcohol 3.32 using a hydroesterification reaction followed by a
OP
N
O
Ph
OH
O
O
3.21 3.29
PO
PO
OP
N
O
Ph
OH
3.30
PO
PO
OP OP
PO
O
O
N
3.323.31  
Scheme 3.7. Approach to lactone 3.21 using Myers chiral auxiliary. 
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3.2. Results  
 
3.2.1. The Synthesis of the precursor of dianion species 3.20 
The synthesis of the precursor of 3.8 started from the preparation of 3,5-di-(tert-
butyldimethylsilyloxy)benzaldehyde 3.26, which was synthesized using a combination of several 
known procedures (Scheme 3.8). Commercially available 3,5-dihydroxybenzoic acid was 
reduced to an alcohol using BH ·THF. Oxidation of the resulting alcohol to its aldehyde with 3
Jones’ reag
2
ent followed by a protection of the hydroxyl groups on the benzene ring as tert-
butyldimethylsilyl ethers gave the desired aldehyde 3.26 in a 34% yield over 3 steps.       
The asymmetric crotylation of aldehyde 3.26, however, proved to be more difficult than 
expected. Crotylation using Brown’s E-(–)-(Ipc) crotylborane (derived from (+)-α-pinene)21 gave 
a 91% yield of homoallylic alcohol 3.24 with poor diastereoselectivity (anti:syn = 2.3:1, 
determined by 1H NMR). The two diastereomers are inseparable (Scheme 3.8).  
 
TBSO
OTBS
O
H
3.26
HO
OH
O
OH
OH
Me
TBSO
OTBS
3.24
a-c d
Reagents: a) 1M BH3 in THF. b) CrO3, H2O, acetone. c) TBDMSCl, iPr2EtN, DMF; 34% 
over 3 steps. d) E-(-)-(Ipc)2crotylborane, THF, -78 oC; H2O2, NaOH; 91%, 2.3:1 dr.  
Scheme 3.8. The synthesis of homoallylic alcohol 3.24. 
 
Crotylation using crotyltrichlorosilane in the presence of Denmark’s bisphosphoramide 
catalyst23 was also investigated (Scheme 3.9). Under Denmark’s conditions, crotylation of 
aldehyde 3.26 yielded homoallylic alcohol 3.24 with an excellent diastereoselectivity (99:1), but 
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moderate enantioselectivity (60% ee, determined by Mosher’s ester analysis) and yield (72%). 
o prove whether the bulky TBS protecting groups on 3.26 has adverse influence on the desired 
groups were changed to methyl 
groups. Substrate 
23
 
T
transition states of the crotylation reactions, the TBS protecting 
3.26' improved the crotylation ee to 78% when using Denmark’s method, 
which is in accord with literature precedents (Scheme 3.9).  However, this reaction was not 
adopted because the deprotection of methyl groups in the final stage of the synthesis can be 
difficult. Also, Denmark’s bisphosphoramide catalyst is difficult to prepare. Crotylation of 
aldehyde 3.26' using Brown’s reagent also afforded improved dr (99:1) and ee (86%) (Scheme
3.9).  
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Scheme 3.9. Crotylations of 3.26 and 3.26'. 
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     Hafner’s crotyltitanium taddolate24 has been claimed to tolerate a broad range of substrates, 
even mismatched cases. This reagent was prepared and tested for our crotylation. To our delight, 
the crotylation of aldehyde 3.26 using Hafner’s reagent (3.33) proceeded efficiently and 
furnished 3.24 in 92% ee with essentially complete diastereocontrol (90:1 dr) and quantitative 
yield (98%) (Scheme 3.10). The resulting homoallylic alcohol 3.24 was then heated with AIBN 
in PhSH to provide thiophenyl ether 3.22 in a 90% yield.19c Thioether 3.22 is the progenitor of 
the dianion species 3.20.  
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Me
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SPh
OH
Me
TBSO
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Scheme 3.10. Hafner’s crotylation. 
 
3.2.2. The synthesis of lactone 3.21 
Several sequences were examined to convert homoallylic alcohol 3.25 into lactone 3.21. In the 
first sequence, known homoallylic alcohol 3.2519b was converted to lactone 3.23 in a 40% yield 
using the strategy developed in Chapter 2. Lactone 3.23 was treated with LDA followed by MeI 
in the presence of LiCl25 and afforded a 1.25-1.8:1 mixture of methylation products 3.34 and 
3.35 in a 80% yield, slightly favoring the desired lactone 3.34 (Scheme 3.11). Lithium chloride 
was found to be a crucial additive in the reaction to accelerate the alkylation rate. In the presence 
of LiCl, methylation was complete within 5 m at –78 ºC, sharply in contrast to when in the 
absence of LiCl, methylation only proceeded to ~80% completion after 45 min at –78 ºC.  
in 
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TBSO
OH
O
O
TBSO
O
O
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1.25-1.8:1
Chapter 2
40%
 
Scheme 3.11. Methylation of lactone 3.23. 
 
methylation of lactone 3.23 proceeded with poor diastereoselectivity, which is consistent 
with one literature precedent.26 The reason may be that the two substituents on the half chair 
transition state of the lactone enolate reside in equatorial positions and do not provide 
diastereofacial bias, and the energy difference between the chair and boatlike methylation 
products is minimal (Figure 3.8).26
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Figure 3.8. Transition states of methylation of lactone 3.23. 
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    Undesired lactone 3.35 can be epimerized to improve the yield of 3.34. Deprotonation of 3.35 
with LDA followed by protonation of the resulting lactone enolate with HOAc provided a 0.8:1 
mixture of 3.34 and 3.35 in 60% yield (Scheme 3.12).  The overall yield for the transformation 
of 3.23→ 3.34 was 60% over 2 steps.  
 
2) HOAc, -78 °C
O
OOO
3.34
60%
1) LDA, THF, -78 °C to 0 °C
TBSO
O O
TBSO TBSO
+
3.35 3.35
Scheme 3.12. The isomerization of lactone 3.35. 
 
The configurations of the methylation product 3.34 and its epimer 3.35 were assigned after 
comparing them with literature analogs. The 
 
α-H of the undesired diastereomer 3.35 has a lower 
hemical shift than that of the desired one 3.34. The α-H of 3.35 also has a coupling pattern of 
ddq and coupling constants of 13.2, 6.2, and 7.0 Hz, which are consistent with literature data.27 
Further confirmation of the assignment was obtained after converting 3.34 and 3.35 to 
compounds 3.36 and 3.37, which were previously prepared by Bartlett28 (Scheme 3.13). A 1:1.7 
mixture of 3.34 and 3.35 was desilylated using acetic acid and then deoxygenated under Myers’ 
conditions29 to afford a 1:1.7 mixture of 3.36 and 3.37, which showed identical spectra to 
Bartlett’s compounds.28  
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Scheme 3.13. Converting 3.34 and 3.35 to Bartlett’s Compounds. 
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The above sequence has the advantage of being very concise (Scheme 3.11). It only needs two 
steps to prepare lactone 3.34 from homoallylic alcohol 3.25. However, the overall yield and 
electivity are not satisfactory. Based on the observation that silyl ether protected 
homoallylic alcohols undergo hydroesterification and give high yield of the corresponding linear 
esters, we designed a sequence to combine the usage of a hydroesterification reaction and a 
methylation using pseudoephedrine chiral auxiliary.  
The sequence started e 3.14). Ozonolysis of 
.38 afforded aldehyde 3.39 in a 70% yield. Crotylation of aldehyde 3.39 using Hafner’s 
cr
diastereos
 with known PMP-protected butenol30 3.38 (Schem
3
otyltitanium taddolate24 (3.33) and subsequent protection using TBSOTf yielded silyl ether 
3.40 (85% over 2 steps). Ether 3.40 was subjected to our previous hydroesterification conditions, 
affording 2-pyridylmethyl ester 3.41 in a 80% yield. Transformation of 3.41 into 
pseudoephedrine amide 3.42 (83%), through a variant of Myers’ aminolysis conditions, followed 
by methylation25 provided amide 3.43 (91%). One-pot removal of the silyl group of 3.43 
followed by acid-mediated lactonization gave lactone 3.21 in a 79% yield. This sequence 
provided lactone 3.21 in an efficient 48% yield from ether 3.40 over 4 steps.  
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l3 to afford 3.20. 
Addition of lactone 3.21 to the resulting alkylcerium species 3.20 afforded, following an acidic 
aqueous work-up, the desired spiroketal 3.46 in a 60% yield through intermediate 3.45. This 
reaction, however, proved to be somewhat capricious due to technical difficulties associated with 
preparing the alkylcerium reagent. An exploration of alternate reagents for effecting the 
transmetalation reaction showed that MgBr2, prepared in situ from 1,2-dibromoethane and Mg 
metal, promoted spiroketal formation in 56% yield and with greater reproducibility than the 
alkylcerium addition.  
3.43 3.21  
Scheme 3.14. Lactone synthesis using pseudoephedrine chiral auxiliary. 
 
3.2.3. Coupling of dianion species 3.20 and lactone 3.21 
     Coupling of 3.20 and 3.21 (Scheme 3.15) was achieved with Cohen’s method.  
Deprotonation of the hydroxyl group of thioether 3.22 with one equivalent of n-BuLi followed 
by reduction of the sulfide with lithium di-tert-butylbiphenylide (LDBB) generated a dilithium 
intermediate 3.44 which underwent transmetalation with anhydrous CeC
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Scheme 3.15. Spiroketal formation. 
3.53.46
 
The PMP protecting group of 3.46 was easily removed using cerium ammonium nitrate (CAN) 
in wet CH3CN to give 3.5 in 79% yield. Alcohol 3.5 is well-suited for subsequent elaboration of 
the C1-C15 portion of integramycin. Significant overlap in the 1H NMR spectra of the 
spiroketals precluded their rigorous structural assignment through NOESY analysis. Therefore, 
we removed the silyl groups from 3.46 to form 3.47 as a solid that crystallized as its 
monohydrate. This allowed our stereochemical assignments to be validated by single-crystal X-
ray diffraction analysis of the monohydrate of 3.47 (Figure 3.9). 
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Figure 3.9. Crystal structure of 3.47. 
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3.3. Discussion 
 
     Given that the separation of homoallylic alcohols 3.24 and 3.48 was expected to be facile on 
the basis of their significantly different polarities, we subjected a mixture of aldehydes 3.26 and 
3.39 to simultaneous crotylation with Hafner’s reagent 3.33 (Scheme 3.16). This experiment 
showed that the additions proceed independently without interfering each other, providing the 
homoallylic alcohols 3.24 and 3.48 with yields and stereoselectivities that are comparable to 
each individual reaction while eliminating one experimental setup, workup, and chromatographic 
separation. This experiment may be expanded to parallel synthesis of multiple homoallylic 
alcohols in one pot with asymmetric crotylations. 
 
OH
Me
TBSO
OTBS
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OTBS
O
H O
O
Ph Ph
PhPh
O
O
Ti
Cp
3.26
3.33
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PMPO O
3.39
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OH
3.48 (93%)
+ +
One-pot
 
Scheme 3.16. One-pot crotylation of two aldehydes. 
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3.4 Summary 
 
The synthesis of the C16-C35 fragment of integramycin was accomplished in a convergent and 
stereoselective manner. The synthesis took 10 steps from commercially available materials 
(longest linear sequence, 14 steps overall). The sequence includes the usage of a highly efficient 
ruthenium-mediated hydroesterification reaction. This sequence also demonstrates the efficiency 
of C,O-dianionic additions into lactones as a method for producing spiroketals in a single 
operation without recourse to extensive protecting group manipulations. Also, Hafner’s 
crotylation was found to be superior to Brown’s or Denmark’s crotylations in the synthesis of 
homoallylic alcohol 3.24. 
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3.6 Experimental  
 
on of 3,5-dihydroxybenzoic acid (2.0 g, 13.0 mmol) in THF (10 
 THF, 42 mL, 42 mmol) 
coo  added dropwise. The resulting solution was stirred for 1 
extr ic layers were combined, washed with brine, then were 
2 4
in aceton ulting solution was added dropwise to stirring 
was dried under vacuum
(30 6
(s, 2
2 2 7 2
water (7 mL) was added concentrated sulfuric acid (4 mL) with shaking. Additional 
L) was added slowly, and the resulting solution was cooled to 0 °C. This 
freshly made Jones’ reagent was added dropwise to a solution of 3,5-dihydroxybenzyl alcohol 
(~1.8 g, ~13 mmol) in acetone (90 mL) at 0 °C. The reaction mixture changed to dark green. 
Jones’ reagent was kept adding until the color of the reaction turned to orange black. The 
3,5-Dihydroxybenzyl alcohol1 
To a stirring solutiHO
mL) at 0 °C was added a solution of BH3·THF (1 M in
dropwise. The resulting mixture was heated under reflux for 2 h. The reaction mixture was 
led to 0 °C and deionized water was
h and brine (~15 mL) was added. The organic layer was separated and the aqueous layer was 
acted with diethyl ether. The organ
dried over Na SO , filtered and concentrated under reduced pressure. The residue was dissolved 
e (with minimal amount) and the res
hexanes (200 mL). A precipitate formed and the resulting mixture was filter. The solid obtained 
 and was used in the next step without further purification. 1H NMR 
0 MHz, acetone-d ) δ 6.33-6.35 (d, J = 2.2 Hz, 2H), 6.19-6.22 (dd, J = 2.2, 2.2 Hz, 1H), 4.45 
H).1 
 
3,5-Dihydroxybenzaldehyde2 
To sodium dichromate dihydrate (Na Cr O · 2H O, 4 g, 13.36 mmol) in deionized 
deionized water (6 m
OH
OH
HO
OH
O
H
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reaction mixture was stirred at 0 °C for 7 min then was poured into diethyl ether (500 mL). The 
rganic layer was separated, washed with saturated NaHCO3 solution (6 × 30 mL) and brine (5 × 
30 mL), then  and concentrated under reduced pressure. The 
d
acetone-d6) δ 9
g, 34% over 3 steps): 1H NMR (300 MHz, CDCl3) δ 9.86 (s, 1H), 6.95 (d, J = 2.3 
J = 2.3, 2.3 Hz, 1H), 0.99 (s, 18H), 0.22 (s, 12H).3 
te
o
was dried over Na2SO4, filtered
resulting resi ue was used in the next step without further purification. 1H NMR (300 MHz, 
.84 (s, 1H), 8.74 (s, 2H), 6.87 (d, J = 2.3 Hz, 2H), 6.63 (dd, J = 2.3, 2.3 Hz, 1H).2 
 
3,5-Bis-(tert-butyldimethylsilyloxy)benzaldehyde (3.26)3 
To a stirring solution of 3,5-dihydroxybenzaldehyde (~0.9 g, 6.5 mmol) in DMF 
(13 mL) at 0 °C was added DIPEA (3.5 mL) followed by TBSCl (2.27 g, 15.07 
mmol). The reaction mixture was stirred at rt for 1.5 h and was quenched with ice. The organic 
layer was separated and the aqueous layer was extracted with diethyl ether (3×15 mL). The 
combined organic layers were washed with saturated NaHCO3 solution, water, and brine, then 
were dried over Na2SO4, filtered and concentrated under reduced pressure. The resulting residue 
was purified by flash column chromatography (2-3% EtOAc in hexanes) to provide the desired 
product (1.61 
TBSO
OTBS
H
O
Hz, 2H), 6.58 (dd, 
 
1-[3,5-Bis-( rt-butyldimethylsilyloxy) phenyl]-2-methylbut-3-en-1-ol (3.24) 
To a solution/suspension of (4R, trans)-2,2-dimethyl-α,α,α’,α’-tetraphenyl-1,3-
dioxolane-4,5-dimethanol (1.91 g, 4.1 mmol) in distilled cyclohexane (100 
mL) was added  freshly sublimed CpTiCl3 (0.9 g, 4.1 mmol). The reaction flask was fitted with a 
Soxhlet extractor containing MgO (4.0 g, flamed dried under vacuum). The reaction mixture was 
heated under reflux for 12 h. The solvent was removed. Absolute Et2O (41 mL) was added and 
OH
TBSO
Me
OTBS
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the resulting solution was stirred for 15 min then was concentrated. This ether washing sequence 
was repeated two additional times. The resulting residue was dissolved in Et2O (60 mL) and 
cooled to -78 oC. Crotylmagnesium chloride (0.5 M in THF, 8.2 ml, 4.1 mmol) was added. The 
resulting mixture was stirred at -78 oC for 0.5 h, warmed to 0 oC for 3 h, and recooled to -78 oC. 
Aldehyde 3.26 (1.165 g, 3.17 mmol) in ether (5 mL) was added. The reaction mixture was stirred 
oC for 2 h then was quenched with saturated NH4Cl (10 mL). The resulting mixture was 
organic layer was separated and the 
 
brine, then wer
3Si2 [M+] 422.2672, found 
22.2682. 
i
at -78 
stirred at rt for 12 h then was filtered through Celite. The 
aqueous layer was extracted with ether (3x). The organic layers were combined and washed with 
e dried over Na2SO4, filtered and concentrated. The resulting residue was purified 
by flash chromatography (2-10% EtOAc in hexanes) to afford the desired product (1.32 g, 98%): 
[α]23D  -32.0º (c = 1.10, CH2Cl2); 1H NMR (300 MHz, CDCl3) δ 6.45 (d, J = 2.2 Hz, 2H), 6.26 (t, 
J = 2.6 Hz, 1H), 5.74 (ddd, J = 8.1, 10.3, 17.5 Hz, 1H), 5.15-5.20 (m, 2H), 4.23 (dd, J = 1.9, 7.6 
Hz, 1H), 2.40 (app sextet, J = 7.2 Hz, 1H), 2.07 (d, J = 2.4 Hz, 1H, OH), 0.98 (s, 18H), 0.87 (d, J 
= 6.8 Hz, 3H), 0.19 (s, 12H); 13C NMR (75 MHz, CDCl3) δ 156.6, 144.9, 140.8, 116.8, 112.2, 
111.6, 77.9, 46.4, 25.9, 18.4, 16.7, -4.2; IR (neat) 3450, 2957, 2930, 2859, 1592, 1450, 1329, 
1254, 1163, 1025, 1004, 833, 780 cm-1; HRMS (EI) calcd for C23H42O
4
 
 (1S,2S)-1-[3,5-B s-(tert-butyldimethylsilyloxy)phenyl]-2-methyl-4-thiophenylbutan-1-ol  
(3.22) 
To a stirring solution of olefin 3.24 (220 mg, 0.52 mmol) in thiophenol (2 
mL) was added AIBN (10 mg, 0.06 mmol). The resulting mixture was heated to 90 °C. An 
additional portion of AIBN (10 mg) was added every 2 h. The reaction mixture was stirred for 10 
OH
TBSO SPh
Me
OTBS
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h, then was cooled to room temperature and diluted with diethyl ether. The resulting solution was 
washed successively with 5% of NaOH (5 × 3 mL) and brine (5 mL). The organic layer was 
dried over Na2SO4, filtered and concentrated under reduced pressure. The resulting residue was 
purified by flash chromatography (long silica gel plug, 3% of EtOAc in hexanes) to give the 
unreacted starting material (13 mg, 6%) and the desired product (234 mg, 90% at 94% 
conversion): [α]23D  -23.3º (c = 1.04, CH2Cl2); 1H NMR (300 MHz, CDCl3) δ 7.24-7.34 (m, 4H), 
7.13-7.19 (m, 1H), 6.42 (d, J = 2.1 Hz, 2H), 6.26 (dd, J = 2.1, 2.1 Hz, 1H), 4.31 (d, J = 6.6 Hz, 
1H), 2.99-3.09 (m, 1H), 2.85-2.95 (m, 1H), 1.90-2.05 (m, 2H), 1.86 (br s, 1H, OH), 1.50-1.60 
(m, 1H), 0.99 (s, 18 H), 0.81 (d, J = 6.7 Hz, 3H), 0.20 (s, 12H); 13C NMR (75 MHz, CDCl3) δ 
156.7, 145.7, 137.1, 129.1, 129.0, 125.9, 111.9, 111.5, 78.7, 39.7, 32.1, 31.8, 25.9, 18.4, 16.1, -
4.2; IR (neat) 2956, 2929, 2858, 1589, 1450, 1162, 831, 780 cm-1; HRMS (EI) calcd for 
C29H48O3Si2S [M+] 532.2862, found 532.2873. 
  
 (3S,5S,6R)-6-[2-(tert-Butyldimethylsilyloxy)ethyl]-3,5-dimethyltetrahydropyran-2-one 
(3.34) 
To a stirring solution of LDA (0.6 M in THF, 3.2 mL, 1.9 mmol) and LiCl (80 
mg, 1.9 mmol, flame dried under vacuum) at –78 °C was added a solution of 3.23 (128 mg, 0.48 
mol) in THF (2 mL) dropwise. The reaction mixture was stirred at –78 °C for 30 min, warmed 
10 
l  (1 mL) was added to the reaction mixture. The organic layer was 
separated and the aqu
O
O
TBSO
m
to –15 °C for 1 h, and was recooled to –78 °C. MeI (0.18 mL, 2.9 mmol) was added. After 
solutionmin, saturated NH4C
eous layer was extracted with ether. The organic layers were combined, 
washed with water and brine, then were dried over Na2SO4, filtered and concentrated under 
reduced pressure. The resulting residue was purified by flash chromatography (15% diethyl ether 
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in hexanes) to give the desired product 3.34 (59 mg, 43%) and the unwanted isomer 3.35 (38 mg, 
28%). Also, 14 mg of the starting material was isolated (11%). 3.24 (faster eluting diastereomer): 
[α]23D +84.7º (c = 0.64, CHCl3); 1H NMR (300 MHz, CDCl3) δ 4.06 (app dt, J = 2.2, 9.6 Hz, 
1H), 3.68-3.86 (m, 2H), 2.55-2.68 (m, 1H), 1.84-1.99 (m, 2H), 1.65-1.74 (m, 2H), 1.19 (d, J = 
6.8 Hz, 3H), 1.00 (d, J = 6.7 Hz, 3H), 0.88 (s, 9H), 0.04 (s, 6H); 13C NMR (75 MHz, CDCl3) δ 
176.5, 80.3, 58.9, 38.7, 36.7, 35.6, 32.6, 31.7, 26.1, 18.4, 18.2, 16.5, -5.1; IR (neat) 2956, 2930, 
2881, 2857, 1736, 1462, 1255, 1189, 1165, 836, 776 cm-1; HRMS (EI) calcd for C14H27O3Si [M-
CH3]+ 271.1729, found 271.1730. 3.35 (slower eluting diastereomer): [α]23D  +45.1º (c = 0.68, 
CHCl3); 1H NMR (300 MHz, CDCl3) δ 4.06 (app dt, J = 2.3, 9.5 Hz, 1H), 3.68-3.85 (m, 2H), 
2.43-2.57 (ddq, J = 13.2, 6.2, 7.0 Hz, 1H), 1.88-1.98 (m, 2H), 1.68-1.75 (m, 2H), 1.27 (d, J = 7.1 
Hz, 3H), 0.99 (d, J = 6.4 Hz, 3H), 0.89 (s, 9H), 0.05 (s, 6H); 13C NMR (75 MHz, CDCl3) δ 
174.3, 84.2, 58.8, 37.9, 37.1, 36.4, 33.9, 26.1, 18.4, 17.6, 17.4, -5.2; IR (neat) 2956, 2929, 2881, 
52, 2735, 1091, 836, 776 cm-1. 
6-(2-Hydroxy-ethyl)-3,5-dimethyltetrahydropyran-2-one 
T
28
 
o a 1:1.7 mixture of 3.34 and 3.35 (50 mg, 0.18 mmol) in THF (1 mL) was 
added glacial acetic acid (3 mL) and deionized water (1 mL). The reaction 
mixture was stirred at 35 °C overnight. The reaction mixture was concentrated under reduced 
pressure and the resulting residue was purified by flash chromatography (60% EtOAc in 
hexanes) to afford a 1:1.7 mixture of the desired products (24 mg, 0.14 mmol, 80%): 1H NMR 
(300 MHz, CDCl3) δ 4.09 (m, 1H), 3.78-3.90 (m, 2H), 2.61-2.71 (m, 37% of 1H), 2.47-2.58 (m, 
63% of 1H), 2.40 (br s, 1H), 1.69-2.07 (m, 5H), 1.26 (d, J = 7.0 Hz, 63% of 3H), 1.19 (d, J = 6.8 
O
O
HO
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Hz, 37% of 3H), 1.01 (d, J = 6.6 Hz, 37% of 3H), 0.99 (d, J = 5.7 Hz, 63% of 3H); IR (neat) 
3416, 1960, 2929, 2873, 1716, 1454, 1378, 1203, 1050 cm-1. 
 
6-Ethyl-3,5-dimethyltetrahydropyran-2-one (3.36 and 3.37)  
To a stirring solution of PPh3 (73 mg, 0.28 mmol) in THF (1 mL) at –30 °C was 
added DEAD (48 mg, 0.28 mmol). After 10 min, a 1:1.7 mixture of 6-(2-hydroxy-
ethyl)-3,5-dimethyltetrahydropyran-2-one (24 mg, 0.14 mmol) in THF (1 mL) was added. After 
additional 10 min, a solution of NBSH (105 mg, 0.42 mmol) in THF (1 mL) was added to the 
reaction mixture. The reaction mixture was stirred at rt for 2 h, then was concentrated under 
reduced pressure. The resulting residue was dissolved in EtOAc (1 mL) and the resultant solution 
was added to hexanes (40 mL) dropwise. A precipitate formed and the resulting mixture was 
filtered through a Celite pad flushing with 5% EtOAc in hexanes. The filtrate was concentrated 
under reduced pressure and the resulting residue was purified by flash chromatography (30% 
tOAc in hexanes) to afford a 1:1.7 mixture of 3.36 and 3.37: 1H NMR (300 MHz, CDCl3) δ 
, 63% of 1H), 1.49-1.94 (m, 7H), 
.
(75 MHz, CDC
E
3.85-3.94 (m, 1H), 2.60-2.70 (m, 37% of 1H), 2.43-2.54 (m
1.27 (d, J = 7 0 Hz, 63% of 3H), 1.21 (d, J = 6.8 Hz, 37% of 3H), 0.97-1.05 (m, 6H); 13C NMR 
l3) δ 178.0, 88.2, 84.8, 37.8, 36.5, 35.4, 32.9, 32.7, 30.9, 26.4, 26.1, 18.1, 17.5, 
16.6, 9.4, 8.9; IR (neat) 2955, 2922, 2851, 1731, 1460, 1372, 1101 cm-1; HRMS (EI) calcd for 
C9H16O2  [M+] 156.1150, found 156.1143.   
 
3-(4-Methoxyphenoxy)propionaldehyde (3.39) 
PMPO O   To 1-but-3-enyloxy-4-methoxybenzene (2.0 g, 11.2 mmol) in MeOH (150 mL) at 
-42 oC was exposed to a stream of ozone for 30 min. Dimethyl sulfide (3 mL) was added and the 
O
O
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resulting mixture was allowed to warm to rt over 3 h. The reaction mixture was concentrated 
under reduced pressure. The resulting residue was dissolved in ether, washed with water and 
rine, then was dried over Na2SO4, filtered and concentrated. The resulting residue was then 
fford the desired product (1.4 g, 
M
2H), 3.70 (s
y)ethyl]-2-methylbut-3-enyloxy}dimethylsilane 
(3.40)  
.04 g, 4.4 mmol) in CH2Cl2 (40 mL) at 0 oC 
were added 2
b
purified by flash chromatography (25% EtOAc in hexanes) to a
70%): 1H N R (300 MHz, CDCl3) δ 9.78 (t, J = 1.6 Hz, 1H), 6.81 (s, 4H), 4.18 (t, J = 6.0 Hz, 
, 3H), 2.78 (dt, J = 1.6, 6.0 Hz, 2H); 13C NMR (75 MHz, CDCl3) δ 200.5, 154.0, 
152.5, 115.5, 114.6, 62.2, 55.5, 43.2; IR (neat) 2945, 2837, 1723, 1508, 1230, 1035 cm-1; 
HRMS-EI (m/z) calcd for C10H12O3 [M+] 180.0786, found 180.0789. 
 
(3R,4S)-1-(4-Methoxyphenoxy)-4-methylhex-5-en-3-ol (3.48)  
Prepare following the procedure for 3.24. [α]23D  +6.9º (c = 1.27, CH2Cl2); 1H 
NMR (300 MHz, CDCl3) δ 6.85 (s, 4H), 5.75-5.87 (m, 1H), 5.09-5.16 (m, 
2H), 4.07-4.16 (m, 2H), 3.77 (s, 3H), 3.69-3.77 (m, 1H), 2.23 (app sextet of triplet, J = 6.8, 0.9 
Hz, 1H), 2.19 (br, 1H, OH), 1.93 (dddd, J = 2.7, 5.5, 6.9, 14.3 Hz, 1H), 1.78 (dddd, J = 5.8, 6.3, 
9.6, 15.1 Hz, 1H), 1.08 (d, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 154.0, 153.0, 140.3, 
116.5, 115.6, 114.8, 72.9, 66.7, 55.9, 44.4, 33.8, 16.2; IR (neat) 3452, 1509, 1231, 1029 cm-1; 
HRMS-EI (m/z) calcd for C14H20O3 [M+] 236.1412, found 236.1414.  
 
tert-Butyl{(1R,2S)-1-[2-(4-methoxyphenox
PMPO
OH
OTBS
To a solution of alcohol 3.48 (1
PMPO
,6-lutidine (2.05 mL, 17.6 mmol) and TBSOTf (1.6 mL, 7.04 mmol). The reaction 
mixture was stirred at 0 oC for 2 h, then was quenched by adding 10% citric acid (10 mL). The 
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organic layer was separated and the aqueous layer was extracted with CH2Cl2. The organic layers 
were combined and washed with brine, then were dried over Na2SO4, filtered and concentrated. 
The resulting residue was purified by flash chromatography (1-3% EtOAc in hexanes) to afford 
the desired product (1.33 g, 86%): [α]23D  +7.5º (c = 0.98, CH2Cl2); 1H NMR (300 MHz, CDCl3) 
δ 6.88 (s, 4H), 5.83-5.95 (m, 1H), 5.09-5.15 (m, 2H), 3.95-4.03 (m, 3H), 3.79 (s, 3H), 2.40-2.51 
(m, 1H), 1.81-1.99 (m, 2H), 1.11 (d, J = 6.9 Hz, 3H), 0.98 (s, 9H), 0.15 (s, 3H). 0.09 (s, 3H); 13C 
NMR (75 MHz, CDCl3) δ 153.9, 153.4, 140.8, 115.5, 114.9, 114.8, 72.5, 65.6, 55.9, 43.7, 32.9, 
26.1, 18.3, 14.6, -4.2, -4.3; IR (neat) 1508, 1231, 1045, 830 cm-1; HRMS-EI (m/z) calcd for 
20H34O3Si [M+] 350.2277, found 350.2273. 
(4 u
ate (408 mg, 3.0 mmol) 
ere added. The resulting mixture was heated at 135 oC for 3 h. The reaction mixture was cooled 
h 
tography (20-25% EtOAc in hexanes) to afford the desired product (388 mg, 80%): [α]23D  
,
PMPO
C
 
S,5R)-5-(tert-B tyldimethylsilyloxy)-7-(4-methoxyphenoxy)-4-methylheptanoic acid 
pyridin-2-ylmethyl ester (3.41)  
To olefin 3.40 (350 mg, 1.0 mmol) in a sample vial were added 
Ru3(CO)12 (32 mg, 0.05 mmol) and 2-pyridylmethyl formate (408 mg, 3.0 mmol). The sample 
vial was flushed with Argon then was capped. The reaction mixture was heated to 135 oC with 
stirring over 30 min. After stirring at 135 oC for 12 h, the reaction mixture was cooled to rt. 
Additional Ru3(CO)12 (32 mg, 0.05 mmol) and 2-pyridylmethyl form
OTBS
w
to 0 oC, and the cap of the sample vial was removed. The reaction mixture was purified by flas
chroma
+11.1º (c = 0.98  CH2Cl2); 1H NMR (300 MHz, CDCl3) δ 8.60 (d, J = 4.7 Hz, 1H), 7.67 (ddd, J = 
1.5, 7.7, 7.7 Hz, 1H), 7.36 (d, J = 7.9 Hz, 1H), 7.20 (dd, J = 4.9, 7.4 Hz, 1H), 6.85 (s, 4H), 5.27 
(s, 2H), 3.97 (t, J = 6.3 Hz, 2H), 3.90-3.94 (m, 1H), 3.76 (s, 3H), 2.46-2.59 (m, 2H), 1.73-1.89 
O
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(m, 4H), 1.52-1.57 (m, 1H), 0.96 (d, J = 6.6 Hz, 3H), 0.92 (s, 9H), 0.07 (s, 3H), 0.03 (s, 3H); 13C 
NMR (75 MHz, CDCl3) δ 173.1, 155.8, 153.5, 153.0, 149.4, 136.6, 122.7, 121.6, 115.1, 114.5, 
71.8, 66.6, 64.9, 55.5, 38.2, 32.2, 31.4, 27.7, 25.8, 18.0, 13.8, -4.5, -4.7; IR (neat) 1736, 1508, 
1229, 1034cm-1; HRMS-EI (m/z) calcd for C27H41O5NSi [M+] 487.2754, found 487.2753.  
 
(4R,5S)-5-(tert-Butyldimethylsilyloxy)-7-(4-methoxyphenoxy)-4-methylheptanoic acid 
[(1S,2S)-(2-hydroxy-1-methyl-2-phenylethyl)]methylamide (3.42)  
To a solution of (1S,2S)-pseudoephedrine (139 mg, 0.84 mmol, 
azeotropic remov
OTBS
al water with toluene in vacuo before use) in THF 
 mL) at 0 oC was added NaH (60% in mineral oil, 32 mg, 0.79 mmol). The reaction mixture 
was stirred at 0 oC for 45 min
with water. 
The organic layer was sep
PMPO
(3
 and a solution of ester 3.42 (137 mg, 0.276 mmol) in THF (2 mL) 
ixture was stirred at 0 was added. The resulting m oC for 40 min then was quenched 
arated and the aqueous layer was extracted with ether (3x). The 
organic layers were combined and washed with brine, then were dried over Na2SO4, filtered and 
concentrated. The resulting residue was purified by flash chromatography (35-45% EtOAc in 
hexanes) to afford the desired product (125 mg, 83%, 2 rotamers in ~2.5 : 1 ratio): [α]23D  +62.4º 
(c = 1.55, CH2Cl2); 1H NMR (300 MHz, CDCl3) δ 7.24-7.36 (m, 5H), 6.83 (s, 70% of 4H), 6.80 
(s, 30% of 4H), 4.60 (d, J = 7.8 Hz, 70% of 1H), 4.56 (d, J = 8.9 Hz, 30% of 1H), 4.38-4.43 (m, 
1H), 3.95-4.00 (m, 2H), 3.85-3.91 (m, 1H), 3.77 (s, 70% of 3H), 3.76 (s, 30% of 3H), 2.93 (s, 
30% of 3H), 2.81 (70% of 3H), 2.34-2.48 (m, 1H), 2.22-2.29 (m, 1H), 1.81-1.89 (m, 2H), 1.63-
1.77 (m, 2H), 1.39-1.49 (m, 1H), 1.13 (d, J = 7.0 Hz, 70% of 3H), 0.99 (d, J = 7.0 Hz, 30% of 
3H), 0.94 (d, J = 6.5 Hz, 30% of 3H), 0.92 (d, J = 6.5 Hz, 70% of 3H), 0.88 (s, 9H), 0.06 (s, 3H), 
0.00 (s, 3H); 13C NMR (75 MHz, CDCl3, peaks shown in parentheses belong to the minor 
N
O
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rotamor) δ 175.7 (174.4), 153.8, 153.4, 142.7 (141.4), 128.6 (129.0), 127.8, 126.5 (127.1), 115.4, 
114.8, 75.8, 72.3, 65.4, 59.3, 55.9 (58.6), 38.7, 32.7 (33.4), 31.6 (32.0), 28.1 (28.4), 27.0, 26.1, 
18.3, 14.7 (15.6), 14.1; -4.2, -4.4; IR (neat) 2955, 2930, 1621, 1508, 1231, 1039 cm-1; HRMS-EI 
(m/z) calcd for C31H49NO5Si [M+] 543.3380, found 543.3361.  
 
(2S,4R,5S)-5-(tert-Butyldimethylsilyloxy)-7-(4-methoxyphenoxy)-2,4-dimethylheptanoic 
acid [(1S,2S)-2-hydroxy-1-methyl-2-phenylethyl)]methylamide (3.43) 
T
n
PMPO
o a mixture of LiCl (120 mg, 2.8 mmol, flame dried under vacuum) 
d LDA (0.5 M in THF, 3.8 mL, 1.9 mmol) at -78 
OTBS
a oC was added an 
ice-cooled solution of amide 3.42 (256 mg, 0.47 mmol) in THF (2 mL). The reaction mixture 
was stirred at -78 oC for 1 h, warmed to 0 oC for 10 min, then was cooled to -78 oC. MeI (0.18 
mL, 2.8 mmol) was added dropwise. The resulting mixture was stirred at -78 oC for 10 min, 0 oC 
for 10 min then was quenched with saturated NH4Cl solution (2 mL). The organic layer was 
separated and the aqueous layer was extracted with ether (3x). The organic layers were combined 
and washed with brine, then were dried over Na2SO4, filtered and concentrated. The resulting 
residue was purified by flash chromatography (35-50% EtOAc in hexanes) to afford the desired 
product (238 mg, 91%, 2 rotamers in ~2.5 : 1 ratio): [α]23D  +63.4º (c = 1.03, CH2Cl2); 1H NMR 
(300 MHz, CDCl3) δ 7.23-7.40 (m, 5H), 6.82 (br, 70% of 4H), 6.72 (m, 30% of 4H), 4.66 (d, J = 
7.1 Hz, 70% of 1H), 4.58 (d, J = 8.8 Hz, 30% of 1H), 4.22 (app pentet, J = 6.9 Hz, 70% of 1H), 
4.04 (app pentet, J = 7.9 Hz, 30% of 1H), 3.90-3.98 (m, 2H), 3.79 (ddd, J = 3.8, 3.8, 7.7 Hz, 1H), 
3.77 (s, 70% of 3H), 3.76 (s, 30% of 3H), 2.94 (s, 30% of 3H), 2.81 (s, 70% of 3H), 2.57 (app 
sextet, J = 6.8 Hz, 1H), 1.69-1.90 (m, 3H), 1.37-1.49 (m, 2H), 1.22 (d, J = 7.1 Hz, 70% of 3H), 
1.16 (d, J = 6.6 Hz, 30% of 3H), 1.01 (d, J = 6.6 Hz, 30% of 3H), 0.98 (d, J = 6.6 Hz, 70% of 
O
N
Ph
OH
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3H), 0.91 (d, J = 8.0 Hz, 30% of 3H), 0.88 (d, J = 8.0 Hz, 70% of 3H), 0.88 (s, 70% of 9H), 0.85 
(s, 30% of 9H), 0.04 (s, 70% of 3H), 0.01 (s, 30% of 3H), -0.01 (s, 70% of 3H), -0.04 (s, 30% of 
3H); 13C NMR (75 MHz, CDCl3 , peaks shown in parentheses belong to the minor rotamer) δ 
179.2 (178.0), 153.9, 153.4, 142.9 (141.4), 129.0, 128.7, 128.5, 127.7, 127.1, 126.4, 115.5, 
14.9, 77.4 (75.8), 72.8, 65.5 (60.7), 56.0 (58.2), 36.8 (37.2), 36.6 (36.2), 34.6 (33.6), 31.7 
71, 
ound 557.3555.  
)-6-[2-(4-Methoxyphenoxy)ethyl]-3,5-dim
23 1
13
-1
+
1
(31.9), 26.1, 18.3, 17.1, 14.7, 14.1 (14.2), -4.1, -4.4; IR (neat) 2955, 2931, 1621, 1508, 14
1231, 1043 cm-1; HRMS-EI (m/z) calcd for C32H51NO5Si [M+] 557.3536, f
 
(3S,5S,6R ethyltetrahydropyran-2-one (3.21) 
To a solution of amide 3.43 (185 mg, 0.33 mmol) in CH2Cl2 (5 mL) was added 
TBAF (226 mg, 0.86 mmol). The reaction mixture was stirred at rt for 24 h and 
para-toluenesulfonic acid (PTSA) was added until the PH of the reaction mixture was ~1. The 
resulting mixture was stirred at rt for additional 24 h then was concentrated under reduced 
pressure. The resulting residue was purified by flash chromatography (20% EtOAc in hexanes) 
to afford the desired product (73 mg, 79%): [α] D  +104.7º (c = 0.75, CH2Cl2); H NMR (300 
MHz, CDCl3) δ 6.81 (s, 4H), 4.03-4.21 (m, 3H), 3.75 (s, 3H), 2.60-2.68 (m, 1H), 2.16-2.24 (m, 
1H), 1,88-1.95 (m, 2H), 1.64-1.74 (m, 2H), 1.19 (d, J = 6.8 Hz, 3H), 1.03 (d, J = 6.7 Hz, 3H); 
C NMR (75 MHz, CDCl3) δ 176.2, 153.9, 152.9, 115.5, 114.6, 80.0, 64.1, 55.7, 35.2, 33.2, 
32.5, 31.7, 17.9, 16.2; IR (neat) 2934, 1743, 1508, 1232 cm ; HRMS-EI (m/z) calcd for 
C16H22O4 [M ] 278.1518, found 278.1520.  
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(2R,3S,5S,6R,8S,9S)-8-[3,5-Bis(tert-butyldimethylsilyloxy)phenyl]-2-[2-(4-
methoxyphenoxy)ethyl]-3,5,9-trimethyl-1,7-dioxaspiro[5.5]undecane (3.46) 
Procedure to make LDBB:  
To a solution of 4,4’-di-tert-butylbiphenyl (DBB) (585 mg, 2.19 mmol) in 
THF (6 mL) under argon atmosphere was added lithium (15 mg, 2.19 mmol, 
cut into 3 pieces with surface oxide removed with a razor blade). The reaction mixture was 
sonicated at rt for 5 min, and then stirred at 5 °C for 12 h.  
To sulfide 3.22 (450 mg, 0.84 mmol) in THF (5 mL) at -78 °C was added n-BuLi (1.6 M in 
hexanes, 0.53 mL, 0.85 mmol) dropwise. After 10 min, the reaction mixture was cannulated into 
a stirring solution of LDBB at -78 °C. The color of the solution changed from dark green to light 
al LDBB was slowly cannulated into the reaction mixture until the color of the 
reaction just changed to light green, indicating the full reduction of sulfide 3.22. The resulting 
mixture was  stirred for 45 min at -78 °C then a solution of MgBr2 [1.26 mmol, made by stirring 
Mg (35 mg, 1.46 mmol) and 1,2-dibromoethane (238 mg, 1.26 mmol) in 3 mL of ether at room 
temperature for 2 h] was added via cannula. The reaction turned to yellowish brown. The 
reaction mixture was stirred at -78 °C for 20 min, warmed to -42 °C for 10 min, and recooled to -
78 °C. To this stirring solution was cannulated lactone 3.21 (125 mg, 0.449 mmol) in THF (1 
mL). The resulting mixture was stirred at -78 °C for 15 min and allowed to warm to 0 °C over 15 
min. After additiona 5 min, to the reaction mixture were added saturated NH4Cl solution (1 mL) 
and HCl (3 M, 4 mL). The resulting mixture was stirred at room temperature for 1 h. The organic 
acted with ether (3x). The organic layers were 
combined and washed with brine, then were dried over Na2SO4, filtered and concentrated. The 
atography (1-3% EtOAc in hexanes) to afford the 
brown. Addition
layer was separated and the aqueous layer was extr
resulting residue was purified by flash chrom
TBSO
OTBS
O
O
H
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desired product as a liquid (171 mg, 56%): [α]23D  -25.0º (c = 1.70, CH2C
6 (m, 4H), 6.42 (d, J = 2.2 Hz, 2H), 6..25 (t, J = 2.2 Hz, 1H), 4.29 (ddd, 
l2); 1H NMR (300 
MHz, CDCl3) δ 6.82-6.9
J = 4.9, 9.0, 9.0 Hz, 1H), 4.00 (ddd, J = 3.8, 5.8, 9.6 Hz, 1H), 3.91 (d, J = 9.3 Hz, 1H), 3.78 (s, 
 = 2.2, 10.4, 10.4 Hz, 1H), 2.18-2.24 (m, 1H), 1.70-1.85 (m, 4H), 1.44-1.60 (m, 
4H), 1.19-1.24 (m, 
, 2858, 1590, 1508, 1451, 1231, 1157, 1027, 832 cm-1; 
3H), 3.45 (ddd, J
2H), 1.00 (d, J = 7.1 Hz, 3H), 0.97 (s, 18H), 0.79 (d, J = 6.6 Hz, 3H), 0.43 (d, 
J = 5.8 Hz, 3H), 0.18 (s, 12H); 13C NMR (75 MHz, CDCl3) δ 156.2, 153.9, 153.6, 144.1, 115.6, 
115.0, 113.4, 111.3, 98.2, 78.5, 71.2, 65.0, 55.9, 36.5, 35.9, 35.6, 33.3, 29.8, 28.7, 26.0, 18.5, 
17.8, 15.4, -4.1; IR (neat) 2955, 2928
HRMS-EI (m/z) calcd for C39H64O6Si2 [M+] 684.4241, found 684.4251.  
 
2-{(2R,3S,5S,6R,8S,9S)-8-[3,5-Bis(tert-butyldimethylsilyloxy)phenyl]-3,5,9-trimethyl-1,7-
dioxaspiro[5.5]undec-2-yl}ethanol (3.5) 
To spiroketal 3.46 (35 mg, 0.051 mmol) in CH3CN (5 mL) at 0 °C was 
added a solution of CAN (140 mg, 0.255 mmol) in H2O (1 mL) dropwise. 
After 7 min, the reaction mixture was diluted with CH2Cl2. The resulting 
solution was washed with brine, dried over Na2SO4, filtered and concentrated under reduced 
pressure. The resulting residue was purified by flash chromatography (8% EtOAc in hexanes) to 
give the desired product (23.4 mg, 79%): [α]23D  +14.5º (c = 0.51, CH2Cl2); 1H NMR (300 MHz, 
CDCl3) δ 6.45 (d, J = 2.2 Hz, 2H), 6.28 (t, J = 2.2 Hz, 1H), 3.96 (d, J = 9.3 Hz, 1H), 3.89 (br, 
2H), 3.42 (ddd, J = 2.7, 9.5, 9.5 Hz, 1H), 3.20 (br, 1H, OH), 1.44-1.95 (m, 9H), 1.18-1.26 (m, 
2H), 1.01 (d, J = 7.1 Hz, 3H), 0.98 (s, 18H), 0.71 (d, J = 6.6 Hz, 3H), 0.67 (d, J = 6.0 Hz, 3H), 
0.19 (s, 12H); 13C NMR (75 MHz, CDCl3) δ 156.24, 143.6, 113.2, 111.6, 98.7, 78.8, 77.0, 62.4, 
36.5, 36.0, 35.0, 24.8, 32.9, 29.1, 28.8, 25.9, 18.5, 17.9, 17.8, 15.2, -4.2; IR (neat) 2960, 2929, 
TBSO
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2858, 1588, 1449, 1152, 1024, 830 cm-1; HRMS-EI (m/z) calcd for C32H58O5Si2 [M+] 578.3823, 
found 578.3803.  
 
5-{(2S,3S,6R,8R,9S,11S)-8-[2-(4-Methoxyphenoxy)ethyl]-3,9,11-trimethyl-1,7-
dioxaspiro[5.5]undec-2-yl}benzene-1,3-diol (3.47) 
To spiroketal 3.46 (30 mg, 0.044 mmol) in THF (3 mL) at room 
temperature was added TBAF (46 mg, 0.176 mmol). The reaction 
mixture was stirred for 1 h and then concentrated under reduced pressure. The resulting residue 
was purified by flash chromatography (35% EtOAc in hexanes) to afford the desired product as a 
solid (13.2 mg, 66%): [α]23   -28.2º (c = 0.73, acetone); 1H NMR (500 MHz, acetone) δ 8.04 (br, 
2H, OH), 6.95-6.97 (m, 2H), 6.85-6.88 (m, 2H), 6.32 (d, J = 2.3 Hz, 2H), 6.26 (t, J = 2.3 Hz, 1H), 
4.32 (app dt, J = 4.6, 9.2 Hz, 1H), 4.03 (ddd, J = 3.7, 6.0, 9.2 Hz, 1H), 3.94 (d, J = 9.6 Hz, 1H), 
3.71 (s, 3H), 3.47 (app dt, J = 2.3, 10.1 Hz, 1H), 2.18-2.22 (m, 1H), 1.74-1.82 (m, 2H), 1.63-1.70 
(m, 2H), 1.49-1.57 (m, 4H), 1.38-1.44 (m, 1H), 1.21 (ddd, J = 2.3, 3.7, 12.8 Hz, 1H), 0.99 (d, J = 
J = 6.4 Hz, 3H), 0.41 (d, J = 6.0 Hz, 3H); 13C NMR (125 MHz, acetone) δ 
158.8, 154.6, 154.1, 145.1, 116.0, 115.4, 107.3, 102.5, 98.5, 79.0, 71.4, 64.9, 55.8, 37.0, 36.3, 
36.1, 33.8, 33.7, 29.0, 18.0, 15.4; IR (neat) 3457, 3293, 2919, 1598, 1510, 1229, 1152 cm-1; 
HRMS-EI (m/z) calcd for C H O  [M+] 456.2512, found 456.2513.  
 
D
6.9 Hz, 3H), 0.74 (d, 
27 36 6
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Chapter 4. Study towards the synthesis of the cis-decalin unit of integramycin 
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4.1 Introduction 
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4.1
Integramycin  
 
  As discussed in Chapter 3, the synthesis of integramycin was reduced into three subtarget 
molecules, one of which is the cis-decalin unit of integramycin (4.1). Molecule 4.1 has two 
hydroxyl groups, one double bond, and one ester in a cis-decalin. The primary hydroxyl and the 
ester groups of 4.1 will allow the connection with other fragments of integramycin. The major 
challenge of this synthesis lies in the establishment of the cis-decalin structure. Because of their 
slightly higher conformational energy than trans-decalins, cis-decalins are more difficult to 
access. There are two common ways to synthesize cis-decalins in literature, using either an oxy-
Cope rearrangement or a Diels-Alder reaction:  
 
thesis of cis-decalins 
 the most widely used 
y faster than neutral oxy-Cope rearrangements (up to 1010-1017 times).1 In Paquette’s 
4.1.1 Oxy-Cope rearrangements in the syn
 The oxy-Cope rearrangement, particularly its anionic variant, is one of
protocols to synthesize cis-decalins. Anionic oxy-Cope rearrangements were found to be 
significantl
study towards the total synthesis of vinigrol, 1,5-diene 4.2 underwent facile anionic oxy-Cope 
react until being heated to 120 °C in a sealed tube, affording cis-decalin 4.5 in a 72% yield 
2
 
rearrangement at 25 °C, providing cis-decalin 4.3 in a 71% yield. However, analog 4.4 did not 
(Scheme 4.1).   
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Scheme 4.1. Anionic oxy-Cope rearrangement in Paquette’s synthesis towards vinigrol. 
 
    In Jin and co-workers’ asymmetric synthesis of the core of superstolides, compound 4.6 was 
treated with KHMDS at 115 °C in a sealed tube in the presence of 18-crown-6, providing a cis-
decalin (4.7) in 51% yield (Scheme 4.2).   
PhMe2Si
PMBO
Me
OH OHOH
H
PhMe Si2
Me
H
O
H
OH
HKHMDS, 18-cr-6, DCE,
51%
115 °C
OH
PMBO
, sealed tube
4.6 4.7  
 oxy-Cope rearrangement.  Scheme 4.2. Jin’s preparation of cis-decalin 4.7 using an
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An oxy-Cope rearrangement was employed by Banwell and co-workers in their synthesis of 
the core of phomopsidin. Compound 4.8, synthesized from cis-1,2-dihydrocatechol, was 
subjected to KH to initiate an anionic oxy-Cope rearrangement. The reaction provided the 
desired cis-decalin 4.9 in a 50% yield (Scheme 4.3).4  
 
MeO
O
OMe H
H
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O
O
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50%
OH
4.8 4.9  
Scheme 4.3. Anionic oxy-Cope rearrangement used in the synthesis of phomopsidin. 
 
Anionic oxy-Cope rearrangements have many advantages. The stereochemical outcome is 
predictable based on the structure of the starting material, especially for cyclic starting 
materials.5 The stereoselectivity is often adjustable and dependent on solvent, temperate, and the 
count sh 
conditions such as high temperature are needed to initiate the reactions, which means less 
fu
 
4.1.2 Diels-Alder reactions in the synthesis of cis-decalins 
The Diels-Alder reaction is one of the most powerful reactions in syntheses. It has the 
capability e 
transition state of a Diels-Alder reaction is often predicable which facilitates the design and 
erion metals.2 Anionic oxy-Cope rearrangements also have drawbacks. Sometimes har
nctional group tolerance. The yields of the rearrangements can be low and are often in the 
range of 50-70%. Also, the stereoselectivity of the vinylation or allylation step in preparing the 
starting materials may be low.  
 of establishing multiple new stereocenters and bonds in one manipulation. Th
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ob
Diels-Alder reactions are also used in the synthesis of cis-decalins. For example, compound 
4.10, which was synthesized from cyclohexenone and (1R,2R)-1,2-diphenylethane-1,2-diol, 
underwent an ionic Diels-Alder reaction with 2,3-dimethyl-1,3-butadiene (4.11) and afforded a 
mixture of cis-decalins in 2:1 ratio (Scheme 4.4).7 Using this strategy by Anderson et al., 
diastere
 
taining the desired product and stereochemistry. Numerous elegant total syntheses have been 
reported using Diels-Alder reactions as the key steps.6 Furthermore, many asymmetric catalysts 
have been developed to provide enantioselective Diels-Alder reactions from achiral starting 
materials.6    
  
oselectivity of up to 83% has been obtained.  
OO
Ph Ph
OO
Ph Ph
OO
Ph Ph
H HH H
Me3SiOTf (cat.)
96%
4.10
4.11
4.12 4.13  
Scheme 4.4. Intermolecular Diels-Alder reactions in the synthesis of cis-decalins. 
 
Intramolecular Diels-Alder reactions are arguably the most widely employed protocols to 
prepare cis-decalins. While an intermolecular Diels-Alder reaction furnishes cis-decalins with 
double bonds at the 6,7-position (Scheme 4.4), an intramolecular Diels-Alder reaction (IMDA) 
commonly leaves double bonds at the 3,4-position (Scheme 4.5). In Yamada’s total synthesis of 
kalihinene X, triene alcohol 4.14 was oxidized with Dess-Martin periodinane in CH2Cl2 at room 
temperature, and the resulting trienone underwent spontaneous intramolecular Diels-Alder 
reaction to give cis-decalin 4.15 as a single diastereomer in 93% yield (Scheme 4.5).     
+
2:16
7 7
6
8
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HH O
H
O
O
Cl
Cl
H
OH
Dess-Martin periodinane
2 2
93%
CH Cl , rt
4.14 4.15
3
 
4.18 in a 9:1 ratio (Scheme 4.6).9 The 
reaction was explained to take a boatlike endo transition state with the large isopropyl group syn 
to the angular hydrogens. The chairlike transition state was proposed to have higher energy 
because of a severe nonbonding interaction (Scheme 4.6).   
4
Scheme 4.5. Yamada’s synthesis of kalihinene X using an IMDA. 
 
A similar reaction had been reported by Taber and Gunn in their synthesis of (±)-torreyol. 
Triene alcohol 4.16, upon treatment with H2Cr2O7 in ether at 0 °C, underwent oxidation followed 
by spontaneous IMDA to afford cis-decalins 4.17 and 
O
OH O O
H
H
H
H
+
H2Cr2O7, ether, 0 °C
87%
4.16 4.17 4.18
9:1
boatlike TS chairlike TS
H
H
O
 
Scheme 4.6. Taber’s synthesis of torreyol using an IMDA.  
 
In Nakada’s total synthesis of phomopsidin, a cyclic triene 4.19 was heated in refluxing 
toluene for one day and furnished a 2:1 mixture of diastereomers with the cis-decalin 4.20 as the 
major product (Scheme 4.7).10   
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OTIPSO
O
BHT, toluene, reflux, 1 d
63%, 2:1 dr
H
H
O
4.20
O
TIPSO
4.19  
Scheme 4.7. An IMDA of a cyclic triene 4.19.  
 
alin 4.22' as the major product.   
 
 
Depending on the substituents on the triene, IMDA’s more often give a mixture of trans- and 
cis-decalins in complex systems. In Roush’s synthesis of chlorothricolide, triene 4.21 was treated 
with bis(trimethylsilyl)acetamide (BSA) and the resulting TMS ether underwent an IMDA 
followed by silyl ether removal under acidic conditions. A mixture of trans-decalin 4.22 and cis-
decalin 4.23 was generated in about 1:1 ratio (Scheme 4.8).11 After modifying the substituents on 
the substrate, triene 4.21' was found to furnish the trans-dec
HO
CO2Me
Br
Me
OCH2Ph
Br Br OCH2Ph
CO2Me
OCH2Ph
CO2MeHO
HO
Me Me
65-70%
1) Bis(trimethylsilyl)acetamide
toluene, 180 °C
2) H3O+
4.234.21 4.22
+
55 : 45
 
OBz
CO2Me
TMS
Me
OMOM
TMS TMS OMOM
CO2Me
OMOM
CO2MeBzO
BzO
Me Me      BHT, toluene, 180 °C
85%
4.23'4.21' 4.22'
+
3.8:1
 
Scheme 4.8. IMDA’s providing a mixture of trans- and cis-decalins. 
 
 171
    Diels-Alder reactions have the advantage of providing quick access to multiple new 
stereocenters. However, they also have the disadvantage of often providing a mixture of 
diastereomers for complex systems. An individual application has to be considered base on its 
own properties to decide whether to use a Diels-Alder reaction or an oxy-Cope rearrangement in 
the synthesis of cis-decalins.  
 
 
4.1.3 Roush’s racemic synthesis of the cis-decalin unit of integramycin 
  When our study towards the synthesis of 4.1 was in progress, Roush reported a racemic 
synthesis of the cis-decalin unit of integramycin using an IMDA as the key step (Scheme 4.9).  
which provided a diene 4.26 in a 60% yield. Installation of a hydroxyl group onto 4.26 with 
Davis’ oxaziridine followed by a silyl protection afforded diene ester 4.27. Ester 4.27 was then 
converted into a Weinreb amide 4.28. Addition of vinyl lithium 4.29 onto 4.28 furnished triene 
4.30 in 84% yield. Triene 4.30 underwent facile IMDA when treated with 0.6 eq of MeAlCl2 in 
CH2Cl2 at -78 °C, providing the desired product 4.31  in an excellent 92% yield with >95:5 dr.  
 
12
The synthesis started with a Suzuki coupling of vinylboronic acid 4.24 and vinyl iodide 4.25, 
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a) Pd(PPh3)4, Tl2CO3, THF-H2O (3/1), 23 °C, 60%. b) KHMDS, THF; Davis' oxaziridine, 73%. c) TBDPSCl, imi, DMF,
DMAP, ~90%. d) i-PrMgCl, Me(OMe)NH.HCl, THF, -20 °C, 83%. e) 4.29, THF, -90 °C, 84%. f) MeAlCl2 (0.6 eq),
CH2Cl2, -78 °C, 15 min, 92%, >95:5 dr. g) Tebbe reagent, THF-toluene (1/1), -40 °C to 23 °C, 69%. h) HCl/MeOH. i)
Dess-martin periodinane, 89% over 2 steps. j) K2CO3, MeOH/THF, 15 h, 100%. k) NaClO2, NaH2PO4. l) TMS-CHN2,
85% over 2 steps. m) NBSH, Et3N, CH2Cl2, 23 °C, 68% (and 10% recovered 4.35).  
Scheme 4.9. Roush’s racemic synthesis of the cis-decalin unit of integramycin. 
 
To complete the synthesis, cis-decalin 4.31 was treated with Tebbe reagent to furnish olefin 
4.32 in a 69% yield. The TBS ether of 4.32 was removed under acidic conditions, and the 
resulting alcohol was oxidized to an aldehyde which has an incorrect stereocenter at the α-carbon 
(4.33). The α-carbon stereocenter was then epimerized under basic conditions to afford the 
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desired stereochemical configuration. The resulting aldehyde 4.34 was converted to methyl ester 
4.35 over two steps in 85% yield. Finally, the exo-cyclic olefin of 4.35 was reduced to a methyl 
group and gave the cis-decalin unit of integramycin 4.36 to complete the synthesis. Roush’s 
sequence took 13 linear steps and provided ~9% overall yield. This is the only integramycin 
related synthesis reported to date other than our published synthesis of the C16-C35 fragment of 
integramycin as introduced in Chapter 3.  
 
 
4.1.4 Retrosynthetic analysis 
 As summarized above, both oxy-Cope rearrangements and IMDA’s are viable choices to 
synthesize the cis-decalin unit of integramycin, and an IMDA seems to be a relatively easier 
approach. Oikawa and Tokiwano proposed that the cis-decalin of 4.1 is an exo-adduct of an 
IMDA.13  However, a close examination revealed that this reaction is unlikely to produce the cis-
decalin product (Scheme 4.10). To yield the cis-decalin 4.1 with the correct stereocenters, a 
triene (4.37) needs to take an exo transition state and has the methyl and hydroxyl groups sit in 
pseudoaxial positions, which would be an unfavorable transition state (4.38). The endo transition 
state (4.39) with the two substituents sit in the pseudoequatorial positions will be more favorable, 
but it will afford the undesired trans-decalin 4.40. Therefore, it is unlikely to obtain 4.1 from 
triene 4.3 und in 
Roush’s report.12 
7. Unsuccessful attempts with trans-decalin as the major product can be fo
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uctions using dissolving metals, changing metal species, solvents, and 
temperature was reported to affect the trans- and cis-decalin product ratios.18  
 
Scheme 4.10. Predicted stereochemical outcomes of an IMDA of triene 4.37. 
 
 
 As an alternative, we anticipated that cis-decalin 4.1 could be generated through a reduction of 
α,β-unsaturated ester 4.41, which is an IMDA product of dienyne 4.42 (Scheme 4.11).  Because 
of the free hydroxyl group, it was expected that a reduction of 4.41 would have a formal hydride 
delivered from the hydroxyl side to afford a cis-decalin.14  Many α,β-unsaturated ester reducing 
reagents that can chelate to a hydroxyl group are available, such as CuH15 and Crabtree’s 
catalyst16 in the presence of H2. Dissolving metals and SmI217 are additional available choices. 
Moreover, in red
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Scheme 4.11. Retrosynthetic analysis of the cis-decalin unit of integramycin. 
 
 
 α,β-Unsaturated ester 4.41 can be prepared using an intramolecular Diels-Alder reaction o
dienyne 4 ne into a 
iene, including IMDA’s under thermal conditions or catalyzed by Lewis acids6 and 
ycloadditions using transition metal catalysts.19 For example, Trost found that the IMDA of 
d
f 
.42 (Scheme 4.11). Many methods have been established to cyclize a dieny
d
c
ienyne 4.47 provided a mixture of products with various ratios depending on the protecting 
group on the alcohol and the reaction conditions (Scheme 4.12).20 IMDA of 4.47 with R = TMS 
under thermal conditions provided 4.48 as the only product (entry 1), while the same substrate 
solely afforded 4.50 under Lewis acid catalyzed conditions (entry 2). When R = TBDMS, 
EtAlCl2 (1.1 eq) catalyzed IMDA furnished 4.49 as the only product (entry 3). When R = MOM, 
a mixture of products was obtained with ratios dependant on the reaction temperature (entries 
4&5).  
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CO2Et
OR OR
H
CO2Et OR
H
CO2Et
H
O
O
      entry                 R                       Lewis acid              T                      product               yield
         1                  TMS                           -                    170 °C                  only 4.48           75%
         2                  TMS                1.1 eq of EtAlCl2      25 °C                    only 4.50           30%
         3                  TBDMS           1.1 eq of Et2AlCl      25 °C                    only 4.49           80%
         4                  MOM                  2 eq of Et2AlCl      25 °C                     4:1:0                50%
         5                  MOM                  2 eq of Et2AlCl        0 °C                     6:1:0                50%
4.48 4.49 4.50
+ +
4.47
 
Scheme 4.12. Trost’s IMDA of triene 4.47. 
 
The dienyne 4.42 can be generated from a Suzuki coupling reaction of alkenylboronic acid 
4.
4.2 Results 
22
e 4.13). The epoxide 4.46 was opened with acetylide 4.51 in the 
presence of BF3·Et2O23 and the resulting product was treated with K2CO3 in methanol to furnish 
epoxide 4.52. Epoxide 4.52 was opened again with allenylmagnesium bromide24 and the 
resulting alcohol was protected with a TBS ether to afford dialkyne 4.45.  
43 and vinyl iodide 4.44 (Scheme 4.11). Alkenylboronic acid 4.43 could be obtained via a 
sequence using a Sharpless asymmetric epoxidation as the key step. Iodide 4.44 is a known 
compound and can be synthesized using several protocols.21  
 
 
4.2.1 The synthesis of dienyne 4.42 
The synthesis of dienyne 4.42 started from known compound 4.46 which was prepared from a 
Sharpless epoxidation  of trans-butenol followed by an in situ derivatization with TsCl in 71% 
yield and 98% ee (Schem
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 Dialkyne 4.45 was subjected to hydroboration conditions with catecholborane and a catalytic 
amount of dicyclohexylborane25 followed by basic workup to give alkenylboronic acid 4.43. 
Suzuki coupling of 4.43 with iodide 4.44 was not as straightforward as expected and required 
extensive optimization. Initially, alkenylboronic acid 4.43 was isolated and then subjected to 
Suzuki coupling conditions following literature procedures.24,26  The reaction provided low yield 
especially on scales larger than 1 mmol. After extensive investigation, a one-pot protocol 
modified from Soderquist’s procedure27 4.45 
pleted, aqueous NaOH was added to the reaction mixture, followed by a mixture of 
palladium
 
 was adopted. After the hydroboration of dialkyne 
was com
 catalyst and iodide 4.44 in THF. Upon heating, the desired Suzuki coupling occurred 
and went to completion within 20 min at 62 °C, providing dienyne 4.53 in 60-70% yield (one-pot, 
two steps). Up to 6 mmol scale reactions were conducted without losing efficiency. 
Deoxygenating the solvents was found to be important for high yields.  
 
O SiEt3
TsO
O
SiEt3Me2Al
1) Et2O/tol, BF3.Et2O,  -78 °C,
2) K2CO3, MeOH
MgBr
•
OTBS SiEt3
2) TBSOTf, 2,6-lutidine, CH2Cl2
(HO) B
 c-Hex2BH, rt
2
OTBS
Et3Si I
 Pd(PPh3)4 (8mol%), NaOH, 
2 THF/H O (5:1), 62°C
OTBS
Et Si3 1) TBAF, THF
3) n-BuLi; ClCOOMe
OTBS
MeO C2
76% over 2 steps
1) Et2O, -78 °C,
OH
OH
2) TBSCl, imi, CH2Cl2
TBSO
91% over 2 steps
1)Catecholborane, THF
(4.51)
4.52
(4.44)
4.46
4.42
4.45 4.43
4.53
2) NaOH, H O
Scheme 4.13. The synthesis of dienyne 4.42.  
2
66%
79% over 3 steps
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The TES group on alkyne 4.53 has executed its masking role and needed to be removed. 
Treatment of 4.53 with a slight excess of TBAF in THF achieved the deprotection of the TES 
group with minimal effect on the secondary TBS ether. To mask the primary alcohol of 4.53, we 
have examined several protective groups such as TBS, TES, and methyl carboxylate. It appeared 
that TBS was the best choice which generated minimal side reaction in the following steps. 
Therefore, 4.53 was converted to a TBS ether using TBSCl. Finally, deprotonation of the 
resulting terminal alkyne with n-BuLi followed by treatment with methyl chloroformate gave the 
methyl ester 4.42 in 79% yield over 3 steps. The Diels-Alder reaction substrate 4.42 with the 
desired olefin geometry and two stereocenters was now synthesized enantioselectively through a 
9-step sequence in an efficient ~36% overall yield.  
 
4.2.2 Cycloaddition of dienyne 4.42  
    With dienyne 4.42 in hand, our attention turned to one of the key steps—the intramolecular 
iels-Alder reaction. This reaction turned out to be very challenging and much effort was 
expended to obtain satisfactory diastereoselectivity. Initially, thermal conditions were tested, 
though the reaction did not occur in refluxing toluene. In refluxing p-cymene (160 °C) under 
slightly basic conditions, dienyne 4.42 underwent intramolecular Diels-Alder reaction, however, 
giving a 1:2 mixture of diastereomers  with the undesired 4.56 (determined by 2-D NMR study) 
as the major product (Table 4.1, entry 1). More than a dozen of Lewis acids were then examined 
seeking to get better selectivity. However, these reagents either did not promote Diels-Alder 
reactions or gave complex products (Table 4.1, entry 2).  
     We then turned our attention to cycloadditions catalyzed by transition metals. Wender et al.  
have used Ni or Rh catalyzed cycloadditions to generate decalins.28 The reaction conditions 
D
 179
us
d us in consideration that the IMDA under 
ermal conditions at 160 °C took 4 h, while using this Rh catalyst, the reaction only took less 
y of the catalyst allows many reaction conditions such as 
ing Ni(acac)2 were tested on dienyne 4.42 (Table 4.1, entry 3). The reaction gave a reversed 
ratio with the desired isomer 4.55 as the major product but along with many other inseparable 
side products.  
     We then investigated cycloadditions using [(naphthalene)Rh(cod)]SbF6 as the catalyst, which 
was also developed in the Wender group.19a This catalyst and its variants have been used by 
Wender and other groups in varieties of cycloadditions, and excellent reactivity and efficiency 
have been observed. Indeed, dienyne 4.42 underwent facile cycloaddition when treated with 5 
mol% [(naph)Rh(cod)]SbF6 in dichloroethane (DCE) at room temperature. The cycloaddition 
was complete in less than 1 h, albeit giving a dr of 1:1.7 still favoring the undesired product 4.56 
(entry 4). However, its amazing reactivity intereste
th
than 1 h at rt. The excellent reactivit
temperature and solvent to be changed. Because the diastereomeric ratio of the reaction is only 
~1:2, the energy difference between the two isomers and their transition states must be minimal 
and changing the reaction conditions may invert the ratio.  
The reaction temperature was indeed observed to have influence on the product ratio. When 
elevating the reaction temperature to 45 °C, a 1:3.4 mixture of products was obtained further 
favoring the undesired diastereomer 4.56 (Table 4.1, entry 5). By lowering the reaction 
temperature to 0 °C, a mixture of 1:1 ratio was obtained (Table 4.1, entry 6), and the reaction still 
appeared to be very clean.  
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HOTBS
OMeO
OTBS
MeO2C OTBS
OMeO
H
+
1:2
i
AlEt3, 50 °C, 20 h
Promising but 
complex products
p-cymene, TEA, 160 °C, 4 h
3 2 4 2 4 3 4 complex products
Ni(acac)2, P(O- C3HF6)3, 
BF .Et O, TiCl , ZnCl , SnCl , AlCl , LiClO  ... No reaction or
Entry
1
Conditions Product (4.55:4.56)
2
3
4.55 desired 4.56 undesired
TBSO TBSO TBSO
4.42
4           [(naph)Rh(cod)]SbF6 (5 mol%)       DCE, 25 °C, <1 h                1:1.7
6           [(naph)Rh(cod)]SbF6 (5 mol%)       DCE, 0 °C, 2 h                    1:1
6
% yield after purification by flash 
ch
5           [(naph)Rh(cod)]SbF6 (5 mol%)       DCE, 45 °C, <15 min          1:3.4
7           [(naph)Rh(cod)]SbF6 (5 mol%)       DCE, -5 °C, 2 h                1.1:1
8           [(naph)Rh(cod)]SbF  (5 mol%)       DCE, -12 °C, 4 h              1.8:1 (60% yield)
9           [(naph)Rh(cod)]SbF6 (5 mol%)       acetone, -5 °C                    1:2
10         [(naph)Rh(cod)]SbF6 (5 mol%)       CH2Cl2, -5 °C                     1:1.8  
Table 4.1. Optimization of the diastereoselectivity of the IMDA of 4.42. 
 
  Further lowering the reaction temperature to -12 °C, the dr was improved to 1.8:1 and the 
desired product 4.55 was obtained in a satisfactory 60
romatography. Investigation of temperature-dr relationship revealed that at -15 °C, the reaction 
gave the best 2.1:1 dr favoring the desired 4.55 (Figure 4.1). When decreasing the reaction 
temperature to -18 °C and -24 °C, the dr went down to 2:1 and 1.3:1 respectively. Brief 
evaluation of other solvents such as acetone or CH2Cl2 did not improve the diastereoselectivity.  
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Figure 4.1. Temperature-dr relationship of the cycloaddition of 4.42. 
 
 
4.2.3 The challenge of reducing the α,β-unsaturated esters 
      Initially, eduction of 
.55 with SmI2 or CuH did not give any desired reaction even in refluxing THF. Reduction of 
4.
 reduction of α,β-unsaturated ester 4.55 was attempted (Scheme 4.14). R
4
55 with Li/NH3 produced the undesired trans-decalin product. It appeared that we needed to go 
back to the original design and synthesize ester 4.41, which has a free secondary hydroxyl group 
that can provide a hydroxyl-assisting effect. However, removing the TBS groups on 4.55 turned 
out to be troublesome. The substrate underwent facile isomerization/aromatization and gave 
complex products when treated with TBAF or acids.   
 
x
H
OTBS
OMeO
H
H
OTBS
OMeO
TBSO TBSO
SmI2; CuH; or Li/NH3
4.55  
Scheme 4.14. Unsuccessful reduction of 4.55.  
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 Eventually, α,β-Unsaturated ester 4.41 was synthesized using a sequence as shown in Scheme 
4.15. Dialkyne 4.57, which has a TES ether rather than a TBS ether, was subjected to 
hydroboration and Suzuki coupling reaction conditions to furnish dienyne 4.58. Dienyne 4.58 
was treated with TBAF in THF to remove both TES groups. Protection of the primary alcohol of 
the resulting product with a TBS ether and the secondary alcohol with a TMS ether provided 
4.59. Installation of a methyl ester onto alkyne 4.59 followed by a spontaneous removal of the 
TMS group upon acidic aqueous workup gave the desired ester 4.60. The cycloaddition of 4.60 
was sluggish, 0% yield of 
4.41.  
 
 requiring 10 mol% of [(naph)Rh(cod)]SbF6 catalyst and provided ~5
OTES
Et3Si
OH
OTES SiEt3 1) TBAF OTMS
TBSO
OH
2) TBSCl, imi, CH2Cl2
[(COD)Rh(naph)]SbF6, 10 mol%
DCE, -12 oC
~50%
H
OH
OMeO
TBSO
MeO C
TBSO
21) BuLi; ClCOOMe
4.57 4.58 4.59
4.60 4.41
2) H3O
 
Scheme 4.15. The synthesis of dienyne 4.41. 
 
 
    Many attempts were made to reduce the α,β-unsaturated ester 4.41. The substrate, however, 
proved to have unusually low reactivity (Table 4.2). In refluxing THF, 4.41 did not react with 
SmI2.17 Reaction conditions using Mg in refluxing MeOH29 did not provide reactivity either. Zn 
in refluxing acidic MeOH, which was successful in a reduction of a similar tetrasubstituted α,β-
unsaturated ester by Over lving metals such as Li 
3) TMSCl, imi, CH2Cl2
+
man,30 also failed to provide any reaction. Disso
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or Na in NH3 or NH3/THF yielded a trans-decalin. CuH in refluxing THF lead to the formation 
of complex products. Hydrogenation using Crabtree’s catalyst and H2 appeared to reduce the 
trisubstituted double bond.  
 
x
H
OH
OMeO
H
H
OH
OMeO
TBSO TBSO
4.41 4.1  
 
Entry Conditions Results 
1 SmI2/∆, Mg/MeOH/∆, or Zn/MeOH/H+/∆ No reaction 
2 Li/NH3 or Na/NH3 trans-Decalin 
3 CuH, ∆ Complex products 
4 Crabtree’s catalyst/H2
Reduced the 
trisubstituted double bond
 
Table 4.2. The challenge of reducing the α,β-unsaturated ester 4.41. 
 
 
4.2.4 Alternative approach to the cis-decalin 
After many unsuccessful attempts of reduction of α,β-unsaturated ester 4.41 and discovering 
its unusually low reactivity, we decided to bypass this difficulty by seeking alternatives such as 
an allylic rearrangement. Allylic rearrangements have been used by Corey in his synthesis of 
protosterol. A tetrasubstituted olefin 4.61 was transformed into a trisubstituted olefin 4.62 which 
could be manipulated more easily (Scheme 4.16).31a  
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OMOM
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H
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1)TsNHNH2, CH3NO2, 4 °C
2) 5% NaOAc-HOAc, 50 °C
78% H
 
Scheme 4.16. Allylic rearrangement in Corey’s synthesis of protosterol. 
 
A similar strategy has been used by Schreiber31b in the synthesis of dynemicin A and by 
McIntosh31c in his synthesis of the core of eunicellin. We envisioned that ester 4.55 ould be 
reduced into an allylic alcohol 4.63, which would undergo an allylic rearrangement to produce 
cis-deca  (Scheme 4.17). The exo-cyclic olefin of 4.64 can be transfor  a carbonyl 
functional up and
 
 c
lin 4.64 med into
 gro  eventually furnish 4.1.  
O O
H
OTBS
Me O
H
OTBS
H
H
OTBS
H
TBSO TBSO TBSO
4. 4.63 4.64
Scheme 4.17. Proposed synthesis of cis-decalin 4.64.  
 
To examine this idea, ester 4.55 was reduced with DIBAH to yield allylic alcohol 4.63 
4.63 to Myers’ reductive allylic transposition 
co
s integramycin—the cis-decalin 
construction was thus achieved.  
55
(Scheme 4.18). To our delight, upon subjecting 
nditions,32 desired cis-decalin 4.64 was obtained as the only diastereomer in 83% yield, 
through the diazene intermediate 4.65. The cis-decalin configuration has been confirmed by 2D-
NMR study of 4.67, generated from 4.66 after removing the TES group under acidic conditions. 
The NOESY spectrum of 4.67 shows a characteristic correlation between H-8 and H-16. (Figure 
4.2). One of the most challenging steps of the synthesis toward
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-78 oC, 95%
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Scheme 4.18. Synthesis of cis-decalin 4.64.  
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Figure 4.2. NOE correlation of cis-decalin 4.67. 
red and generates the cis-decalin.  
 
The allylic rearrangement proceeded with excellent diastereoselectivity. The proposed 
explanation is shown in Figure 4.3. The cyclohexadiene ring of the diazene intermediate 4.65 
exists in a puckered transition state like a half-opened book. Approaching of the diazene to the 
double bond from the top face (the convex face) is hindered. Moreover, when approaching from 
the top face, the diazene comes to the vicinity of Me-37 and generate steric interactions with it. 
The bottom face is the concave face and there is no severe interaction between the diazene and 
Me-37. Thus this approach is favo
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Figure 4.3. Proposed transition states of the cis-decalin formation. 
 
With the success of syn
to access the same intermediate in fewer steps. Dieneallene 4.69 was prepared through a two-step 
sequence from 4.54 (Scheme 4.19).33 Though 4.69 underwent facile cycloaddition, the reaction 
gave a product that was consistent with trans-decalin 4.70, presumably through the transition 
state of 6.71. This reaction can be taken to support our previous assump ion that a triene 
substrate 4.37 would not generate a cis-decalin via a Diels-Alder reaction.  
thesizing 4.64 through an allylic rearrangement, we then sought ways 
t
SO2NHNH2
H
OTBS
H
TBSO
Rh[COD][naph]SbF6 (5 mol%)
DCE, -5 oC
OTBS
TBSO
•
BuLi; (CH2O)nOTBS
TBSO
HOH2C OTBS NO2
TBSO PPh3, 
DIAD, 
THF4.54 4.68
4.69 4.70  
Me Me
OTBS
H
H
•
TBSO
MeMe
OTBSHH
•
TBSO
Undesired, major Desired
H
OTBS
H
TBSO
H
TBSO OTBS
H
4.71 4.72
 
Scheme 4.19. Cycloaddition of dienallene 4.70. 
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4.4.5 Attempts to functionalize the exo-cyclic olefin of 4.64  
      With cis-decalin 4.64 in hand, it seemed that the completion of the cis-decalin unit of 
integramycin could be completed in a straightforward manner. As shown in Scheme 4.20, 
selective hydroboration of the exo-cyclic olefin of 4.64 followed by oxidation of the resulting 
alcohol to an aldehyde (4.73) was expected to furnish the carbonyl functional group and the last 
stereocenter. If necessary, the carbon center next to the carbonyl can be epimerized to give the 
desired stereochemistry. Aldehyde 4.73 could be transformed into 4.1 after oxidation and ester 
formation.  
H
H
OTBS
OMeO
TBSO
4.1
H
OTBS
H
TBSO
∗
H
H
TBSO
H O
1) hydroboration OTBS
2) [O]
4.734.64  
Scheme 4.20. Proposed transformation of 4.64 to 4.1. 
 
   There are several methods in the literature that can selectively hydroborate an 1,1-
disubstituted olefin in the presence of a trisubstituted olefin. The first conditions we tested were 
hydroboration of 4.64 using 9-BBN or disiamylborane at room temperature.34  Surprisingly, no 
reaction was observed. Upon heating, the product obtained still contains the exo-cycli in, 
with the trisubstituted double bond being more reactive and undergoing hydroboration.  
 Many researchers have demonstrated selective hydroborations using catecholborane catalyzed 
by transition metal catalysts.35 For example, Evans and co-workers have shown that diene 4.74 
underwent selective hydroboration with catecholborane in the presence of Wilkinson’s catalyst 
to afford alcohol 4.75 (Scheme 4.21).35a The Evan’s conditions were tested on 4.64, however, 
c olef
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provided no reaction even upon heating. Hydroboration of 4.64 with BH3·THF also failed. A diol 
was generated without showing any selectivity. 
OH
1.1 eq of catecholborane
2% Rh(PPh ) Cl
           80%
3 3
4.74 4.75 · 
Scheme 4.21. Evan’s selective hydroboration.  
 
n of the low reactivity of the exo-cyclic olefin of 4.64, after careful analysis, could 
be that the exo-cyclic olefin is buried in between the Me-37 group and the cyclohexane ring 
(Figure 4.4). Setting up stereocenters in this crowded environment can be very challenging.  
 
 The reaso
OTBS
Me
H
TBSO
H 37  
Figure 4.4. Possible conformation of cis-decalin 4.64. 
 
      Knowing that the exo-cyclic olefin is actually less reactive than the internal trisubstituted 
ol
4.1 (Scheme 4.22).  
 
efin, we sought a strategy that can protect the internal olefin, after which the exo-cyclic olefin 
could be manipulated. For example, after protecting the internal olefin, the exo-cyclic olefin can 
be converted into an alcohol and thereafter a mesylate (4.80). Mesylate 4.80 would allow a 
displacement reaction with NaCN to provide cyanide 4.81, which is synthetically equivalent to 
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Scheme 4.22. Proposed cyanide formation. 
 
     Both electronically and sterically, the interna isubstituted olefin should be more reactive 
to
tone 
.77 in 73% yield. The epoxide has executed its masking function and was reduced back to an 
olefin using zinc metal36 to provide 4.78 in 81% yield at 74% conversion. The ketone (4.78) was 
then reduced to its corresponding alcohol 4.79 with LAH in 92% yield. 
 
 
l tr
wards epoxidation conditions than the exo-cyclic olefin. 4.64 was treated with mCPBA at 0 °C 
and the reaction indeed gave epoxide 4.76 as the only product, even when excess mCPBA was 
used (Scheme 4.23). Epoxide 4.76 was subjected to ozonolysis conditions36 and provided ke
4
H H
OTBS
TBSO
O
H H
OTBS
TBSO
O
H
H
OTBS O3, CH2Cl2/MeOH, -78 oC;
Me2S    
  73%
mCPBA, CH2Cl2
TBSO 0 C, 90%o
Zn, NaI, NaOAc,
CH2Cl2, 81%
4.64 4.76
H H
TBSO
O
O
OTBS
4.77 4.78
 LAH, -60 oC
H H
OTBS
TBSO
OH
H H
OTBS
TBSO
OMs
MsCl
Et3N
92%
elimination
4.79 4.80
                                  Scheme 4.23.  Functionalization of the exo-cyclic olefin of 4.64.
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      When alcohol 4.79 was treated with MsCl or TsCl in the presence of a base, mesylate or 
sylate formation occurred but followed by an in situ elimination that resulted in a diene 
formation. Attempts to con ey-Chaykovski reaction37 
lead to olefin isomerization and generated an 2I38a, LiCH2Br38b, or 
CH2I2/Sm38c onto the carbonyl also failed because of deprotonation under basic conditions to 
      The study directed towards the synthesis of the cis-decalin unit of integramycin has yielded 
several successes. cis-Decalin 4.64 has been prepared through a 12-step sequence in 15% overall 
yield. The highlights of the sequence include an efficient preparation of the dienyne substrate 
starting from a Sharpless asymmetric epoxidation, a rhodium-catalyzed cycloaddition whose 
diastereo-selectivity can be modified by changing the reaction temperature and solvent, and an 
allylic rearrangement that established the cis-decalin structure.  
     The functionalization of the exo-cyclic olefin of 4.64 proved to be difficult. Selective 
hydroboration of the exo-cyclic olefin under various conditions was not successful. Alternative 
attempts to establish a carbonyl functional group using alcohol 4.79 or ketone 4.78 were also 
unsuccessful. The results suggest that functionalizing the hindered exo-cyclic olefin using 
intermolecular reactions may be difficult. As an alternative, an intramolecular reaction can be 
to
vert ketone 4.78 into an epoxide using Cor
 enone. Addition of LiCH
generate enone products.       
 
 
 
4.3 Summary and project perspectives  
 
 191
used which may  4.81 (Scheme  provide better reactivity towards the exo-cyclic olefin. Compound
4.24), which has one less carbon on the alcohol side chain than 4.64, may undergo chelate-
controlled hydrosilylation,39 hydrostannylation,40 or hydroboration13 to functionalize the exo-
cyclic olefin.  
 
H
OTBS
TESO
4.64' 4.81
H OH H
OTBS
H
Intramolecular
hydrosilylation...
 
Scheme 4.24. Functionalize the exo-cyclic olefin using intramolecular reactions. 
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4.5 Experimental  
ethyl-(3-oxiranylbut-1-yny
 
Tri l)silane (4.52) 
reac red for 15 min, and AlMe3 (2 M in toluene, 18.3 mL, 36.6 mmol) was 
4.4 0.6 mmol) in toluene (100 mL) was added, followed by BF3·Et2O (4.9 g, 34.5 mmol). 
rated sodium 
otassium tartrate (50 mL). The resulting mixture was warmed to room temperature and was 
irred until the emulsion was broken down. The organic layer was separated, and the aqueous 
yer was extracted with ether (3×). The organic layers were combined, washed with water and 
rine, then were dried over Na2SO4, filtered, and concentrated. The resulting residue was 
issolved in MeOH (250 mL). Anhydrous K2CO3 (10 g) was added. The reaction mixture was 
irred at rt for 20 min, diluted with ether (200 mL), and was filtered. The filtrate was 
oncentrated to remove most of the solvents. The resulting residue was dissolved in ether and 
ashed with saturated NH4Cl and brine, then dried over Na2SO4, filtered, and concentrated. The 
sulting residue was purified by flash chromatography (10→15→20% EtOAc in hexanes) to 
ive the desired product (3.3 g, 76% over 2 steps): [α]23D  +64.4º (c = 1.09, CH2Cl2); 1H NMR 
00 MHz, CDCl3) δ 2.82 (ddd, J = 2.5, 3.8, 6.3 Hz, 1H), 2.70 (dd, J = 3.8, 5.2 Hz, 1H), 2.62 (dd, 
= 2.6, 4.9 Hz, 1H), 2.34 (app p, J = 6.8 Hz, 1H), 1.24 (d, J = 6.9 Hz, 3H), 0.93 (t, J = 7.8 Hz, 
H), 0.49 (q, J = 7.8 Hz, 6H);  13C NMR (75 MHz, CDCl3) δ 107.2, 83.7, 54.8, 46.1, 30.3, 18.2, 
-1.  
Butyllithium (1.6 M in hexane, 21.6 mL, 34.5 mmol) was added to a stirring 
solution of triethylsilylacetylene (5 g, 34.5 mmol) in Et2O (100 mL) at -78 °C. The 
tion mixture was stir
O SiEt3
added. The resulting mixture was stirred at -40 °C for 1 h, then was cooled to -78 °C. Epoxide 
6 (5 g, 2
The reaction mixture was stirred at -78 °C for 1.5 h, and was quenched with satu
p
st
la
b
d
st
c
w
re
g
(3
J 
9
7.4, 4.5; IR (neat) 939, 1013, 1458, 2161, 2872 cm
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4-(tert-Butyldimethylsilyloxy)-3-methyl-1-triethylsilyl-octa-1,7-diyne (4.45) 
To a solution of epoxide 4.52 (3.3 g, 15.7 mmol) in ether (150 mL) at -78 °C 
 M in ether, 25 mL, 50 mmol). The 
tu
saturated sodi
O T BS S iE t3
was added allenylmagnesium bromide (2
reaction mix re was stirred at -78 °C for 5 min, warmed to 0 °C for 1 h, then was quenched with 
um potassium tartrate (20 mL). The resulting mixture was stirred until the cloudy 
emulsion separated into two layers. The organic layer was separated, and the aqueous layer was 
extracted with ether (3×). The organic layers were combined, washed with water and brine, then 
were dried over Na2SO4, filtered, and concentrated. The resulting residue was dissolved in 
CH2Cl2 (50 mL) and the resultant solution was cooled to 0 °C. 2,6-Lutidine (3.3 mL, 28.3 mmol) 
was added, followed by TBSOTf (4 mL, 17.3 mmol) dropwise. The reaction mixture was stirred 
at rt for 1.5 h then was quenched with saturated NH4Cl (10 mL) and water (10 mL). The organic 
layer was separated and the aqueous layer was extracted with CH2Cl2 (3×). The organic layers 
were combined, washed with water and brine, then were dried over Na2SO4, filtered, and 
concentrated. The resulting residue was purified by flash chromatography (2→4→5% EtOAc in 
hexanes) to give the desired product (5.2 g, 91% over 2 steps): [α]23D  +34.6º (c = 1.74, CH2Cl2); 
1H NMR (300 MHz, CDCl3) δ 3.65 (dt, J = 3.6, 6.5 Hz, 1H), 2.51 (app p, J = 6.3 Hz, 1H), 2.24-
2.35 (m, 2H), 1.91 (t, J = 2.6 Hz, 1H), 1.89-2.00 (m, 1H), 1.69-1.79 (m, 1H), 1.13 (d, J = 7.0 Hz, 
3H), 0.99 (t, J = 7.4 Hz, 9H), 0.90 (s, 9H), 0.53 (q, J = 7.8 Hz, 6H), 0.08 (s, 6H);  13C NMR (75 
MHz, CDCl3) δ 110.3, 84.6, 83.3, 73.9, 68.5, 33.7, 33.1, 26.0, 18.3, 17.7, 14.2, 7.7, 14.2, 7.7, 
4.8, -4.7; IR (neat) 1082, 1249, 1429, 2165, 2953 cm-1; HRMS-EI (m/z) calcd for C19H35OSi [M 
– C2H5]+ 335.2226, found 335.2233. 
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5,13-Bis-(tert-butyldimethylsilyloxy)-4,10-dimethyltrideca-8,10-dien-2-ynoic acid methyl 
ted NH4Cl (1 mL) and water (1 mL). The organic layer was 
parated and the aqueous layer was extracted with CH2Cl2 (3×). The organic layers were 
combined, washed with water and brine, then were dried over Na2SO4, filtered, and concentrated. 
ester (4.42) 
To a solution of alkyne 4.45 (730 mg, 2 mmol) in THF (10 
mL) at rt were added catecholborane (288 mg, 2.4 mmol) and freshly made dicyclohexylborane 
(0.5 M in THF, 0.2 mL, 0.1 mmol). After 2 h, additional catecholborane (0.05 mL) and 
dicyclohexylborane (0.1 mL) were added. The reaction mixture was stirred for another 1 h, and a 
solution of NaOH (440 mg, 11 mmol) in water (degassed by bubbling with N2, 3 mL) was added 
dropwise. The reaction mixture was stirred for 5 min and a mixture of trans-4-iodo-pent-3-en-1-
ol (475 mg, 2.4 mmol), Pd(PPh3)3 (185 mg, 0.16 mmol), and degassed THF (4 mL) was added. 
The reaction mixture was heated to 62 °C over 5 min and was stirred at that temperature for 20 
min. The reaction mixture was cooled to rt then was quenched with water. The organic layer was 
separated and the aqueous layer was extracted with ether (3×). The organic layers were 
combined, washed with water and brine, then were dried over Na2SO4, filtered, and concentrated. 
The resulting residue was purified by flash chromatography (10→15% EtOAc in hexanes) to 
give the desired product 4.53, which was dissolved in THF (20 mL), and TBAF (391 mg, 1.5 
mmol) was added. The reaction mixture was stirred for 15 min and was quenched with water. 
The resulting mixture was extracted with ether (3×). The organic layers were combined, washed 
with water and brine, then were dried over Na2SO4, filtered, and concentrated. The resulting 
residue was dissolved in CH2Cl2 (10 mL), cooled to 0 °C, and  2,6-lutidine (0.58 mL, 5.0 mmol) 
and TBSOTf (0.52 mL, 2.25 mmol) were added successively. The reaction mixture was stirred 
for 1 h and was quenched with satura
OTBS
se
CO2Me
TBSO
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The resulting residue was purified by flash chromatography (0→4% EtOAc in hexanes) to give 
solved in THthe desired product, which was dis F (10 mL). To the resulting solution at -78 °C 
was added butyllithium (1.56 M in hexane, 2.3 mL, 3.7 mmol) dropwise. The reaction mixture 
was stirred at -78 °C for 10 min and methyl chloroformate (0.58 mL, 7.5 mmol) was added 
dropwise. The cold bath was removed and the reaction mixture was further stirred for 15 min. 
Saturated NH4Cl (1 mL) and water (1 mL) were added. The organic layer was separated and the 
aqueous layer was extracted with ether (3×). The organic layers were combined, washed with 
water and brine, then were dried over Na2SO4, filtered, and concentrated. The resulting residue 
was purified by flash chromatography (0→1→1.5% EtOAc in hexanes) to give the desired 
product (496 mg, 52% over 4 steps): [α]23D  +12.7º (c = 0.29, CH2Cl2); 1H NMR (300 MHz, 
CDCl3) δ 6.05 (d, J = 15.6 Hz, 1H), 5.51 (dt, J = 14.3, 6.9 Hz, 1H), 5.35 (t, J = 7.5 Hz, 1H), 3.76 
(s, 3H), 3.67-3.73 (m, 1H), 3.60 (t, J = 7.1 Hz, 2H), 2.65 (p, J =6.8 Hz, 1H), 2.33 (q, J = 7.0 Hz, 
2H), 2.02-2.21 (m, 2H), 1.74 (s, 3H), 1.70-1.82 (m, 1H), 1.56-1.66 (m, 1H), 1.19 (d, J = 7.1 Hz, 
3H), 0.91 (s, 9H), 0.90 (s, 9H), 0.09 (s, 3H), 0.08 (s, 3H), 0.06 (s, 6H); 13C NMR (75 MHz, 
CDCl3) δ 135.3, 127.4, 126.7, 91.9, 74.1, 63.1, 52.7, 34.7, 32.4, 32.3, 29.9, 28.2, 26.2, 26.1, 18.6, 
15.8, 12.8, -4.1, -4.3, -5.0; IR (neat)  829, 1098, 1254, 1719, 2234, 2917 cm-1; HRMS-ESI (m/z) 
calcd for C28H52O4Si2Na [M + Na]+ 531.3302, found 531.3266. 
 
7-(tert-Butyldimethylsilyloxy)-2-[2-(tert-butyldimethylsilyloxy)-ethyl]-3,8-dimethyl-
2,4a,5,6,7,8-hexahydronaphthalene-1-carboxylic acid methyl 
ester (4.55) 
To dienyne 4.42 (2.2 g, 4.3 mmol) in DCE (100 mL) at -12 °C was added [(COD)Rh(naph)]SbF6 
(124 mg, 0.2 mmol) in one portion. The reaction mixture was stirred at -12 °C for 1.5 h and 
H
OTBS
OMeO
TBSO
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additional catalyst (20 mg) was added. The reaction mixture was stirred for another 1 h then was 
concentrated. The resulting residue was purified by flash chromatography (long silica gel plug, 
2% EtOAc in hexanes) to give the desired product (1.3 g, ~60%): [α]23D  -35.0º (c = 0.40, 
CH2Cl2); 1H NMR (300 MHz, CDCl3) δ 5.31 (d, J = 3.3 Hz, 1H), 3.74 (s, 3H), 3.56 (dt, J = 5.5, 
11.0 Hz, 3H), 3.36-3.46 (m, 2H), 3.04 (d, J = 3.3 Hz, 1H), 2.45 (dd, J = 3.8, 11.5 Hz, 1H), 2.10-
2.20 (m, 1H), 1.86-2.01 (m, 2H), 1.70 (s, 3H), 1.45-1.60 (m, 2H), 1.08 (d, J = 6.6 Hz, 3H), 0.89 
(s, 18 H), 0.05-0.06 (m, 12H); 13C NMR (75 MHz, CDCl3) δ 172.4, 139.7, 131.6, 125.3, 124.5, 
74.5, 60.5, 51.5, 47.8, 42.2, 40.9, 36.6, 33.2, 32.3, 26.2, 26.1, 21.0, 18.3, 13.4, -4.1, -4.4, -5.0, -
5.1; IR (neat) 1245, 1728 cm-1; HRMS-ESI (m/z) calcd for C28H52O4Si2Na+ [M + Na]+ 531.3302, 
found 531.3325. 
 
3-(tert-Butyldimethylsilyloxy)-6-[2-(tert-Butyldimethylsilyloxy)ethyl]-4,7-dimethyl-5-
methylene-1,2,3,4,4a,5,6,8a-octahydronaphthalene (4.64) 
 To a solution of ester 4.55 (1.2 g, 2.4 mmol) in CH2
il layer separation occurred. The 
rganic layer was separated and the aqueous layer was extracted with CH2Cl2 (3×). The organic 
red, and 
g
was concentrated to give all .63.  
In another flask, to a soluti
Cl2 (50 mL) at -78 
°C was added DIBAH (1 M in hexanes, 10 mL, 10 mmol) dropwise. The 
reaction mixture was warmed to -20 °C over 2 h. Saturated sodium potassium tartrate (20 mL) 
was added slowly. The resulting emulsion was stirred at rt unt
H H
OTBSTBSO
o
layers were combined, washed with water and brine, then were dried over Na2SO4, filte
 residue was filtered through a short silica gel column. The filtrate 
ylic alcohol 4
concentrated. The resultin
on of PPh3 (810 mg, 3.1 mmol) in THF (45 mL) at -30 ° was added 
DIAD (0.57 mL, 2.8 mmol) dropwise. After 5 min, the above allylic alcohol 4.63 in THF (9 mL) 
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was added. After 10 min, NBSH (651 mg, 2.6 mmol) was added in one portion. The reaction 
mixture was stirred at -30 °C for 45 min, warmed to rt for 30 min, and was poured into a mixture 
of ether (30 mL) and water (30 mL). The organic layer was separated and the aqueous layer was 
extracted with ether (3×). The organic layers were combined, washed with water and brine, then 
were dried over Na2SO4, filtered, and concentrated. The residue was purified by flash 
chromatography (1→2% EtOAc in hexanes) to give the desired product (763 mg, 70% over 2 
steps): [α]23D  -14.8º (c = 1.28, CH2Cl2); 1H NMR (300 MHz, CDCl3) δ 5.40 (dd, J = 1.5, 3.2 Hz, 
1H), 5.11 (s, 1H), 4.89 (s, 1H), 3.93 (dt, J = 4.7, 10.3 Hz, 1H), 3.63-3.70 (m, 1H), 3.49 (dt, J = 
4.8, 9.1 Hz, 1H), 2.78 (s, 1H), 2.56 (t, J = 4.6 Hz, 1H), 2.07-2.17 (m, 2H), 1.84-1.91 (m, 2H), 
1.72-1.82 (m, 1H), 1.69 (s, 3H), 1.47-1.52 (m, 1H), 1.13 (d, J = 7.2 Hz, 3H), 1.05-1.15 (m, 1H), 
.80-0.90 (m, 1H), 0.91 (s, 9H), 0.90 (s, 9H), 0.09 (s, 3H), 0.07 (s, 3H), 0.06 (s, 6H);  13C NMR 
, 31.0, 
33, 1074, 1254, 1466, 2851 cm-1; 
f
 
z, 3H), 1.00-1.12 (m, 1H), 0.99 (s, 9H), 0.07 (s, 
0
(75 MHz, CDCl3) δ 145.5, 135.6, 128.5, 109.2, 71.4, 60.6, 48.2, 44.3, 43.7, 42.0, 36.9
26.24, 26.19, 21.8, 15.8, -3.7, -4.3, -4.9; IR (neat) 767, 8
HRMS-EI (m/z) calcd or C27H52O2Si2 [M+] 464.3506, found 464.3498. 
7-[2-(tert-Butyldimethylsilyloxy)ethyl]-1,6-dimethyl-8-methylene-1,2,3,4,4a,7,8,8a-
octahydro-naphthalen-2-ol (4.67) 
1H NMR (300 MHz, C6D6) δ 5.30 (d, J = 4.9 Hz, 1H), 5.14 (s, 1H), 4.84 
(s, 1H), 3.72-3.80 (m, 2H), 3.56 (td, J = 4.9, 9.3 Hz, 1H), 2.70 (d, J = 3.8 
Hz, 1H), 2.37 (t, J = 4.5 Hz, 1H), 2.10-2.20 (m, 1H), 1.75-1.95 (m, 3H), 1.62 (s, 3H), 1.50-1.54 
(m, 1H), 1.25-1.40 (m, 2H), 1.18 (d, J = 7.1 H
H
OH
H
TBSO
3H), 0.06 (s, 3H);  13C NMR (75 MHz, CDCl3) δ 145.0, 135.8, 128.2, 109.4, 70.9, 60.5, 48.1, 
44.3, 43.6, 42.1, 30.9, 29.9, 27.8, 26.2, 21.8, 15.1, -5.0.  
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6-(tert-Butyldimethylsilyloxy)-3-[2-(tert-butyldimethylsilyloxy)ethyl]-2,5-dimethyl-4-
methylenedecahydronaphthalen-2-ol (4.76) 
 To diene 4.64 (400 mg, 0.86 mmol) in CH2Cl2 (20 mL) at 0 °C was 
added mCPBA (300 mg, ~1.7 mmol). The reaction mixture was stirred 
at 0 °C for 65 min, and was purified using a short silica gel column (eluting with 0→5→8→10% 
EtOAc in hexanes). The fractions of the filtrate containing the product were combined and 
concentrated to give the desired product (370 mg, 90%): [α]23D -1.3º (c = 0.77, CH2Cl2); 1H 
NMR (300 MHz, CDCl3) δ 5.03 (s, 1H), 4.89 (s, 1H), 3.76-3.88 (m, 2H), 3.61-3.70 (m, 1H), 2.92 
(d, J = 5.5 Hz, 1H), 2.42 (d, J = 8.9 Hz, 1H), 2.36 (t, J = 5.6 Hz, 1H), 1.84-2.11 (m, 4H), 1.41-
1.71 (m, 4H), 1.34 (s, 3H), 1.18-1.30 (m, 2H), 1.02 (d, J = 7.1 Hz, 3H), 0.89 (s, 9H), 0.88 (s, 
9H), 0.04-0.06 (m, 12H);  13C NMR (75 MHz, CDCl3) δ  142.0, 111.8, 71.4, 64.2, 63.5, 62.6, 
48.0, 45.4, 42.8, 40.5, 39.1, 36.3, 29.8, 26.2, 26.1, 22.5, 21.5, 18.5, 18.3, 15.2, -3.8, -4.4, -5.0, -
5.1; IR (neat) 829, 1074, 1254, 1470, 2855, 2929, 2958 cm-1; HRMS-EI (m/z) calcd for 
C27H52O3Si2 [M+] 480.3455, found 480.3434. 
 
5-(tert-Butyldimethylsilyloxy)-2-[2-(tert-Butyldimethylsilyloxy)-ethyl]-1a,4-dimethy
octahydro-1-oxacyclopropa[a]naph
l-
thalen-3-one (4.77) 
73%): [α]23D +13.8º (c = 1.03, CH2Cl2); 
To a solution of olefin 4.76 (130 mg, 0.27 mmol) in CH2Cl2 (10 mL) and 
MeOH (0.33 mL) at -78 °C was introduced O3 until a blue color showed 
up and sustained. The reaction mixture was further stirred for 3 min, and Me2S (1 mL) was 
added. The reaction mixture was warmed to rt and stirred at rt for 1 h. The reaction mixture was 
concentrated and the resulting residue was purified by flash chromatography (4→6→10% 
EtOAc in hexanes) to give the desired product (95 mg, 
H H
OTBSTBSO
O
H H
OTBSTBSO
O
O
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1H NMR (300 MHz, CDCl3) δ 3.90 (dt, J = 4.4, 10.0 Hz, 1H), 3.73 (ddd, J = 3.9, 5.8, 
1H), 3.54 (dt, J = 4.3, 9.7 Hz, 1H), 3.13 (d, J = 5.6 Hz, 1H), 2.96 (dd, 
9.9 Hz, 
J = 4.2, 6.9 Hz, 1H), 2.83 
)
2H), 1.41 (s, 3H), 1.12-1
with 2→8% EtOAc in hexanes to give the desired 
roduct (46 mg, 81% yield at 74% conversion) and unreacted starting material (21 mg): [α]23D  -
7, 10.4 
-2.46 (m, 1H), 1.73 (s, 3H), 1.63-2.00 
 
9H), 0.11 (s, 3H), 0.07 (
(dd, J = 1.2, 8.8 Hz, 1H , 2.41-2.50 (m, 1H), 2.02-2.12 (m, 1H), 1.84-1.93 (m, 1H), 1.64-1.75 (m, 
.33 (m, 3H), 0.97 (d, J = 5.9 Hz, 3H), 0.87 (s, 18H), 0.00-0.07 (m, 12H);  
13C NMR (75 MHz, CDCl3) δ 209.7, 70.83, 66.6, 62.9, 61.4, 52.6, 51.0, 41.0, 40.1, 35.4, 27.7, 
26.1, 23.6, 24.1, 18.4, 18.3, 15.3, -4.0, -4.4, -5.1, -5.2; IR (neat) 829, 1074, 1098, 1254, 1466, 
1720, 2921 cm-1; HRMS-EI (m/z) calcd for C26H50O4Si2 [M+] 482.3248, found 482.3216. 
 
7-(tert-Butyldimethylsilyloxy)-2-[2-(tert-butyldimethylsilyloxy)-ethyl]-3,8-dimethyl-
4a,5,6,7,8,8a-hexahydro-2H-naphthalen-1-one (4.78) 
To a mixture of NaOAc (200 mg), NaI (600 mg), and Zn (400 mg) under 
Ar was added HOAc (1 mL). A solution of epoxide 4.77 (80 mg, 0.16 mmol) in CH2Cl2 (5 mL) 
was added to the above mixture. The reaction mixture was stirred vigorously for 3 h then was 
directly loaded onto silica gel column, eluting 
H H
OTBSTBSO
O
p
6.7º (c = 0.51, CH2Cl2); 1H NMR (300 MHz, CDCl3) δ 5.56-5.58 (m, 1H), 3.99 (dt, J = 4.
Hz, 1H), 3.56 (t, J = 7.4 Hz, 2H), 2.98-2.99 (m, 2H), 2.40
(m, 4H), 1.41-1.53 (m, 1H), 1.16-1.25 (m, 2H), 1.10 (d, J = 6.9 Hz, 3H), 0.89 (s, 9H), 0.88 (s, 
s, 3H), 0.04 (s, 6H);  13C NMR (75 MHz, CDCl3) δ 210.6, 135.4, 127.7, 
71.1, 61.3, 54.2, 42.7, 41.8, 36.2, 29.8, 29.5, 26.2, 21.5, 18.5, 18.3, 15.9, -3.9, -4.3, -5.0; IR 
(neat) 837, 1078, 1249, 1470, 1711 cm-1; HRMS-EI (m/z) calcd for C26H50O3Si2 [M+] 466.3299, 
found 466.3276. 
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7-(tert-Butyldimethylsilyloxy)-2-[2-(tert-Butyldimethylsilyloxy)-ethyl]-3,8-dimethyl-
1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-ol (4.79) 
To ketone 4.78 (39 mg, 0.08 mmol) in ether (3 mL) at -60 °C was added 
LAH (1 M in ether, 0.7 ml, 0.7 mmol). The reaction mixture was warmed 
to -20 °C over 2 h, and was quenched with water (three drops). The resulting mixture was 
directly loaded onto silica gel column, eluting with 2% EtOAc in hexanes to give the desired 
product (36 mg, 92%): [α]23D  -1.4º (c = 1.17, CH2Cl2); 1H NMR (300 MHz, CDCl3) δ 5.47-5.48 
, 1H), 4.23 (s, 1H), 3.95 (dt, J = 4.1, 10.1 Hz, 1H), 3.86-3.91 (m, 1H), 3.65 (t, J = 9.9 Hz, 1H), 
, 1.63 (s, 
H 1 (s, 3H), 0.10 (s, 
3H), 0.04 (s, 6H);  13C
75 MHz, CDCl3) δ 136.7, 134.3, 130.6, 128.0, 111.0, 83.0, 75.2, 66.2, 59.5, 
34.6, 33.5, 28.0, 26.3, 26.2, 18.4, 17.8, 15.5, 12.8, 7.8, 4.8, 4.5, -4.0, -4.2; IR (neat) 722, 771, 
(m
3.12 (d, J = 4.4 Hz, 1H), 1.85-2.15 (m, 4H), 1.77 (t, J = 5.5 Hz, 1H), 1.53-1.73 (m, 2H)
), 1.07 (d, J = 6.9 Hz, 3H), 0.92 (s, 9H), 0.90 (s, 9H),  0.13H), 1.21-1.29 (m, 2
 NMR (75 MHz, CDCl3) δ 131.5, 128.3, 73.6, 66.0, 63.0, 45.8, 43.4, 42.7, 
37.3, 36.3, 31.3, 29.9, 26.3, 26.1, 21.8, 18.4, 18.3, 15.9, -3.8, -4.4, -5.4, -5.5; IR (neat) 820, 1070, 
1254, 3489 cm-1; HRMS-ESI (m/z) calcd for C26H52O3Si2Na [M + Na]+ 491.3353, found 
491.3379. 
 
8-(tert-Butyldimethylsilyloxy)-3,9-dimethyl-11-triethylsilylundeca-2,4-dien-10-yn-1-ol 
[α]23D  +21.6º (c = 1.25, CH2Cl2); 1H NMR (300 MHz, CDCl3) 
δ 6.06 (d, J = 15.6 Hz, 1H), 5.66 (dt, J = 14.1, 6.9 Hz, 1H), 
5.55 (t, J = 6.9 Hz, 1H), 4.27 (d, J = 6.9 Hz, 2H), 3.57 (dd, J = 6.0, 10.4 Hz, 1H), 2.54 (p, J = 6.9 
Hz, 1H), 2.10-2.25 (m, 2H), 1.82-1.92 (m, 1H), 1.79 (s, 3H), 1.54-1.68 (m, 2H), 1.14 (d, J = 7.0 
Hz, 3H), 0.96 (t, J = 8.1 Hz, 9H), 0.90 (s, 9H), 0.53 (q, J = 8.1 Hz, 6H), 0.08 (s, 3H), 0.07 (s, 
3H);  13C NMR (
OTBS
HO
SiEt3
H H
OTBSTBSO
OH
 205
837, 1000, 1090, 1249, 1446, 2161, 2868, 2925 cm-1; HRMS-EI (m/z) calcd for C25H46O
H
Si2 [M – 
l
yldimethylsilyloxy)-4,10-dimethyl-12-triethylsilyloxydodeca-8,10-dien-2-ynoic 
acid methyl ester 
Cl3) 
δ 7
6.4 Hz, 2H), 3.75 (s, 3H), 3.66-3.
2O]+ 418.3087, found 418.3074. 
 
8-(tert-Butyldimethy silyloxy)-3,9-dimethylundeca-2,4-dien-10-yn-1-ol 
 [α]23D  +16.9º (c = 1.35, CH2Cl2); 1H NMR (300 MHz, CDCl3) δ 6.08 
(d, J = 15.6 Hz, 1H), 5.69 (td, J = 6.8, 14.0 Hz, 1H), 5.56 (t, J = 6.8 
Hz, 1H), 4.27 (d, J = 6.8 Hz, 2H), 3.60 (dd, J = 6.0, 10.2 Hz, 1H), 2.51 (dq, J = 2.3, 6.8 Hz, 1H), 
2.10-2.28 (m, 2H), 2.05 (d, J = 3.2 Hz, 1H), 1.77-1.87 (m, 1H), 1.80 (s, 3H), 1.56-1.65 (m, 2H), 
1.12 (d, J = 7.0 Hz, 3H), 0.88 (s, 9H), 0.09 (s, 3H), 0.08 (s, 3H);  13C NMR (75 MHz, CDCl3) δ 
136.5, 134.9, 130.3, 128.0, 86.9, 74.7, 69.9, 59.4, 34.2, 32.1, 28.0, 26.1, 18.3, 17.3, 12.7, -4.1, -
4.3; IR (neat) 767, 833, 1094, 1249, 1466, 2361, 2847, 2925, 3313 cm-1; HRMS-ESI (m/z) calcd 
for C19H34O2SiNa [M + Na]+ 345.2226, found 345.2220. 
 
5-(tert-But
OTBS
HO
OTBS COOMe
[α]23D  +24.0º (c = 0.87, CH2Cl2); 1H NMR (300 MHz, CDEt3SiO
 6.05 (d, J = 15.6 Hz, 1H), 5.5  (dt, J = 6.8, 14.0 Hz, 1H), 5.48 (t, J = 6.2 Hz, 1H), 4.28 (d, J = 
75 (m, 1H), 2.65 (p, J = 6.8 Hz, 1H), 2.10-2.22 (m, 2H), 1.73 (s, 
3H), 1.56-1.80 (m, 3H), 1.18 (d, J = 7.8 Hz, 3H), 0.94 (t, J = 7.9 Hz, 9H), 0.90 (s, 9H), 0.57 (q, J 
= 7.9 Hz, 6H), 0.08 (s, 3H), 0.07 (s, 3H);  13C NMR (75 MHz, CDCl3) δ 134.9, 134.5, 129.7, 
128.8, 91.8, 74.4, 74.1, 60.0, 52.7, 34.6, 32.5, 28.2, 26.1, 18.4, 15.9, 12.9, 7.0, 4.8, -4.0, -4.3; IR 
(neat) 1098, 1245, 1715, 2234, 2953 cm-1; HRMS-ESI (m/z) calcd for C27H50O4Si2Na [M + Na]+ 
517.3145, found 517.3145.  
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 7-(tert-Butyldimethylsilyloxy)-3,8-dimethyl-2-triethylsilyloxymethyl-2,4a,5,6,7,8-
hexahydronaphthalene-1-carboxylic acid methyl ester 
[α]23D  -60.9º (c = 0.59, CH2Cl2); 1H NMR (300 MHz, CDCl3) δ 5.41 (d, 
45-3.54 (m, 2H), 2.91 
4
1H),1.74 (s, 3H), 1.48-1.5
e-6-triethylsilyloxymethyl-
,2,3,4,4a,5,6,8a-octahydronaphthalene (4.64′) 
42 
(dd, J = 1 5 (s, 1H), 4.88 (s, 1H), 3.91-4.02 (m, 2H), 
 
J = 3.8 Hz, 1H), 3.71 (s, 3H), 3.64-3.70 (m, 1H), 3.
(d, J = 3.6 Hz, 1H), 2.1 -2.53 (m, 1H), 2.14-2.22 (m, 1H), 1.94-2.00 (m, 1H), 1.84-1.89 (m, 
6 (m, 1H), 1.14-1.28 (m, 2H), 1.08 (d, J = 7.1 Hz, 3H), 0.92 (t, J = 8.0 
Hz, 9H), 0.89 (s, 9H), 0.53 (q, J = 7.4 Hz, 6H), 0.06 (s, 3H), 0.05 (s, 3H); 13C NMR (75 MHz, 
CDCl3) δ 172.6, 141.7, 131.4, 125.6, 124.2, 77.9, 64.0, 51.4, 48.2, 47.5, 43.3, 37.0, 34.2, 26.3, 
21.6, 18.5, 13.7, 7.1, 4.7, -3.9, -4.3; IR (neat) cm-1; HRMS-EI (m/z) calcd for C26H47O4Si2 [M – 
CH3]+ 479.3013, found 479.2996. 
 
3-(tert-Butyldimethylsilyloxy)-4,7-dimethyl-5-methylen
1
 [α]23D -19.2º (c = 0.85, CH2Cl2); 1H NMR (300 MHz, CDCl3) δ 5.
.5, 2.9 Hz, 1H), 5.2
3.80 (dd, J = 7.4, 10.5 Hz, 1H), 2.71 (s, 1H), 2.58 (t, J = 4.7 Hz, 1H), 2.05-2.15 (m, 1H), 1.82-
1.91 (m, 1H), 1.68-1.80 (m, 1H), 1.72 (s, 3H), 1.42-1.53 (m, 1H), 1.20-1.30 (m, 2H), 1.14 (d, J = 
7.2 Hz, 3H), 0.95 (t, J = 7.7 Hz, 9H), 0.90 (s, 9H), 0.57 (q, J = 7.5 Hz, 6H), 0.09 (s, 3H), 0.07 (s, 
3H); 13C NMR (75 MHz, CDCl3) δ 144.5, 134.3, 129.2, 109.6, 71.5, 61.6, 49.8, 48.0, 43.7, 41.9, 
36.6, 29.9, 27.8, 26.2, 21.5, 18.4, 15.8, 7.1, 4.7, -3.8, -4.3; IR (neat) 767, 1078, 1249, 1458, 
2876, 2953 cm-1; HRMS-EI (m/z) calcd for C26H50O2Si2 [M+] 450.3349, found 450.3344. 
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APPENDIX 
 
Supporting information of Chapter 4: study towards the synthesis of the cis-
decalin unit of integramycin 
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